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Abstract 
During the last few decades, radiotherapy treatment delivery 
techniques have been developed into an extremely valuable modality for 
delivering high curative or palliative doses of ionising radiation for the 
treatment of cancer in a way that is safer and more accurate than ever before. 
However, one major hurdle with respect to the planning and delivery of 
radiotherapy is the preservation of normal tissue while still ensuring the 
effective targeting of tumour cells and eradication of tumours. Hence, the 
radiation dose delivery to the target is limited by the tolerance of non-
tumour cells to minimise toxicity to normal, healthy surrounding tissues. As 
a quality assurance tool, three dimensional (3D) polymer dosimeters were 
developed as part of the process of monitoring and improving dose delivery. 
Conceivably, one of the most significant developments in 3D dosimetry over 
the past decade was the introduction of the PRESAGE® dosimeter. The 
PRESAGE® dosimeter is a unique 3D radiochromic dosimeter with great 
potential for clinical applications. Although the majority of studies have 
focused on clinical applications of the PRESAGE® dosimeter, few studies 
have focused on the optimisation of the main components of the PRESAGE® 
dosimeter to suit specific dosimetric situations. 
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An emerging strategy to target tumours and enhance radiotherapy 
involves the utilisation of metal nanomaterials, such as gold nanoparticles 
(AuNPs). From a therapeutic perspective, free radicals generated by heavy 
metals such as gold when combined with low energy ionising radiation have 
been shown to enhance the effects of radiation. Although the idea of using 
metal nanoparticles to enhance the effects of radiation is gaining acceptance, 
one major limitation to date has been the lack of an independent dosimetric 
method that reveals the way in which the nanoparticles interact with ionising 
radiation and the 3D spatial dose distributions of the dose enhancement. 
Thus, there is an urgent need to develop an independent experimental 
approach to answer these questions. 
Therefore, this thesis had two major aims: (1) to carry out a series of 
PRESAGE® dosimeter component-specific investigation studies with an 
ultimate goal of developing a novel suite of formulations for different clinical 
applications, and (2) to develop and characterise novel 3D radiochromic 
dosimeters for nanoparticle-enhanced radiotherapy dosimetry. 
Results for the first aim show that the sensitivity, stability and 
radiological properties of the PRESAGE® dosimeter could be customised by 
using different concentrations or types of its typical component, or by the 
inclusion of novel chemical components in the dosimeter formulation. In 
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brief, a range of novel and optimised PRESAGE® dosimeters were fabricated 
as part of this research, which are expected to find  specific and general 
dosimetric applications. 
The second aim was achieved through the development of a novel 3D 
radiochromic dosimeter referred to as the Sensitivity-Modulated Advanced 
Radiation Therapy (SMART) dosimeter, which can be used as an 
independent method for nanoparticle-enhanced radiotherapy dosimetry and 
verification. This research represents the first documented experimental 
confirmation and 3D visualisation of the nanoparticle-enhanced radiotherapy 
effect, as demonstrated using AuNPs as an initial example. Furthermore, the 
SMART dosimeter provides a generalised approach for investigating the 
influence of nanomaterial composition, size, morphology and surface 
chemistry on metal nanoparticle-radiation interactions. Although AuNPs 
have been touted as the ideal radiation-enhancing candidates, studies with 
the SMART dosimeter have shown that cheap and non-toxic bismuth-based 
nanoparticles are promising alternatives for improving the efficacy of 
radiotherapy, and approximately double the deposited dose of radiation. 
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Chapter 1 
Background, Theory and Literature 
Review 
 
1.1 Overview  
This chapter contains an introduction and background to radiotherapy 
and basic radiation physics. It includes an examination of the production of 
X-rays by conventional clinical modalities, and an overview of common 3D 
dosimeters, including fundamental theory and clinical applications. This 
chapter also provides an introduction into applications of nanotechnology in 
radiotherapy. Some radiation interaction processes at an atomic level and the 
effects of these interactions on target materials are also discussed. 
Furthermore, an introduction to the properties of gold and bismuth 
nanoparticles as radiosensitisers is also provided. This chapter concludes 
with a description of the objectives and outline of this thesis.  
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1.2 Introduction to radiotherapy 
Malignant tumours continue to be the leading cause of mortality this 
century. A recent investigation by the International Agency for Research on 
Cancer (IARC) estimated that approximately 7.5 million deaths globally 
resulted from cancer, with approximately 13 million new cases being 
diagnosed per year [1]. In Australia, over 100,000 new cases of cancer are 
diagnosed each year [2].  Radiotherapy (or external beam radiotherapy) is 
currently one of the most common and effective treatment modalities for 
delivering high curative or palliative ionising radiation doses [3]. It is 
estimated that more than one-half of all cancer patients receive radiotherapy 
during the course of their treatment [4, 5]. Worldwide statistics show that 12.4 
million new cancer cases were diagnosed and 7.6 million deaths were 
reported from the disease in 2008 [6].  
Radiotherapy utilises ionising radiations and has been used for over 
100 years to treat a wide variety of cancer types [7]. When radiotherapy was 
first introduced, X-rays in the kilovoltage energy range were prescribed to 
treat cancerous tissues, but the low penetration of such radiations meant that 
they had limited effects on deep-seated tumours and delivered high doses 
(sometimes above the threshold) to the tissues they traversed on route to the 
tumour, leading to low skin sparing effects. To address these shortcomings, 
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major developments have been made, and within the last decade electron 
linear accelerators (LINAC) have been introduced, which can generate higher 
energy X-rays and electron beams in the megavoltage energy range for 
radiotherapy. These are now the most common sources of ionising radiations 
and have been replacing kilovoltage and orthovoltage X-rays for use in 
clinical centres to deliver most forms of radiotherapy. Furthermore, 
conventional two dimensional (2D) radiotherapy using simple rectangular 
fields based on plane X-ray imaging has largely been replaced by modern and 
complex three dimensional (3D) conformal radiotherapy techniques, 
resulting mainly from advances in imaging, computers and information 
technologies over the last few decades [1]. As a result, an improvement has 
been achieved in dose distribution and skin sparing by such high energy X-
rays and continues to improve the effectiveness of radiotherapy in treating 
cancer since an adequate dose can be delivered to tumours without 
producing acute reaction of the skin or the surrounding normal tissues. As 
well as producing X-rays, electron LINACs can also be used to generate high 
energy electron beams, which are useful for treating superficial cancers. They 
have therefore also replaced most of the kilovoltage X-rays for this 
application. In addition, with modern LINACs it is possible to perform 
sophisticated techniques such as stereotactic radiosurgery (SRS) and intensity 
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modulated radiotherapy (IMRT) and its successor, intensity-modulated arc 
therapy, which produce conformal dose to the tumours with high precision 
[1, 3]. Accurate delivery of the radiation dose to tumours can also be 
enhanced through the use of imaging equipment such as the ones used in 
Image-guided radiotherapy (IGRT) to better localise the tumours [8, 9]. Such 
technique is currently available in many radiotherapy centres While LINACs 
generating megavoltage X-rays are the most common modality employed 
today in modern radiotherapy centres, megavoltage gamma-rays from high 
radioactivity cobalt-60 sources or radioactive seeds such as iridium-192 are 
used in brachytherapy, which serves as an alternative modality in 
radiotherapy for the treatment and management of certain types of tumours 
[10].  
Other radiotherapy modalities, such as particle radiotherapy, are also 
finding their way to clinical application, most notably proton radiotherapy 
[11, 12] and treatments using heavy ion beams [13, 14]; however, due to their 
high installation and maintenance costs, they are currently less common. 
Particle radiotherapy provides better dose concentration at the tumour and 
has a proven role in the management of orbital tumours such as base of skull 
sarcomas as a result of the increased energy deposition toward the finite 
range of the beam in tissue (commonly known as the Bragg peak), which 
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allows a precise dose delivery. However, the selectivity of particle therapy 
can also cause adverse therapeutic complications in cases of accidental 
exposure of healthy tissues or in the case of incorrect dose delivery [6, 11-14] .   
1.3 Principles and applications of 3D dosimetry in radiotherapy 
Indeed, modern radiotherapy delivery techniques such as 3D 
conformal radiotherapy, IMRT, and SRS have been specifically developed 
with the ultimate goal of conforming the radiation dose in such a way that 
delivers maximum lethal dose to the target volume. This improves the 
therapeutic ratio and enables dose escalation in the target volume while 
minimising doses to organs at risk, hence reducing radiation-related 
complications [15, 16]. However, optimisation protocols for these complex 
treatment delivery techniques involve very steep dose gradients and are 
therefore, extremely sensitive to errors in treatment delivery. To minimise 
such errors, 3D dosimeters were developed as a relative method for 
improving dose monitoring and delivery [16]. Current 3D dosimeters can be 
broadly classified into either gel-based [17, 18] or non-gel-based dosimeters 
[19, 20]. Dose readout for 3D dosimeters  is determined by quantitatively 
measuring the change in the properties of the dosimeter (e.g., X-ray 
absorption, optical density changes/scattering or nuclear magnetic resonance) 
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when exposed to a radiation dose [16]. Therefore, each type of dosimeter has 
its own unique way of interacting with radiation and method of recording the 
radiation dose distribution in 3D compared to conventional ion chambers and 
film dosimeters, which are limited to point or planar measurements [15, 16]. 
In addition, the utilisation of 3D dosimetry has been extended to the 
validation of spatial distributions and elevated dose in nanoparticle-
enhanced radiotherapy via the recently introduced sensitivity modulated 
advanced radiation therapy (SMART) dosimeter [19]. 
3D dosimetry systems are true 3D dosimeters suitable for relative dose 
measurements. The dosimeter is at the same time a phantom that can 
measure absorbed dose distribution in a full 3D geometry. Some types of 
dosimeters are nearly tissue equivalent and can be molded to any desired 
shape or form. Research into 3D dosimeters has been dominated by two types 
of dosimeters according to the 3D matrix used (i.e., gel-based and non-gel-
based dosimeters). 
1.3.1 Gel-based dosimeters 
The idea of using a gel to measure radiation dose originated in the 
early 1950s [21, 22]. Significant developments in gel dosimeter were made 
throughout the 1980s [23] and in early 1990, new polymer gel formulations 
 7 
were proposed. Since then, polymer gel dosimeters have been applied in a 
number of preclinical applications in radiotherapy [24-26]. The development 
of polymer gel dosimeters has also been highly dependent on imaging 
systems in radiology, which have enabled gel dosimetry to be used in 
radiotherapy. There are different types of gel-based dosimeters available, but 
polymer gel systems are more prevalent than other types of gels (e.g., Fricke-
type gels). 
 The 3D matrix of gel-based dosimeters contain predominately water, 
with the remainder  being organic components, such as gelatin and 
polymerisable monomers [27]. Considering the number of different 
compositions of gels that have been investigated and the length of time over 
which these investigations have occurred, the fundamental chemical 
reactions and responses of the gels to ionising radiations are well understood. 
In general, for gel-based dosimeters, water is the main constituent; 
comprising > 90% of the gel’s mass. The chemical changes which occur in the 
gels resulting from ionising radiation are indirectly related to the radiolysis of 
water [27]. In this process, water molecules are dissociated into several highly 
reactive radicals and ions, such as hydrogen radical (H•) and hydroperoxy 
radicals (HO2•) [28]. These radicals and ions subsequently react with 
monomers resulting in their polymerisation. The decomposition of water to 
 8 
the reactive primary intermediate (R•) can be written as shown in equation (1-
1) [16]:  
 
 R2OH
Dk
2  
 
(1-1) 
H2O = water   
R• = reactive primary intermediate 
kD = dissociation rate  
  
Interaction of the primary radicals produced from the dissociation of 
water with the monomer leads to the polymerisation of the monomers [16]. 
The initiation process is represented in equation (1-2): 
    MRMR  
                 
(1-2)                                                                                              
R• = free radical  
M = monomer  
R-M• = initiating radical  
 
This initiation process leads to growth of the polymer by the chain 
propagation reaction represented in equation (1-3): 
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  M   (M)R   M+ MR nn                          (1-3)                                                    
 R-(M)n = Polymer      
M•  = monomer radical                                                 
 
The propagation reaction continues until termination occurs 
predominantly through radical combination or disproportionation [16, 29].  
The most common gelling agents investigated for gel-based dosimeters 
have been agarose, gelatin and polyvinyl alcohol (PVA) [30]. Gelatin is 
currently the most commonly used chemical for preparing gel-based 
dosimeters. Its main function is to provide a 3D matrix into which the 
polymers are formed and minimise their diffusion, therefore preserving the 
spatial integrity of the radiation dose distribution [30]. This is attributed to its 
optical clarity when compared with agarose, which is translucent in nature. 
This high optical clarity allows higher spatial resolution and dynamic range 
measurement. In addition, PVA has been a subject of a number of 
investigations as a potential 3D matrix material for gel-based dosimeters. 
These investigations were driven by the fact that PVA is a relatively inert 
polymer with high purity and low diffusion coefficients [30, 31]. However, 
one limitation of PVA is its high viscosity, which causes trapped air bubbles 
 10 
when preparing and handling the dosimeter, resulting in non-uniformities 
within the dosimeter. This increases the scattering coefficients, which are 
especially problematic for optical readouts [31]. As a result, PVA gels are no 
longer commonly used in 3D dosimetry [30, 31].  
1.3.1.1 Ferrous gel dosimeters 
In Fricke gels, the solution is an acidic oxygenated aqueous solution of 
ferrous ion (Fe2+), which undergoes oxidation from Fe2+  to ferric ions (Fe3+) 
upon exposure to radiation [16, 18]. When the solution is irradiated, water 
decomposition occurs leading to the formation of hydroperoxy radicals 
(HO2•). The hydroperoxyl radicals react with the ferrous ions, leading to their 
conversion to ferric ions [18]. The ferric ions have a different longitudinal (R1) 
nuclear magnetic relaxation rate than water. Therefore, the dose distribution 
can be derived from R1 images obtained by magnetic resonance imaging 
(MRI) [18]. Some of the limitations of Fricke gel systems are their low 
sensitivity to radiation dose and the continual post irradiation diffusion of 
ferrous and ferric ions, resulting in a blurred dose distribution [32, 33].  
1.3.1.2 Ferrous xylenol-orange gel dosimeters 
Radiochromic ferrous xylenol-orange (FX) gel dosimeters are based 
upon ferrous benzoic acid xylenol-orange (FBX) aqueous solutions [34]. FX 
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gels consist of a transparent gelatin matrix with the embedded metal ion 
indicator xylenol-orange (XO) and ferrous (Fe+2) ions [34]. XO is an organic 
reagent that has a nitrogen atom and short chain carboxylic groups [34]. 
Radiolysis of water occurs upon irradiation resulting in the production of free 
radicals and oxidising species that convert ferrous (Fe2+) ions into ferric (Fe3+) 
ions. When adding XO, it binds with Fe3+ forming a 1:1 coloured complex 
(XO–Fe3+) in the visible range of the spectrum that can be measured using 
optical imaging methods (i.e., spectrophotometry) [35] . In addition, this was 
found to increase the sensitivity and reproducible detection of ferric ions in 
Fricke gel dosimeters to radiation dose. Although FX gels showed great 
potential in 3D dosimetry as a result of their facile preparation and improved 
dose sensitivity, subtle variations in dose responses have been reported, 
which have been attributed to the chemical purity of XO [30]. In addition, it is 
known to suffer from rapid image deterioration due to a high diffusion rate 
after irradiation [36]. 
1.3.1.3 Radiochromic micelle gels 
Micelles can be defined as an aggregate of surfactant molecules 
dispersed in a liquid colloid. In general, surfactants consist of a hydrophilic 
head and hydrophobic tail. When dissolved in water above the critical micelle 
concentration, the surfactant molecules self-assemble to form aggregates, 
 12 
such as spherical micelles, in which the hydrophobic tails are shielded in the 
centre from the polar aqueous environment by the peripheral hydrophilic 
head groups [37, 38]. 
In radiochromic micelle gels, a colourless leuco dye is combined in a 
hydrogel matrix using a surfactant (Figure 1-1). The poor solubility of leuco 
dyes in aqueous systems requires that the dye is stabilised in the hydrophobic 
central region of the micelles. Upon exposure to radiation, free radicals 
generated from water radiolysis interact with the leuco dye molecules 
converting it to its oxidised coloured form. The leuce dye is also one of the 
main components of the PRESAGE® dosimeter as well [39] (vide infra); 
however, micelle gel dosimeters are composed predominantly from water 
and are therefore  more tissue-equivalent than the PRESAGE® dosimeter [37]. 
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Figure 1-1: Illustration of leuchomalachite green (LMG) and its chromatic form 
(malachite green) within a micelle before and after irradiation.   
  
The rationale of using micelles in gel dosimeters is to emulsify the 
mostly insoluble leuco dye, thereby distributing it uniformly throughout the 
3D gel dosimeter [37, 40]. In addition, micelles are significantly larger than 
individual molecules and thus, the emulsified leuco dye molecules would 
have low diffusivity compared to reporter molecules, as in the case where 
micelles are not added to gel dosimeters [41]. Consequently, micelle gel 
dosimeters have improved spatial stability compared with traditional 
dosimeters such as Fricke gel dosimeters [41]. 
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1.3.1.4 Radiochromic cross-linked gels 
Genipin, extracted from the fruits of Gardenia jasminoides Ellis, has been 
used widely in herbal medicine and is considered a natural cross-linker of 
gelatin [42]. Genipin forms molecular cross-links with the amino acids 
present in gelatin resulting in a blue radiochromic gel that bleaches with time 
after radiation. Radiochromic genipin gel dosimeters have a fast bleaching 
process that produces stable dose information with minimal diffusion. The 
dose readout is determined by quantifying the degree of bleaching (change in 
colour) using imaging modalities such as optical CT scanners without 
interference of vessel walls, and the gel response is uniform throughout 
allowing the potential for surface dosimetry as well [43]. As a result of the 
chemical simplicity of radiochromic genipin gel-based systems and the 
relatively small amount of organic materials added, one could consider this 
type of dosimeter a candidate for reference water equivalent dosimetry [30, 
43]. 
1.3.1.5 Polymer gel dosimeters 
The most common type of polymer gel is the polyacrylamide gel 
(PAG) introduced by Baldock et al. in 1998 [44], although there are also other 
types of polymer gels with different compositions [45, 46]. Many publications 
on different compositions and formulations of polymer gels are available [47, 
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48] and numerous studies have also been conducted on potential clinical 
applications of polymer gels, especially using normoxic-type gel dosimeters 
[16]. 
Polymer gels consist of monomers dissolved in a viscous matrix. Upon 
irradiation, a polymerisation reaction takes place resulting in cross-linking of 
the co-monomers to afford a random 3D cross-linked polymer network 
(Figure 1-2). For example, the copolymerisation of acrylamide and N,N’-
methylenebisacrylamide within a water-based gelatin matrix [49]. The degree 
of radiation-induced polymerisation is dose-dependent and the resulting 
cross-linked polymer network influences the mobility of the surrounding 
water molecules, thus affecting the transverse (R2) nuclear magnetic 
relaxation rates. Therefore, dose maps from polymer gels are constructed 
from MRI (R2) images [17, 50, 51]. In addition, the potential application of the 
optical CT system as an alternative imaging technique to MRI has also been 
demonstrated for polymer gel dosimeters [52]. One of the major 
advantageous of polymer gels over Fricke gels is their integrity in dose 
distribution [50], although it is worth noting that polymer gels are sensitive to 
atmospheric oxygen [53]. As a result, normoxic polymer gels were developed, 
which can be fabricated, stored and irradiated under normal atmospheric 
conditions [54].  
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Figure 1-2: Typical reaction between acrylamide and bis-acrylamide to form cross-
linked polyacrylamide. 
 
Polymer gels have some specific advantages over other types of 
radiation dosimeters; the most significant of these is their sensitivity to small  
(< 0.05 Gy) radiation dose, which makes them ideal in steep dose gradient 
dosimetry, such as IMRT and SRS [16]. The effects of foreign materials such 
as inhomogeneities and contrast agents can be easily quantified using 
polymer gels [16].  
1.3.2 Applications and limitations of gel-based dosimeters 
Gel-based dosimeters, in particular polymer gels, have been shown to 
be capable of basic dosimetry, including the measurement of dose 
distributions, determination of internal dosimetry, and evaluation of tissue 
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inhomogeneities for various clinical applications [16, 55]. The ability to record 
doses in 3D makes polymer gels a desirable dosimetric tool to measure and 
validate dose distribution obtained with modern conformal radiotherapy 
treatment [56]. In addition, the potential of using X-ray computed 
tomography or dose readout has been explored [57]. Polymer gel dosimeters 
have also been proven to be applicable for IMRT and SRS treatment 
verification and regular quality assurance [58-60]. Furthermore, polymer gels 
are also very useful for visualisation of steep dose gradients and dose 
distributions in high and low dose brachytherapy sources [60, 61].  
Polymer gels have also been successfully applied for measurement of 
3D dose distributions of proton beams [62, 63] and heavy ion beams [64], and 
boron neutron capture therapy to measure the increase in dose response in a 
PAG doped with boron as compared to an undoped PAG [65]. The 
applications of polymer gels have been extended to include the dosimetry of 
targeted radionuclide therapy using unsealed radionuclides, including 
iodine-131 [66, 67] and technetium-99 [68]. This extensive range of 
applications is attributed to the unique dosimetric properties of gel-based 
dosimeters in general; their sensitivity, stability, spatial integrity, temperature 
insensitivity, dose rate, energy independence and tissue equivalency [16]. 
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Nonetheless, gel-based dosimeters suffer from a number of limitations 
which must be taken into account every time they are employed. The process 
of preparing gel experiments are time consuming,  and the entire process of 
fabrication, irradiation, and scanning often  takes two days to complete [16]. 
Oxygen contamination is a significant issue and should also be considered 
when preparing any gel-based dosimeters. For example, precautions such as 
the use of well-sealed glass or Barex vials, and complicated experimental 
protocols must be followed in order to avoid any oxygen contamination. In 
addition, there are potential errors when using MRI for dose readout [55]  
related to reducibility [69] and physico-chemical effects, such as temperature 
history (pre, during and post irradiation), scanning parameters, and 
volumetric effects [55, 70]. Collectively, these potential errors increase 
uncertainty, and reduce the reliability of the results.  
However, probably the most unattractive feature of gel-based 
dosimeters is the need for a supporting container since they are not shape 
persistent (i.e., solid). This major limitation is not desirable when using 
optical imaging for dose readout as it increases refraction and reflection at the 
surface of the container and leads to significant artefacts that require optical 
modelling to minimise [15, 16]. This also advocates that gel-based dosimeters 
may not measure surface doses efficiently [16]. 
 19 
1.3.3 Solid-based dosimeters 
Unlike gel-based dosimeters, the 3D matrix of solid-based dosimeters 
is made of synthetic plastic resins, such as polyurethane. The plastic resins 
are formed from liquid precursors that solidify after a period of time as a 
result of step-growth polymerisation reactions (also called polymerisation), 
which involves the reaction between complementary functional groups, such 
as alcohols and isocyanates in the case of polyurethanes [71]. The most 
notable example of solid-based dosimeters is the PRESAGE® dosimeter [72, 
73]. 
1.3.3.1 The PRESAGE® dosimeter 
The PRESAGE® dosimeter is an optically clear, solid polyurethane 
matrix containing leuco dye (e.g., leucomalachite green (LMG)) as a reporter 
component and halocarbons (e.g., chloroform) as a radical source [72, 74]. 
Upon irradiation, free radicals are generated from the radiolysis of the radical 
initiator. These free radicals oxidise the leuco dye leading to a change in 
optical density (i.e., colour) (Figure 1-3), hence the name radiochromic 
dosimeter [72].  
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Figure 1-3: Photographs of two PRESAGE® dosimeters after irradiation. The areas 
surrounded by a dashed line represent the areas that were irradiated. 
 
1.3.3.1.1 Components of the PRESAGE® dosimeter  
The PRESAGE® dosimeter can be formulated using three well-
documented ingredients that include a transparent polyurethane plastic 
prepolymers mixture, leuco dye as a reporter, and a radical initiator/s as a 
source of radical species. Optionally, one or more ultraviolet (UV) stabilisers 
can be added to the formulation in order to minimise dosimeter damage from 
UV radiation. The solid PRESAGE® dosimeter can easily be made deformable 
by replacing the polyurethane plastic by a transparent polyurethane rubber, 
which would allow the dosimeter in cases where deformable registration is of 
interest [75].  
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As mentioned, the 3D matrix of the PRESAGE® dosimeter is composed 
of polyurethane resin doped with leuco dye and a radical initiator that cures 
to a solid block conformed to the shape of the mould used in the fabrication 
process. Polyurethanes are a class of materials known as reaction polymers 
such as polyesters and epoxies [71, 76]. The polyurethane precursors consist 
of two components, referred to as Parts A and B; Part A is an aliphatic 
diisocyanate and Part B is a polymer with hydroxyl functional groups (also 
referred to as polyol) [76]. The isocyanate group is highly reactive towards 
nucleophilic functional groups (e.g., hydroxyl groups) and this reaction is 
commonly used to prepare polyurethanes for a wide range of applications 
[77].  
In a typical polymerisation process, one isocyanate group of the 
diisocyanate reacts with the hydroxyl group of the polyol to form a urethane 
linkage (– NH-(C=O)-O) (Figure 1-4) [77, 78].  The polymerisation reaction is 
exothermic (produces heat) and the rate of curing is dependent on the 
temperature, concentration of reactive groups and the presence of a suitable 
catalyst [79]. 
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Figure 1-4: Typical reaction between polyols and diisocynates to form 
polyurethanes. 
 
The rational for using polyurethanes as a matrix for the PRESAGE® 
dosimeter is the fact that the polyurethane precursors can be mixed and 
polymerised at room temperature, whereas other potential materials (i.e., 
epoxides or polyesters) require higher curing temperatures (> 100 °C) that 
would oxidise the leuco dye prior to irradiation, rendering the dosimeter 
unusable [80, 81]. 
The fundamental function of polyurethane catalysts is to increase the 
polymerisation rate and extent, thus improving the structural integrity of the 
resin. There are a variety of commercial polyurethane catalysts that can be 
classified into two broad categories: (i) tertiary amine compounds, such as 
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triethylenediamine (TEDA) and dimethylethanolamine (DMEA); and (ii) 
metal compounds (organometallic complexes). The most commercially 
utilised metal compounds for manufacturing polyurethanes are tin-based 
compounds, such as dibutiltin dilaurate (DBTDL), which is considered the 
standard catalyst for the promotion of the reaction of an isocyanate with the 
active hydroxyl groups of a polyol [76, 82-84]. However, a wide range of 
metal compounds, including zinc, bismuth, cobalt and aluminium 
carboxylates, are also capable of efficiently catalysing the reaction [85, 86]. 
Since the introduction of the PRESAGE® dosimeter [73], the potential 
influence of adding such high atomic number (Z) metal compounds to the 
formulation of the dosimeter on the overall characteristics of the dosimeter 
have not previously been investigated. Nonetheless, a comprehensive 
investigation into the influence of some of the commercially available metal 
compounds on the sensitivity, curing rate, and radiological properties of the 
PRESAGE® dosimeter can be found in Chapter 5 of this thesis. 
Compounds that can produce radical species under explicit conditions 
and promote radical reactions are known as radical initiators [87]. These 
compounds generally possess weak/unstable covalent bonds with low bond 
dissociation energies [87]. The weak bond dissociation energies mean that 
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such compounds are easily cleaved under specific conditions (e.g., heat or 
radiation) leading to the production of free radical species [88]. Radical 
initiators are classified into three main classes: (i) azo compounds; (ii) organic 
peroxides, such as benzoyl peroxide; and (iii) halocarbons, such as 
chloroform. Each of these classes is also divided into subclasses [87]. All of 
these radical initiator classes have the potential of being used in the 
composition of the PRESAGE® dosimeter; however, both azo and organic 
peroxide compounds are inherently sensitive to elevated temperatures and 
are unstable. In comparison, halocarbons have been shown to give consistent 
results even with high energy radiation [81]. Halocarbons (or Halogenated 
carbons) are organic compounds containing covalently bonded carbon and 
halogens, such as chlorine (Cl), bromine (Br) or iodine (I). Upon irradiation of 
the dosimeter free radicals are generated from the homolysis of the bond 
between the carbon and the halogen. The number of free radicals produced is 
directly proportional to the C−X bond dissociation energy (X = Cl, Br, I) [74]. 
Leuco dyes are considered a class of chemicals that can obtain two 
distinct forms, one of which is colourless (Figure 1-5) [89]. There are a 
number of leuco dyes that are suitable for use as a reporter compound in the 
PRESAGE® dosimeter formulation, including LMG, leuco crystal violet 
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lactone (LCV), green diaminofluoran and orange aminofluoran [81]. 
Although LCV is the most sensitive to radiation dose and most stable post-
exposure to radiation, LMG is the most desirable leuco dye as a reporter 
compound in the formulation of the PRESAGE® dosimeter as the typical 
visible maximum absorption wavelength (λmax) of its oxidised form 
(malachite green) is approximately 633 nm compared to 609 nm for LCV [80]. 
The 633 nm  λmax corresponds to the helium-neon laser output or LED source 
(633 nm) of the commercially available optical scanning systems such as 
OCTOPUSTM (MGS Research) and VistaTM (Modus Medical Devices Inc.) [72]. 
Therefore, utilising LMG as a reporter compound allows the PRESAGE® 
dosimeter to be used in 3D dosimetry using these systems with optimum 
sensitivity. Nevertheless, Chapter 4 represents an investigation into novel 
LMG derivatives that are more sensitive than the parent LMG. 
 
Figure 1-5: Transformation between leucomalachite green dye and its oxidised 
product   (chromatic malachite green). 
 26 
1.3.4 Applications and limitations of the PRESAGE® dosimeter 
Conceivably, one of the most significant developments in 3D 
dosimetry over the past decade was the introduction of the PRESAGE® 
dosimeter [73]. The PRESAGE® dosimeter is a unique 3D radiochromic 
dosimeter with great potential for various clinical applications [90-95]. In 
addition, some specific applications include the dosimetry of beta-emitting 
radionuclides (e.g., Yttrium-90) [96] and evaluation of the peak-to-valley dose 
ratio of synchrontron microbeams [97]. Furthermore, the PRESAGE® 
dosimeter has been investigated for proton therapy [98, 99] and measuring 
electron dose distributions around tissue inhomogeneities within the target 
volume (e.g., tumours) [100].   
 Some of the attractive features and potential advantages of the 
PRESAGE® dosimeter over gel dosimeters include its lack of sensitivity to 
oxygen and diffusion [20, 72, 73]. Furthermore, in contrast to polymer gel 
dosimeters that use precursors dissolved in a fluidic matrix, the PRESAGE® 
dosimeter is solid, easily handleable, can be fashioned into any shape and 
requires no supporting container. The latter is particularly important from an 
optical imaging prospective as it means that light has to pass through fewer 
interfaces on its transit through the dosimeter, therefore minimising optical 
artefacts and simplifying any optical modelling required [15]. It also infers 
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that, the PRESAGE® dosimeter could be employed to measure surface doses 
such as electron beam dosimetry [100].   
Although the majority of studies have focused on clinical application 
of the PRESAGE® dosimeter, little is known about the potential influence of 
modifying each of the PRESAGE® dosimeters typical components, namely the 
radical initiators, leuco dye and polyurethane on the overall characteristics of 
the dosimeter (e.g., sensitivity to radiation dose, radiological properties and 
stability). In addition, it has been reported that earlier PRESAGE® dosimeter 
formulations, as a result of their high effective atomic number (Zeff) of 8.65 
[101], were not water-equivalent in the kilovoltage energy range (0.01 to 0.1 
MeV) where photoelectric absorption is predominant [102]. This was 
attributed to the increase in the concentration of the high atomic number (Z) 
halocarbon radical initiator [101]. In addition, the potential influence of 
incorporating high Z metal compounds in the PRESAGE® dosimeter 
formulation on its typical characteristics (e.g., sensitivity to radiation dose) 
has not been reported. The sensitivity to radiation dose is a key parameter to 
consider, since most dosimetric applications are performed with relatively 
low radiation doses (< 5 Gy), and therefore, the dosimeter needs to have a 
strong and linear response at low radiation doses, whilst maintaining tissue-
like radiological properties.  
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In addition, contrary to gel-based dosimeters, it has been almost a 
decade since the introduction of the PRESAGE® dosimeter [73] yet, there have 
been no reports about the mechanism by which the dosimeter changes its 
colour after irradiation. In other words, the mechanism and potential 
chemical pathways by which the LMG dye gets oxidised by the radical 
initiator and converted to its chromatic form. Indeed, such information is 
valuable for further optimisation of the PRESAGE® dosimeter formulation for 
potential clinical use.  
1.4 Basic radiation physics 
Radiation can generally be categorised as either ionising or non-
ionising. From a clinical paradigm, ionising radiation is more relevant as it is 
used mainly in the treatment of cancer. The term ionising radiation means the 
ability of radiation to dissociate an atom into ions when sufficient energy is 
applied. Photons (X- and gamma-rays) are commonly used in radiotherapy, 
as well as other ‘particle-type’ radiations, including alpha, beta, neutrons, 
protons and heavy ions. The ionising radiations are aimed at the target and 
result in damage to the tumour due to specific interactions of the ionising 
radiation with biological material.   
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According to the mode of ionisation, ionising radiation can be further 
divided into two categories, directly ionising and indirectly ionising. For 
example, charged particles such as electrons, protons and alpha particles can 
directly interact with matter and thus, be classified as directly ionising 
radiation. This type of ionising radiation loses energy in a large number of 
small increments along the ionising track in the medium, which is utilised in 
radiotherapy to produce damage to the target tissues [102]. The ionising 
process will occur if the incident particles have enough energy to eject an 
electron from an atom. In the absence of sufficient energy, excitation process 
would occur, whereby the electron is only moved to higher energy levels. The 
ejected electron in some conditions will have enough energy to produce 
secondary ionising radiation, which is known as delta (δ)-rays [102]. 
Indirectly ionising radiation, which comprises neutral particles 
(photons such as X- and gamma-rays, and neutrons), deposit their energy in 
the matter through a multi-step process. Initially, charged particles are 
released in the absorbing matter (photons releases either electrons or 
electron/positron pairs; neutrons may release protons or heavier ions). Upon 
the interaction of photons with the atom of the absorbing material, secondary 
electrons would be released that subsequently produce a track of ionisation in 
the absorbing material. The energy deposited by these secondary electrons 
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are responsible for most of the damage caused by the incident radiation in 
targets, such as tumours [103].   
1.4.1 Production of X-rays  
X-rays used for imaging or therapeutic applications are produced by 
two different mechanisms that result in two types of X-rays; ‘Bremsstrahlung’ 
X-rays and characteristic X-rays. In a typical LINAC or conventional X-ray 
tube, electrons are accelerated in vacuum and aimed at a high Z target (e.g., 
tungsten). This can result in a radiative ‘collision’ interaction between the 
high speed electrons and the field of an atomic nucleus to produce 
bremsstrahlung X-rays (braking rays) [102]. In this interaction, an electron 
passing near a nucleus will be deflected or decelerated because of the 
attractive force of the target nucleus and the electron will lose energy, which 
is irradiated as bremsstrahlung X-rays. In comparison, characteristic X-rays are 
generated from the interaction between an electron with the target atom by 
ejecting an orbital electron and results into a transition in the orbital electron 
such as K, L and M. Such sudden transition from high energy levels to lower 
energy levels results in the emission of characteristic X-rays. The emission of 
bremsstrahlung radiation may have any energy up to the energy of the initial 
electron, but the characteristic radiations are emitted at discrete energies 
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[102]. The mechanisms of both interactions are illustrated in Figure 1-6 and 
Figure 1-7. 
 
Figure 1-6: Illustration of the production of bremsstrahlung X-rays. 
 
 
 
Figure 1-7: Illustration of the production of characteristic X-rays. 
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1.5 Interaction of radiation with matter  
The action of ionising radiations is initiated by the transmission of its 
energy to a material as it traverses along its path through secondary electrons 
that are generated by photoelectric, Compton and pair production effects. 
This energy deposition is heavily reliant on the target’s radiological 
properties, in particular Z number, mass density and electron density.  
1.5.1 Photoelectric effect 
The primary photoelectric effect involves incident photons ejecting inner shell 
orbital electrons from atoms; kinetic energy is transferred to release the 
electron from the shell. The energy used to release the electron is equivalent 
to the binding energy of the electron. The ejected electron leaves a vacancy in 
the inner shell, which is filled by an electron from an outer orbit. The transfer 
of an outer orbital electron to the inner shell releases characteristic X-rays or 
fluorescent photons of energy exactly equal to the energy change (∆E). These 
characteristic X-rays are often absorbed locally by orbital electrons and are 
emitted as Auger electrons, which are characterised as a secondary 
photoelectric effect.  
 
 33 
 
Figure 1-8: Illustration of the photoelectric interaction.   
 
The probability of either of these photoelectric effects occurring is 
highly dependent on the energy of the photon and Z number of the absorbing 
materials. The relationship between the photon energy and Z number is 
estimated to be proportional to (Z/E)3, where E is the incident photon energy. 
For high Z materials, the interaction dominates energies < 100 keV [102].  
1.5.2 Compton interaction 
Compton interactions involve the interaction of photons with loosely 
bound electrons (free electron) of atoms. The electrons receive some of the 
energy from the incident photons and the rest of the energy is emitted as 
scattered photons. The Compton process is illustrated schematically in Figure 
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1-9. In this process, the incident energy must be large compared to the 
binding energy of the electron. Therefore, when the energy increases more 
than the binding energy of the K shell electrons, the Compton interactions 
will dominate the photoelectric effects. In addition, the Compton interaction 
is independent of the Z number of the absorbing material since the process 
involves only free electrons at the very outer orbits. 
 
 
Figure 1-9: Illustration of the Compton interaction. 
 
1.5.3 Pair production  
As the photon energies increase, the Compton interactions will 
subsequently decrease. When the energy reaches more than 1.02 MeV, pair 
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production interactions become prominent. The mechanism of pair 
production involves the interaction of photons with the electromagnetic field 
of atomic nuclei. The incident energy must be more than twice the rest mass 
of the electrons (0.511 MeV) in order for it to be absorbed to create an 
electron-positron pair, as illustrated in Figure 1-10.  
 
 
Figure 1-10: Illustration of the pair production process. 
 
In summary, the interaction of radiation with matter leads to the 
emission of photoelectrons, Compton electrons, scattered X-rays, Auger 
electrons and positrons, which produce localised ionisation resulting in 
significant deposition of radiation dose. Thus, these low energy electrons are 
responsible for most of the damage caused to biological materials. 
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Furthermore, when radiation interacts with matter, it either gets absorbed or 
attenuated, thus resulting in the reduction of the intensity of the incident 
radiation. The intensity (I) of radiation that goes through a material with 
thickness (x) can be described by equation (1-4): 
 
 μx
0
eII(x)   
                                                 
(1-4) 
 
I (x) = intensity transmitted through absorber  
Io = intensity incident on the absorber 
µ = linear attenuation coefficient (cm-1) 
x = distance travelled (thickness)  
 
The transmitted intensity I (x) results from photons that do not interact 
with the material. On the other hand, the fraction of photons absorbed or 
removed over the distance transversed during the attenuation process is 
described by the linear attenuation coefficient (µ). This coefficient depends on 
the energy of the photons, and density and atomic composition of the 
material [102]. If the density factor is removed, the mass attenuation 
coefficient (µ/ρ) is determined, which takes into account the atomic 
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composition of the material only [102]. In addition, photons that undergo the 
absorption and attenuation processes would have part/all of their energy 
converted into the kinetic energy of electrons. Therefore, the fraction of 
photon energy that is attenuated or absorbed by the material can be described 
using the mass energy attenuation coefficient (µ/ρ) and mass energy 
absorption coefficient (µen/ρ). From a radiotherapy prospective, the sum of 
energy absorbed in the target can be determined using these coefficients 
[103]. 
1.6 Introduction to nanotechnology in radiotherapy 
Technical advances in radiotherapy treatment delivery techniques, 
including the introduction of new equipment, have not only expanded the 
range of beam energies and delivery techniques that can be utilised to treat 
patients but also, provided better tumour targeting while minimising 
radiation dose to the surrounding normal tissues. Modern LINAC-based 
sophisticated techniques including SRS, IMRT, or accurate localisation when 
employing IGRT, result in the delivery of conformal doses to targets with 
high precision. This may indeed fulfil the ultimate goal of radiotherapy. 
Nevertheless, despite such technical advances, and in spite of the fact that 
radiotherapy as a treatment modality is one of the effective methods of cancer 
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management, there are still reports that patients suffer from local recurrence 
of cancer after radiotherapy or have local control probability [104], which is 
attributed to the radiobiological properties of  tumours [104, 105]. 
Consequently, efforts have focused on novel strategies to complement 
recent technical advances in order to improve the efficacy of radiotherapy, 
such as the utilisation of radiosensitising agents [105]. These agents alter the 
radiosensitivity of tumours with the aim of delivering tumoricidal radiation 
doses that can eradicate the tumours completely without exceeding normal 
tissues tolerances. Radiosensitising agents (or radiation dose enhancers) have 
the potential to improve the effects of radiation on the tumours provided that 
cancer cells can be selectively targeted by such agents. Initially, the 
effectiveness of oxygen as an agent to increase the radiosensitivity of tumours 
was assessed and various investigations have shown that, well-oxygenated 
cells show enhanced radiosensitisation compared to hypoxic cells [106, 107]. 
However,  in some studies, the potential enhancement from concurrent 
treatment using hypoxic cell sensitisers was not significant [108]. In addition, 
chemotherapy drugs such as carboplatin and cisplatin have been investigated 
as complementary drugs to enhance radiotherapy; however, lack of dose 
enhancement was observed and hence, this strategy has been deemed 
unsuitable for future clinical application [109].  
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Another strategy that has been investigated involves radiosensitisation 
of tumours by increasing the cross section of radiation interaction using high 
Z materials. Such strategies has been explored over the last few decades, 
mainly using iodinated contrast agents as dose enhancing agents [110]. 
Radiation dose enhancement radiation by iodine has been observed in many 
in vitro and phantom studies that substantiated the potential applicability of 
high Z materials as radiosensitisers [111-113]. This exploration has continued 
with the study of various high Z compounds and more recently, 
nanoparticles as a result of the emergence of the nanotechnology field, which 
has created unprecedented potential for improving the outcome in cancer 
treatment [105, 114, 115].  
According to the American Society for Testing and Materials (ASTM), 
the standard definition of nanoparticles (or nanomaterials) is “particles with 
lengths in two or three dimensions in the range of 1-100 nm” [116]. In this 
range (approximately one hundred times smaller than cells), nanoparticles 
can easily interact with biomolecules such as proteins and cellular structures. 
As radiosensitisers, metallic nanoparticles have been found to increase the 
therapeutic efficiency of radiotherapy by selectively scattering and/or 
absorbing X-rays resulting in a localised boost in cell death within tumours 
while preserving the surrounding normal tissues, which is the ultimate goal 
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in radiotherapy [117]. Although various high Z nanoparticles, such as 
platinum and silver nanoparticles [118], have been investigated, gold 
nanoparticles (AuNPs) as a noble element have appeared to be the most 
studied and one of the most efficient and biologically compatible [105]. 
Nevertheless, bismuth-based nanomaterials have been shown recently as 
promising candidates for biomedical applications [119, 120].  
Previous investigations concerned with nanoparticle-enhanced 
radiotherapy using AuNPs have been limited to point-dose measurements 
[120-127], and knowledge of the influence of such nanoparticles on the 3D 
spatial aspects of the radiation dose distribution, which includes doses to 
surrounding critical structures, the effects of particle composition, aspect 
ratio, and polymer coating, on radiotherapy dose enhancement is still 
unknown. One of the general aims of this thesis is to develop an independent 
experimental approach to answer these questions through the development 
of novel multi-compartments 3D radiochromic dosimeters to better 
understand the radiation-metal nanoparticle interaction outcomes. Details of 
the aims and objectives of the thesis will be covered at the end of this chapter. 
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1.7 Nanoscale properties  
The ability to engineer materials on the nanometre scale provides 
access to promising avenues for research and development as a result of 
unique nanscale phenomena. This has attracted a great amount of interest in 
research into the possibilities of exploiting such materials in biomedical 
applications. Indeed, this has resulted in a rapid increase in the number of 
scientific publications in diverse fields including imaging, material science, 
bio-engineering and molecular biology [105].  
 Typical atomic basic properties such as melting point, conductivity, 
structure, electrical conductivity, magnetic and optical properties change 
significantly when materials are reduced to nanometre scale [128, 129]. In 
addition, because of their small size, nanoparticles can be taken up and 
retained in cells to a greater extent more than larger particles [130]. Such size 
dependant phenomena is also known as quantum confinement effects, which 
result from the fact that the particle decrease in size (below the Bohr radius of 
the semiconductor materials) and electrons become more confined in the 
particle [131]. This results in an increase in the band gap energy. Furthermore 
the valence and conduction bands become quantised in terms of energy levels 
unlike bulk materials where no gap between the valence and conduction 
bands exists [128]. In addition,  freely mobile electrons are trapped in a so-
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called quantum boxes and show a collective oscillation frequency 
characteristic of dubbed surface plasmon resonance (SPR) [128].  For AuNPs 
for example, the SPR is usually in the visible region of the spectrum giving 
rise to the strong SPR absorption. Therefore, the origins of the vivid colours 
exhibited by some nanoparticles when their size is altered is as a result of the 
SPR [131]. 
In addition, contrary to bulk materials, nanoparticles possess a much 
higher surface-to-volume ratio as they decreases in size. Form radiotherapy 
prospective, this means that it is possible to pack hundreds of atoms inside 
each nanoparticle as shown in Figure 1-11. Therefore, by delivering one 
nanoparticle to the target site, hundreds of atoms would be transported with 
nanoparticles and hence increase the radiation interaction probability [132].  
 
Figure 1-11: Many atoms inside one nanoparticle means hundreds of atoms can be 
delivered to the target site.   
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 In addition,  the number of atoms at the surface can be almost equal to 
the number of the atoms inside the particles hence, leading to an enhanced 
contact area with their surroundings than bulk materials of the same mass 
[129]. Surface atoms are chemically more active compared to the bulk atoms 
because they usually have fewer adjacent coordinate atoms and unsaturated 
sites or more dangling bonds [129, 133].  The surface characteristics of 
nanoparticles are also important factors in controlling the nanoparticles’ 
properties. Any alteration to the nanoparticles’ surface induces further 
electronic states in the band gap and hence changes the physical and chemical 
properties of the nanoparticles [133].  
1.7.1 Gold nanoparticles in radiotherapy 
As a result of their unique physicochemical properties, including SPR 
and the ability to bind thiols groups allowing surface modification, AuNPs 
stand out as one of most efficient and well-investigated agents for radiation 
dose enhancement [105]. The use of colloidal gold dates back to the 5th 
century B.C where it has been used by ancient Egyptian and Romans in 
medicine and for making ruby glass and for colouring ceramics which 
provided different colours for the glass and ceramic [134]. It has been also 
shown to have healing properties for various medical conditions such as 
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heart diseases, dysentery, syphilis and epilepsy [128]. Gold is also considered 
an inert material and can be easily be functionalised with biocompatible 
coatings. Although, AuNPs are usually safe and non-toxic to human further 
research is required [135] and high doses may be certainly linked to toxicity 
[135]. Several studies have noted that the modification of the biocompatible 
surface and polymer coating reduces the toxicity of AuNPs [124, 136, 137]. 
Nevertheless, comprehensive knowledge about the potential toxicity of  
AuNPs and factors that may affect the toxicity are still not well known and 
this is currently an area of active research [135].  
AuNPs were first indentified as potential radiation enhancing agents 
for in vivo computed tomography (CT) imaging by Hainfeld et al. In 2006 
[138]. The high Z number of gold (Au = 79) compared to the commonly used 
iodine (I = 53), and its significantly higher absorption coefficient (Au: 5.16 cm2 
g-1; I: 1.94 cm2 g-1, at 100 keV), results in a 3 times greater contrast per unit 
weight for gold than iodine [138]. AuNPs also show great promise as contrast 
agents for imaging purposes before delivery of treatment such as in IGRT 
[139, 140]. Therefore, treatments aided by AuNPs have additional advantages 
where the potential of real-time imaging of targets during and after 
irradiation is possible; thus, it has the potential to be implemented in image 
guided radiotherapy.  
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In terms of potential therapeutic applications of AuNPs in 
radiotherapy, their dose enhancing capabilities have been observed in many 
in vitro investigations [120-123, 141, 142]. In addition, it has been reported that 
greater enhancement could be achieved by 50 nm diameter AuNPs compared 
to smaller and larger diameters ones [142].  Monte Carlo simulations have 
also been employed to theoretically simulate and quantify the interactions 
between AuNPs with different types of surface treatment techniques and 
beam energies [125, 143-147]. The majority of these computational 
simulations have found that low energy X-rays and gamma-rays are more 
efficient in enhancing radiation doses compared to the high energy ones.  
However, the apparent variation in the dose enhancement factors (DEFs) 
obtained by these different studies can be attributed to the type of code used 
and their limitations (such as not taking into account microscopic dose 
enhancement around the AuNPs), which prevents accurate and absolute 
calculations of the DEFs [148].  
All aforementioned studies have attributed AuNPs dose enhancement 
to the increase in photoelectric absorption by high Z materials at kilovoltage 
photon energies. Such dose enhancement would not occur at clinically 
relevant megavoltage energies as Z-independent Compton interactions are 
dominant [103]. Regardless of this, several studies have observed an increase 
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in cell death by AuNPs with clinically relevant megavoltage energies [19, 123, 
148, 149]. As outlined in section 1.6, clinical implementation of nanoparticles 
for radiation enhancement requires a comprehensive understanding of the 
influence of AuNPs size, polymer coating, concentration, and distance from 
target material (such as tumours) on the AuNPs-mediated dose enhancement. 
Such knowledge is vital for the rational development of AuNPs for clinical 
use [105, 127].  
However, higher Z materials may preform even better with less toxic 
effects so are well worth investigating, and many researchers are currently 
considering new nanoparticles to replace the expensive AuNPs that would 
behave just as well. The scarcely explored bismuth nanoparticles (BiNPs) 
show great promise in that respect.   
1.7.2 Bismuth nanoparticles in radiotherapy 
Bismuth and its compounds are not new to medicine, and have been 
used for the treatment of a number of medical conditions. Unlike gold, 
inexpensive bismuth-based medications are widely available in many 
countries as result of their efficiency and efficacy in treating many medical 
conditions. Currently, bismuth compounds are primarily used clinically as 
antiulcer drugs. For example, colloidal bismuth sub-citrate (De-Nol®) and 
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ranitidine bismuth citrate (Tritec® and Pylorid®) are used in the treatment of 
peptic ulcers [150]. In addition, bismuth subsalicylate (Pepto-Bismol®) is an 
over the counter medication in the USA for the treatment and prevention of 
both peptic and duodenal ulcers. Furthermore, it has been shown that the 
growth of the pathogen responsible for most gastric complaints (Helicobacter 
pylori) can be inhibited by the administration of colloidal bismuth [151]. Pure 
bismuth is readily oxidised by atmospheric oxygen, and is therefore primarily 
found in the ores bismuthinite (bismuth sulfide) and bismite (bismuth oxide) 
[152]. Similar to AuNPs, bismuth sulfide (Bi2S3-NPs) have been shown to 
enhance in vivo computed tomography (CT) imaging [119, 153, 154]; however, 
despite their efficacy in CT imaging, their potential exploitation as 
radiotherapy enhancing agents has not been investigated to date and is one of 
the objectives of this thesis, as indicated in section 1.8. 
1.7.3 Theoretical calculation of radiation dose enhancement by 
nanoparticles 
The enhancement in radiation dose produced by high Z materials can 
be determined by a parameter known as DEF, which is defined as the ratio of 
the dose absorbed in the target doped with nanoparticles over the dose 
absorbed in the target without nanoparticles. However, Roeske et al. 
presented a method of calculating the DEF values for various high Z 
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materials by means of analysing the mass energy absorption coefficient (µen/ρ) 
[155]. Their mathematical formula for determining the DEF values for poly-
energetic beams was derived using the following equation:  
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NP = nanoparticles 
µen/ρ = the mass energy absorption coefficient  
E = energy ranging from background 0 to maximum 
Ψ = energy fluence  
Ψ′ = differential photon energy fluence  
kNP = mass composition of the nanoparticles  
 
However, the aforementioned equation does not take into account the 
backscatter produced at the interface of the low and high Z materials, and 
therefore underestimates the dose enhancement by a factor of about 2 [155]. 
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Nevertheless, elements with high Z values (Z > 65) were more effective in 
enhancing radiation dose than elements with lower Z values (Figure 1-12).  
 
Figure 1-12: Plot of the DEF values against various Z numbers for 140 kV energy 
(adapted from Roeske et al., [155]). 
 
Furthermore, an estimation of the DEF values could also be made by 
analysing the µen/ρ values for mono-energetic beams, which have been 
previously reported for elements such iodine and gadolinium [156, 157]. This 
method is based upon calculating the ratio of the µen/ρ values of nanoparticles 
to water as follows:  
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NP = nanoparticles 
µen/ρ = mass energy absorption coefficient  
wNP = fraction by weight of NP in the mixture 
E = energy of the monochromatic beam  
 
1.8 Thesis objectives 
One of the most exciting advances in 3D dosimetry during recent years 
has been the introduction of the PRESAGE® dosimeter with its unique 
characteristics that have distinguished it from previous dosimeters.  Not 
surprisingly, it has dominated dosimeter research over the past few years, 
with research focusing mainly on the clinical applications of the dosimeter; 
however, the fundamental processes influencing the dosimeters 
characteristics, including mechanism of radiation response, optical absorption 
properties, radiological properties, dose sensitivity and stability, have not 
received significant attention to date. In order to rationally formulate 
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different PRESAGE® dosimeters to suit specific clinical applications and 
increase clinical use, a thorough understanding of the factors affecting the 
dosimeters characteristics are required.  
 Therefore, the first main objective of this thesis is to carry out a series 
of PRESAGE® dosimeter component-specific investigations to 
comprehensively understand the influence of each component on the unique 
characteristics of the dosimeters, with an ultimate aim of developing a novel 
suite of formulations for different clinical applications. In addition, these 
studies were expanded to evaluate the possibilities of introducing novel 
components in the dosimeter formulation as well. The specific objectives of 
this section include the following:  
 
 To understand the effects of using different trihalomethane radical 
initiators on the characteristics of the PRESAGE® dosimeter and the 
mechanism of radiation-induced homolysis of the radical initiators, with 
reference to tuning the properties for specific clinical applications whereby 
very high or low sensitivity maybe required.  
 
 To carry out a comparison between the commercially available LMG 
dye and three newly synthesised derivatives incorporated into the 
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PRESAGE® dosimeter to determine their effects on the dosimeters 
characteristics. Furthermore, to investigate the fundamental underlying 
mechanism of radical-induced oxidation of LMG to its chromatic form (MG).  
 
 To examine the impact of introducing different commercially available 
metal compounds on the characteristics of the PRESAGE® dosimeter, and to 
investigate the relationship between the concentration of each metal 
compound relative to the sensitivity of the dosimeter to radiation dose. 
Furthermore, to study the influence of the metal compounds activity as 
catalysts for the curing reaction and as stabiliser for post-response stability of 
the PRESAGE® dosimeter.    
 
 To formulate novel water-equivalent PRESAGE® dosimeters optimised 
for use in both megavoltage and kilovoltage beam dosimetry, and to 
determine their water-equivalency both theoretically and experimentally.   
 
Nanoparticles-enhanced radiotherapy is a relatively new technique 
that holds great promise in the treatment of cancer with minimal effects on 
normal tissue. This technique will increase the differential dose received 
between targets and the surrounding normal structures. However, until now 
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no one has been unable to quantify the amount of radiation and spatial 
distribution of the delivered dose to target volumes baring nanoparticles, 
which is problematic and may likely hinder future applications of 
nanoparticles as a radiation enhancing agents. The second main objective of 
this thesis is to pioneer an independent method for nanoparticle-enhanced 
radiotherapy dosimetry through the development and experimental 
validation of a novel multi-compartment radiochromic dosimeter referred to 
as the Sensitivity Modulated Advanced Radiation Therapy (SMART) 
dosimeter. The specific objectives of this section include the following: 
 
 To develop a method of fabricating multi-compartment 3D 
radiochromic dosimeters/phantoms. The multi-compartments approach 
would allow the imitation of a target volume (e.g., tumour) surrounded by 
healthy tissue. Also, to introduce a method of dispersing nanoparticles in 
polymeric matrices. 
 
 To develop a method for investigating the dependence of the DEFs 
and the 3D spatial aspects of the radiation dose distribution, this includes 
doses to surrounding critical structures on composition, aspect ratio, and 
polymer coating of the nanoparticles. 
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 To yield the first experimental insights concerning the spatial 
distributions and elevated dose in target volumes baring nanoparticles, 
which cannot be performed using current methods such as Monet Carlo 
simulation. 
 
 To provide the first direct experimental confirmation of metal 
nanoparticle-enhanced radiotherapy using AuNPs as an initial instance. 
 
 To conduct phantom studies using the SMART dosimeter to quantify 
the DEFs produced by different concentrations and diameters of AuNPs for 
megavoltage and kilovoltage beam energies.  
 
 To pioneer research into exploiting bismuth-based nanoparticles as 
radiotherapy enhancing agents. To conduct phantom studies using the 
SMART dosimeter to quantify the DEF of two common forms of bismuth 
available commercially, bismuth oxide and bismuth sulfide (Bi2O3-NPs, and 
Bi2S3-NPs, respectively), and Investigate their potential superiority over 
AuNPs in terms of dose enhancement.  
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1.9 Outline of thesis 
This thesis has two major goals: (1) to carry out a series of PRESAGE® 
dosimeter component-specific investigations with an ultimate goal of 
developing a novel suite of formulations for different clinical applications; 
and (2) to develop and characterise novel 3D radiochromic dosimeters for 
nanoparticle-enhanced radiotherapy dosimetry. The thesis is divided into 
individual chapters; the outline of each chapter is as follows:   
 
Chapter 2 describes the experimental methods used to obtain the 
results discussed in subsequent chapters. This chapter outlines the type of 
chemicals used, their potential health hazards, how they were handled, and 
procedures for disposing old dosimeter samples containing such chemicals. 
This is then followed by the description of the PRESAGE® and SMART 
dosimeters fabrication methods used in each individual chapter. Methods for 
selecting, preparing, and dispersing nanoparticles in polymeric matrices are 
also discussed. The irradiation procedure used in each chapter is highlighted 
followed by the procedures used for both spectrophotometric and optical CT 
measurements. The chapter concludes with a description of the methods used 
for radiological properties calculations and potential sources of experimental 
uncertainties.   
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Chapter 3 contains the results of the experiments that were conducted 
to compare the influence of different concentrations of trihalomethane radical 
initiators (iodoform, bromoform and chloroform) on the characteristics of the 
PRESAGE® dosimeter. This chapter also establishes a link between the rate of 
the radiation-induced radical formation and the carbon-halogen bond 
dissociation energy of any radical initiator. The chapter concludes by 
discussing specific dosimetric situations where some of the investigated 
radical initiators might be appropriate in dosimeters for clinical use. 
 
In Chapter 4, newly synthesised LMG derivatives (with either 
methoxy, chlorine or bromine substituents) were investigated for potential 
use in the composition of the commercial PRESAGE® dosimeter. They were 
compared with commercial LMG to determine their effect on the sensitivity 
and post-response photofading of the dosimeter. This chapter also, reports 
the first proposed mechanism of radiation-induced colour change of the 
PRESAGE® dosimeter, which is considered to take place through the 
deprotonation of the triaylmethane tertiary hydrogen leading to conversion 
of LMG (colourless) to MG (green colour). 
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Chapter 5 reports the results of an investigation into the radiation-
modifying effects of incorporating different concentrations of commercially 
available bismuth, tin and zinc-based compounds in the composition of the 
PRESAGE® dosimeter, and the feasibility of employing such compounds for 
radiation dose enhancement. In addition, the unique chemical structures of 
these compounds allow them to accelerate the polymerisation process of the 
PRESAGE® dosimeter and improve its post-response photofading. The 
chapter concludes with describing how metal compounds could be exploited 
to yield water-equivalent PRESAGE® dosimeters with enhanced dose 
response and excellent post-response stability.  
  
Chapter 6 follows on from the previous chapter by formulating three 
metal-optimised, water-equivalent novel PRESAGE® dosimeters for use in 
kilovoltage and megavoltage beams dosimetry. The radiological properties of 
each formulation are reported and discussed in terms of their equivalency to 
water. Also, the chapter evaluates the agreements between experimentally 
measured percentage depth dose curves for kilovoltage and megavoltage 
beam energies and that of water. The chapter concludes by discussing the 
suitability of these formulations for clinical use. 
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Chapter 7 is one of two chapters concerned with dosimetry of 
nanoparticles using the SMART dosimeter. The chapter begins by describing 
the benefits and rationale for having a multi-compartment 
dosimeter/phantom. Using a single concentration of AuNPs, this chapter 
reports the first experimental confirmation of the nanoparticle-enhanced 
radiotherapy and provides insights into the spatial distributions of the 
radiation dose enhancement in target volumes bearing AuNPs. It should also 
be noted that this work represents the first precedent of utilising 3D 
dosimetry for nanoparticle-enhanced radiotherapy dosimetry. This chapter 
concludes by recommending the SMART dosimeter system as a novel 
independent method for nanoparticle-enhanced radiotherapy dosimetry.   
 
Chapter 8 follows on from the previous chapter by reporting the first 
application of bismuth-based nanomaterials as potential radiation dose 
enhancing agents. The chapter begins by presenting the first experimental 
validation and quantification of the dose enhancement capability of Bi2O3-
NPs and investigates their potential superiority over AuNPs in terms of 
radiation dose enhancement upon irradiation with kilovoltage and 
megavoltage beams for different applied radiation doses. In addition, the 
relationship between the concentration of nanoparticles and dose 
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enhancement is reported and discussed. The chapter then describes initial 
experiments with Bi2S3-NPs by developing a SMART dosimeter embedded 
with both Bi2S3-NPs and AuNPs. The chapter concludes by encouraging and 
justifying further research to fully understand the processes of radiation dose 
enhancement achieved by bismuth-based nanomaterials. 
 
Chapter 9 summarises the progress made in 3D dosimetry and 
applications of nanoparticles in radiotherapy based on the findings of this 
thesis, and outlines some recommended future studies arising from this 
thesis.  
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The majority of contents of this chapter have been formatted for publication and 
have been published in a number of publications as indicated in some chapters. 
Refer to appendices i-iv for permission to reproduce published materials. 
Chapter 2 
Materials, Methods and Procedures   
 
2.1 Introduction 
This chapter provides details of the materials, instrumentation and 
experimental methodologies used in this thesis. The experimental methods 
are divided into several parts. The first part describes the chemical 
components, handling and fabrication procedure of the PRESAGE® and 
SMART dosimeters. The second section describes the methods for selecting, 
preparing, and dispersing nanoparticles in polymeric matrices. After this, the 
irradiation procedure used in this work with kilovoltage and megavoltage X-
ray beams is explained. This is followed by the procedure used for both 
spectrophotometric and optical CT measurements.  Finally, the methods used 
for radiological properties calculations and potential sources of experimental 
uncertainties are discussed.  
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2.2 Materials used for the fabrication of PRESAGE® and SMART 
dosimeters 
2.2.1 Polyurethane resins 
In this thesis, the polyurethane resin precursors used were Crystal 
Clear 206 (Chapter 3,5-8) and Crystal Clear 200 (Chapter 4) (Smooth-On, 
Easton, PA, USA), which are supplied in two parts (Part A and Part B). 
According to the manufacturer, both Crystal Clear 206 and 200 have the same 
physical properties and the only difference between them is the pot life, (i.e., 
the period of time before the premixture becomes unworkable).  
The exact chemical compositions of the commercially available 
prepolymer mixtures are often protected as trade secrets. However, in order 
to accurately calculate the radiological properties of each PRESAGE® 
composition an exact elemental composition of the polyurethane used is 
required. Therefore, Part A and Part B of the polyurethanes used in this study 
were sent to a specialized laboratory (Chemical & Micro Analytical Services 
Pty. Ltd, Melbourne, Australia) to conduct elemental analysis, which revealed 
an elemental composition of C: 63.3%; H: 9.4%; N: 5.0%; O: 21.3%. This is a 
typical composition of aliphatic polyurethanes and is very similar to that 
previously reported in the literature [72, 73]. The polyurethane used in this 
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study has a specific gravity of 1.036 g/cm3 as determined by the 
manufacturer. 
2.2.2 Leuco dyes 
As indicated in Chapter 1 section 1.3.3.1.1, leuco dyes are considered a 
class of chemicals that can acquire two distinct forms, one of which is 
colourless. Leucomalachite green (LMG) is the most desirable leuco dye to be 
used as a reporter compound in the formulation of the PRESAGE® dosimeter 
because the typical visible maximum absorption wavelength (λmax) of its 
oxidized form (malachite green) is at approximately 633 nm, which 
corresponds to the helium-neon laser output or LED source (633 nm) of 
commercially available optical scanning systems (e.g., OCTOPUSTM (MGS 
Research) and VistaTM (Modus Medical Devices Inc.)) [72]. Therefore, utilising 
LMG as a reporter compound allows the PRESAGE® dosimeter to be used in 
3D dosimetry using these systems with optimum sensitivity. In this thesis, 
the LMG dye was acquired from Sigma Aldrich (St Louis, MO). However, in 
Chapter 4, an investigation into three novel LMG derivatives that are more 
sensitive than the parent was carried out.  
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2.2.3 Radical initiators 
The class of radical initiators used in this thesis was halocarbons, 
which have been studied in detail in Chapter 3, refer to chemicals in which 
one or more carbon atoms are covalently linked with one or more halogen 
atoms (e.g., chlorine, bromine or iodine). The halocarbon radical initiators 
used in this thesis were chloroform (Chem-Supply), bromoform (Hopkins 
and Williams Ltd), iodoform and tetrabromoethane (Sigma Aldrich). 
2.2.4 Catalysts 
As discussed in Chapter 1 (section 1.3.3.1.1) the purpose of using 
polyurethane catalysts is to accelerate the polymerisation rate and improve 
the structural integrity of the polymer. Since metal compounds (e.g., 
organometallic complexes) are the most commercially utilised metal 
compounds for manufacturing polyurethanes, they were employed in this 
thesis. In general, dibutyltin dilaurate (DBTDL) (Merck) was predominately 
used as a catalyst in this thesis. However, in Chapter 5 the influence of 
different metal compounds catalysts on the overall characteristics of the 
PRESAGE® dosimeter were studied. The selection criteria for the metal 
compounds used are described in section 2.3.1.3. 
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2.2.5 Handling, storage and disposal  
In general, all chemicals used in this thesis are considered hazardous 
and harmful to both humans and the environment, with some considered 
toxic and potentially carcinogenic [158]. In addition, the PRESAGE® and 
SMART dosimeters do not readily degrade in natural environmental 
conditions and a method of disposal is yet to be reported. Therefore, 
disposing such dosimeters when obsolete causes waste disposal issues.  
2.2.5.1 Potential health hazards 
It is known that direct contact of polyurethane precursors, especially 
diisocyanates, can cause irritation of the eyes, respiratory tract, and skin. 
They may also cause allergic reactions of the skin and lungs. In addition, 
halocarbons are both toxic and carcinogenic. For example, most halocarbons 
are considered volatile organic compounds (VOCs). Inhalation of high 
concentrations of their vapour may cause dizziness, disorientation, 
incoordination, nausea or vomiting and ultimately leading to 
unconsciousness. In general, chronic exposure to some halocarbons is 
believed to cause liver and kidney damage. In addition, most halocarbons are 
air and water pollutants and their release into the environment has 
substantial risks [158, 159]. Moreover, the leuco dye used in this thesis (LMG) 
can cause damage to the skin, eye, and the tissue upon contact. Inhalation of 
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its dust may also produce severe irritation of respiratory and gastrointestinal 
tracts. Finally, different sizes of gold nanoparticles were fabricated in this 
thesis. In general, nanoparticles carry considerable health risks depending on 
their size and characteristics such as composition, morphology and size. [160, 
161]. The potential human toxicity arising from combining these 
chemical/substances to form the PRESAGE® or SMART dosimeters has yet to 
be investigated and is one of the future directions of this work. 
2.2.5.2 Handling 
Due to the potential environmental and human risk from the 
chemicals/materials, storage and handling of the chemicals/materials was 
strictly carried out according to the recommendations outlined in the 
Material Safety Data Sheet (MSDS) supplied by the manufacture. In addition, 
to limit exposure to hazardous fumes, dusts or vapours, all fabrication 
procedures were conducted in laboratory fumehood with dynamic means of 
ventilation. In addition, gloves, safety glasses and lab coats were also worn 
throughout the fabrication procedure.  
2.2.5.3 Storage of the PRESAGE® and SMART dosimeters 
All PRESAGE® and SMART dosimeter blocks and cuvettes were stored 
in a cold (ca. -18 °C) and dark environment prior and post irradiation to avoid 
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any accidental absorbance change due to exposure to ultraviolet or visible 
light.  
2.2.5.4 Disposal 
Dosimeters that have been used or rejected due to damage during the 
fabrication process were discarded according to the guidelines of the relevant 
laboratory/University. Such samples were labelled indicating the potential 
toxic ingredients (e.g. halogenated waste) and then sent to a specialised waste 
disposal company (Envirochem) that treat waste according to its physical and 
chemical characteristics. 
2.3 PRESAGE® dosimeter general fabrication procedure  
The polyurethane resin precursors used in this study are supplied in 
two parts (Part A and Part B) and are mixed together to afford an optically 
clear polyurethane resin that forms the matrix of the PRESAGE® dosimeter 
and allows the dosimeter to be scanned optically. The PRESAGE® dosimeters 
were fabricated in 5 steps, as follows: (i) One equivalent of the commercially 
available polyol (Part B) was thoroughly mixed with two equivalents of the 
diisocyanate (Part A) to afford a prepolymer. (ii) The chosen free radical 
initiator and reporter compound were thoroughly mixed with a specific 
equivalent of Part B. (iii) The solutions prepared in steps (i) and (ii) were 
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combined together and thoroughly mixed [72]. (iv) To the mixture prepared 
in step (iii) a catalyst was added with vigorous stirring. (v) The mixture 
prepared in step (iv) was then poured into poly(methyl methacrylate) 
spectrophotometer cuvettes with a wall thickness of 1 mm and internal 
dimensions of 1 × 1 × 4.5 cm, or any larger desirable mould. The filled 
cuvettes and/or moulds were then placed in a pressure pot (ca. 60 psi) for 48 h 
to eliminate the formation of air bubbles inside the dosimeters as a result of 
outgassing [72, 74, 162] as illustrated in Figure 2-1.  
It may be noted that throughout this thesis and in the literature, 
different radiochromic dosimeters may have different optical appearance 
(colour). Such appearance is attributed to the colour of the 
chemicals/substances used in the composition and has no influence on how 
the dosimeter measures radiation [74, 162].  For example, iodoform is 
naturally yellow, so obviously dosimeters with idodform will be yellow. 
Bromoform should be colourless and if discoloured it will contain trace 
impurities such as bromine which provide colour. The same with LMG, if it is 
slightly green it is because of MG impurities. 
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Figure 2-1: Images showing general steps for fabricating the PRESAGE® 
dosimeter. (a) General fabrication set-up. (b) Dosimeter precursors are initially 
mixed together. (c) They are then poured into a desired mould and (d) Placed in a 
pressure pot. (e) The pressure is maintained at ca. 60 psi for 48h to eliminate the 
formation of air bubbles inside the dosimeters as a result of outgassing. (f) The 
PRESAGE® dosimeter is demoulded.  
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2.3.1 Specific PRESAGE® fabrication procedures  
2.3.1.1 Fabrication of PRESAGE® with trihalomethane radical initiators 
In Chapter 3 the influence of different concentrations of three 
commercially available trihalomethane radical initiators (chloroform, 
bromoform or iodoform) on the sensitivity and radiological properties of the 
PRESAGE® dosimeter was investigated. The PRESAGE® dosimeters were 
fabricated according to the procedure outlined in section 2.3. To investigate 
the effects of using different trihalomethane radical initiators on radiation 
dose sensitivity and stability of the PRESAGE® dosimeter, different molar 
concentrations (50 and 100 mM) of each radical initiator were added to the 
PRESAGE® dosimeter composition containing a fixed concentration of LMG 
(2 wt%) and Crystal Clear 206/catalyst to ensure a total of 100 wt% of all 
constituents.  
2.3.1.2 Fabrication of PRESAGE® with novel reporter compounds 
In Chapter 4 the influence of different reporter compounds on the 
sensitivity and radiological properties of the PRESAGE® dosimeter was 
investigated. The polyurethane resin was prepared from Crystal Clear 200 
and tetrabromoethane was used as the radical initiator. Various reporter 
compounds were studied including the commercially available LMG dye and 
 70 
three novel LMG derivatives (with either methoxy, chlorine or bromine 
substituents) which were supplied by Heuris Pharma, LLC (Skillman, NJ, 
USA). They were referred to as MeO-LMG, Cl-LMG and Br-LMG. In order to 
directly compare between the LMG dye and its derivatives, the concentration 
of the radical initiator and dye were kept constant throughout (0.5 and 2 wt%, 
respectively) and only the type of leuco dye was varied. The fabrication 
process involved the steps outlined in section 2.3. 
2.3.1.3 Fabrication of PRESAGE® with various metal compounds 
In Chapter 5 the influence of different metal compounds on the 
fabrication, sensitivity and radiological properties of the PRESAGE® 
dosimeter was investigated. The fabrication process involved the steps 
outlined in section 2.3. However, with the addition of different concentrations 
of three metal compounds. The selection of metal compounds used in this 
investigation was based upon the following criteria: (i) As mentioned 
previously, the 3D matrix of the PRESAGE®  dosimeter has to be optically 
clear, thus each metal compound selected for this study had to be compatible 
with the dosimeter formulation (i.e., totally soluble in the dosimeter 
precursors). (ii) The selected metal compounds had to be chemically 
compatible with the polyurethane resin, reporter compound and radical 
initiator. As a result, three compatible metal carboxylates were selected, 
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namely dibutyltin dilaurate (DBTDL) (Merck), bismuth neodecanoate (Bi 
Neo) (Aldrich) and zinc octanoate (Zn Oct) (Alfa Aesar). The three selected 
metal compounds are also one of a number of metal compounds capable of 
catalysing the polymerisation reaction of the PRESAGE®  dosimeter 
precursors [163]. To investigate the possible radiation-modifying effects of 
using metal compounds as part of the composition a new formulation of the 
PRESAGE®  dosimeter was developed with a chemical composition of 
chloroform (5 wt%), LMG (2 wt%) and Crystal Clear 206/catalyst (93 wt%). 
For each of the metal compounds a large batch of formulation was prepared 
according to steps (i) to (iii) described previously and then this was equally 
divided into 5 smaller batches. To four of these batches were added different 
concentrations (1, 3, 6, 10 mM) of the metal compound and the other had no 
catalyst (control). The batches with metal compounds were observed to cure 
much faster (< 24 h) compared to batches that had no catalyst (ca. 96 h), thus 
demonstrating one advantage of using metal compounds to accelerate the 
polymerisation reaction. 
2.3.1.4 Fabrication of water-equivalent PRESAGE® 
In Chapter 6 novel metal-optimised PRESAGE® dosimeters were 
formulated and fabricated. Their radiological properties, sensitivity and post-
response photostability were investigated. The polyurethane resin used in 
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this study was Crystal Clear 200 and the radical initiators used were 
chloroform and tetrabromoethane. The reporter compound used was LMG, 
and DBTDL and zinc octoate were employed as catalysts. The fabrication 
process involved the steps outlined in section 2.3. 
2.3.2 Optimising the structural integrity of radiochromic dosimeters 
Proper mixing of individual components that make-up the PRESAGE® 
and SMART dosimeters, in particular the polyurethane matrix, plays an 
important role in how uniform the distribution of the components are and 
also the optical density.. Well mixed and homogenous matrices eliminate 
many types of imaging artefacts. For example, there have been some reports 
indicating that optical CT scanners based on pixelated detectors together with 
a wide beam can introduce imaging artefacts as a result of refractive index 
inhomogeneities within the dosimeter (Schlieren) (Figure 2-2) [164]. Such 
variations in refractive index typically result from incomplete mixing of the 
various components of the dosimeter. If these inhomogeneities are present in 
the dosimeter after complete curing then they can lead to spectral artefacts 
that can produce a high sensitivity to Schlieren bands within the dosimeter, 
which in turn leads to high noise. The presence and challenges associated 
with these bands in the PRESAGE® dosimeter have been reported by a 
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number of groups [165-167]. Although a time consuming method to correct 
for such artefacts based on manipulating optical CT data has been suggested 
[164], a more efficient and facile method is to eliminate the formation such 
Schlieren bands during the fabrication process by ensuring that parts A and B 
of the polyurethane resin are homogenously mixed prior to curing. The time 
required for mixing varies depending on the volume prepared and the skill of 
the operator. In general, for volumes < 500 mL mixing the two components (A 
and B)  for approximately 2 min, followed by 1 min after adding the catalyst, 
which includes scraping the side and bottom of the mixing container, ensures 
that the final dosimeter is free from any Schlieren bands. In addition, careful 
inspection of the mixture prior to casting would indicate any evidence of 
nonuniform mixing or Schlieren patterns. 
 74 
 
 
Figure 2-2: A photograph of two different PRESAGE® dosimeters with a visual 
indication of the consequence of Schlieren bands, which affect the sharpness of 
the barcode lines behind the dosimeters. (A) Was not mixed properly (with 
Schlieren bands) and (B) Was mixed properly (note: the optical appearance of the 
different dosimeter cuvettes has no influence on the appearance of Schlieren bands 
and results from the unique colour of the different individual chemical components 
used in both dosimeters).  
 75 
2.4 The SMART dosimeter 
The SMART dosimeter is considered a more advanced version of the 
PRESAGE® dosimeter. The principle of the SMART dosimeter and its 
fabrication procedure allows for a combination of compartments with 
different characteristics to be introduced in a single dosimeter block. In this 
thesis this principle has been exploited to design and fabricate novel multi-
compartment radiochromic dosimeters with tissue-equivalent (TE) outer 
compartments (in terms of radiological properties) and nanocomposite inner 
compartments, as an independent relative dosimetric method for 
nanoparticle-enhanced radiotherapy [19].  
The concept of a multi-compartment dosimeter could also be used for 
different applications, including the investigation of tissue inhomogeneity on 
radiation dose distribution. In this case, the SMART dosimeter could 
potentially be employed in situations where there are density variations in 
the tissues irradiated. For example, the determination of the dose 
distributions inside and around an inhomogeneity in 3D for advanced 
techniques, including volumetric arc therapy (VMAT) and intensity 
modulated radiation therapy (IMRT). However, employing the SMART 
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dosimeter in tissue inhomogeneity dosimetry is outside the scope of this 
thesis and remains one of the future directions of this work. 
2.4.1 General fabrication procedure for SMART dosimeters  
The steps required to fabricate a SMART dosimeter depends on the 
number and format of the compartments required. In this study, two 
different SMART dosimeter formats were prepared; cylinder-in-cylinder 
format (Figure 2-3) and a multi-stack format (Figure 2-4). It should be noted 
that the sensitivity of the SMART dosimeter can be tailored by variation of 
the type and amount of radical initiator, dye and catalyst; however, in the 
current study these were precisely controlled to ensure that the SMART 
dosimeter was tissue-equivalent (TE). 
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Figure 2-3: Photographs showing the (a-b) base of a SMART dosimeter after 
machining of the inner compartment and (c-d) a completely cured SMART 
dosimeter with perfect fusion between both compartments. For visualisation a 
transparent yellow pigment was added to the inner compartment as a proof-of-
concept. 
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Figure 2-4:  Photographs showing a SMART dosimeter in a multi-stack format (a) 
Vertical view after completely cured and (b) Side view showing perfect fusion 
between both compartments. For visualisation a transparent yellow pigment was 
added as a proof-of-concept. 
 
2.4.2 Fabrication of a SMART dosimeter with gold nanoparticles  
In Chapter 7 a multi-compartment SMART dosimeter doped with 50 
nm diameter gold nanoparticles (AuNPs) was fabricated. The dosimeter has 
two compartments that are arranged in order to mimic a tumour doped with 
AuNPs inside normal (healthy) tissue (refer to section 2.4.6.1 and 2.4.6.2) for 
details about the AuNPs fabrication method used). 
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2.4.2.1 Cylinder-in-cylinder SMART dosimeter 
2.4.2.1.1 The outer compartment 
The fabrication process of the outer compartment involves 4 steps as 
follows: (i) The radical initiator (tetrabromoethane, 0.56 wt%) and LMG dye 
(2 wt%) were thoroughly mixed with the diisocyanate Part A (51.2 wt%); (ii) 
The polyol Part B (46.2 wt%) was then added and mixed thoroughly; (iii) 
DBTDL (0.05 wt%) was then added with vigorous stirring to afford the TE 
polyurethane precursor mixture; (iv) This mixture was then poured into the 
desired mould and placed in a pressure pot (ca. 60 psi) for 48 h to minimise 
outgassing. The cuvette dosimeters were prepared by pouring the TE 
polyurethane precursor mixture into poly(methyl methacrylate) 
spectrophotometer cuvettes with a wall thickness of 1 mm and internal 
dimensions of 1 × 1 × 4.5 cm.  
2.4.2.1.2 The inner compartment 
Initially, the TE polyurethane precursor mixture prepared in step (iii) 
(section 2.4.2.1.1) was poured into a polypropylene container (120 mL) and 
placed in a pressure pot (ca. 60 psi) for 48 h. The resulting polyurethane resin 
block (d × h = 4.2 × 6 cm) (the outer compartment) was precisely machined 
using a lathe (Gedee-Weiler, MLZ-250) to generate a centrally located 
cylinder cavity (d × h = 1.4 × 3 cm).  The size of the inner compartment 
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depends on the intended dosimetric application and can be ready tailored. 
Ideally, only drill-bits that do not leave rough edges should be used when 
fabricating a SMART dosimeter as this allows perfect fusion between the 
different compartments and eliminates any related imaging artefacts (Figure 
2-3). In addition, a combination of low lint wipers and compressed air was 
used to clean the inner cavity of the SMART dosimeter from any 
debris/particulates prior to the next stage. 
The next stage involves preparing the TE nanocomposite precursor by 
adding the desired concentration of AuNPs to polyol Part B (46.2 wt%) and 
sonicating for 1 h to ensure complete dispersion on the particles. Further 
details for dispersing nanoparticles using ultrasoniaction are provided in 
section 2.4.7.2. Subsequently, this mixture was added to the Part A mixture 
prepared in step (i) (section 2.4.2.1.1), mixed thoroughly, and then poured 
into the cavity (the inner compartment). The polyurethane resin block was 
placed in a pressure pot (ca. 60 psi) for 48 h and then demoulded to afford the 
SMART dosimeter with no visible diffusion between the different 
compartments.  
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2.4.3 Double-stack SMART dosimeter 
The fabrication process involves the following steps: (i) The radical 
initiator (tetrabromoethane, 0.56 wt%) and LMG dye (2 wt%) are thoroughly 
mixed with the diisocyanate Part A (51.2 wt%) (to allow visualisation a few 
drops of a yellow pigment is added); (ii) The polyol Part B (46.2 wt%) is then 
added with thorough mixing to afford a final Part A:Part B ratio of 10:9; (iii) 
DBTDL (0.05 wt%) was then added with vigorous stirring to afford the TE 
polyurethane precursor mixture; (iv) This mixture was then poured into a 
polypropylene container (100 mL) and placed in a pressure pot (ca. 60 psi) for 
48 h to minimise outgassing; (v) Separately, a TE nanocomposite precursor 
was prepared by adding the desired concentration of AuNPs to polyol Part B 
(46.2 wt%) and sonicating for 1 h to ensure complete dispersion on the 
particles; (vi) This mixture was added to the Part A mixture as prepared in 
step (i) and mixed thoroughly; (vii) This mixture was then poured into the 
specimen container on top of the already cured polyurethane resin and 
placed in a pressure pot (ca. 60 psi) for 48 h; (viii) Finally, the resin block is 
demoulded to afford the double-stack SMART dosimeter (Figure 2-4).  
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2.4.4 Fabrication of a SMART dosimeter with bismuth oxide 
nanoparticles 
In Chapter 8 (section A), a cylinder-in-cylinder SMART dosimeter with 
bismuth-based nanomaterials was fabricated to provide the first evidence 
that bismuth-based nanomaterials are efficient dose enhancing agents and 
have great potential for application in clinical radiotherapy. The fabrication 
method employed was identical to that report in the previous section 
(2.4.2.1.), however, the AuNPs were replaced with 0.5 mM of bismuth oxide 
nanoparticles (Bi2O3-NPs). 
2.4.5 Fabrication of a SMART dosimeter with gold and bismuth 
sulfide nanoparticles 
In Chapter 8 (section 8.4.2), a dual cylinder-in-cylinder SMART 
dosimeter with two types of nanoparticles (AuNPs and bismuth sulfide 
nanoparticles (Bi2S3-NPs)) was fabricated, allowing for the first insights 
concerning the spatial distributions and elevated dose of more than one type 
of nanoparticle in a single target. Both nanoparticles have an average 
diameter of 4 nm (refer to section 2.4.6.2 for details about the fabrication of 
the nanoparticles) 
The fabrication process of the outer compartment is similar to that 
described in section 2.4.2.1., with the exception that the dosimeter precursors 
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were poured into a polypropylene beaker (250 ml) and placed in a pressure 
pot (ca. 60 psi) for 48 h. The resulting polyurethane resin block (d × h = 5 × 6.8 
cm) (the outer compartment) was precisely machined using a lathe (Gedee-
Weiler, MLZ-250) to generate two cavities (d × h = 1.4 × 3 cm).  The next stage 
involved preparing the TE nanocomposite precursors by adding 0.25 mM of 
AuNPs and Bi2S3-NPs to two separate batches of polyol Part B (46.2 wt%) and 
sonicating each for 1 h to ensure complete dispersion on the particles. 
Subsequently, the mixtures were added to two separate Part A mixtures 
prepared in step (i) (section 2.4.2.1.1), mixed thoroughly, and then poured 
into each cavity (the inner compartments). The polyurethane resin block was 
then placed in a pressure pot (ca. 60 psi) for 48 h and then demoulded to 
afford the SMART dosimeter with two different types of nanoparticles 
homogeneously distributed in two different compartments. 
2.4.6 Metal nanoparticles selection 
In Chapters 7 and 8 AuNPs were selected for initial SMART dosimeter 
investigations since their enhancing properties have been demonstrated in 
several imaging and therapeutic studies [120, 142, 168]. In addition, a recent 
study has shown that maximum cellular uptake and dose enhancement 
occurs with 50 nm diameter particles [142, 169]; therefore, 50 nm diameter 
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particles were selected (Chapter 7). However, since 50 nm AuNPs are not 
readily available commercially, it was necessary to fabricate such particles.  
2.4.6.1 Synthesis of 50 nm diameter gold nanoparticles 
50 nm diameter AuNPs complete with dodecanethiol coated surfaces 
were synthesized using a one-pot procedure described in the literature [170]. 
Briefly, dodecanethiol (3.0 mmol) (Aldrich) was added with stirring (250 
rpm) to a solution of gold(III) chloride trihydrate (H[Au(Cl4)]·3H2O) (1 mmol) 
(Aldrich) in anhydrous tetrahydrofuran (30 mL) (RCI Labscan) under argon. 
The mixture was stirred for 25 min at room temperature and then 1.0 M 
super-hydride solution (Aldrich) in tetrahydrofuran (THF) (20 mL) was 
slowly added. The mixture immediately turned dark purple. After 3 h the 
mixture was added to ethanol (200 mL) (Merck) to precipitate the 
nanoparticles. The nanoparticles were isolated via centrifugation, washed 
with ethanol (4 × 50 mL) and dried in vacuo (50 °C, 0.1 mbar). The 
nanoparticles were characterised using transmission electron microscopy 
(TEM), which provided an average diameter of 48 nm (Figure 2-5). 
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Figure 2-5: (a) TEM image of AuNps prepared (scale bar = 200 nm) and (b) size 
distribution of AuNps determined from TEM (> 100 particles were measured). 
 
2.4.6.2 Synthesis of 5 nm diameter gold nanoparticles  
In Chapter 8 (section 8.4.2), a comparison between small diameter (~5 
nm) AuNPs and Bi2S3-NPs in term of radiosensitisation was carried out. 4 nm 
diameter Bi2S3-NPs were kindly donated  by Dr. Kelong Ai (Changchun 
Institute of Applied Chemistry, China) and were synthesised according to a 
previously published method [154]. Thiol-stabilized 5 nm diameter AuNPs 
were prepared according a previously reported method [171]. Initially, stock 
solutions of   HAuCl4-3H2O (0.05 M) in 1.0 M aqueous HCl (A), NaBH4 (0.05 
M) in 1.0 M aqueous NaOH (B) and dodecanethiol (5 g) in n-hexane (250 mL) 
(C) were prepared. Solution A (5 mL) was added to Milli Q water (500 mL) 
under rapid stirring (1200 rpm) and then solution B (5 mL) was added 
dropwise. Acetone (250 mL) was added and the mixture was shaken 
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manually for 5 s. Then solution C was added rapidly and the mixture was 
shaken manually for a further 30 s. Finally, the mixture was transferred to a 
separating funnel, left to settle and the organic phase was removed. The 
whole procedure was repeated 3 times and all of the organic extracts were 
combined together and the hexane was removed in vacuo on a rotary 
evaporator. The remaining solution was diluted with ethanol (5 mL) and the 
AuNPs precipitated as dark amorphous solid. The precipitate was 
redissolved in hexane and reprecipitated with ethanol to remove 
dodecanethiol. 
2.4.6.3 Transmission electron microscopy  
All AuNPs fabricated in this thesis were characterised using a JEOL 
TEM 1010 operating at 100 keV and equipped with a CCD camera. The 
samples were prepared by evaporating dilute solutions of nanoparticles in 
THF onto carbon-coated 400-mesh copper TEM grids. More than 100 particles 
were measured to determine the average diameter of the nanoparticles 
(Figure 2-5). 
2.4.6.4 Refractive index measurements 
Refractometry measurements were carried out using an Abbe 
refractometer (Bellingham and Stanley) at 20 °C. Samples of polyurethane 
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precursor mixture (liquid form; as prepared in steps (i)-(iii) described in 
section 2.4.2.1.) with and without AuNPs and Bi2O3-NPs were measured. 
Negligible difference in the refractive index values was found for the TE 
polyurethane precursor mixture with and without both nanoparticles. 
2.4.7 Dispersion of nanoparticles in polymeric matrix 
As mentioned in Chapter 1, the miniaturisation of matter leads to 
significant changes in its unique electronic properties resulting in new 
characteristics, including optical density (colour), interaction with other 
materials, chemical reactivity and quantum confinement effects (depending 
on article size and morphology). In addition, reducing particle size increases 
the surface area to volume ratio, which means that more functional material 
can be packed into a smaller volume. Such unique effects are only 
pronounced when the nanoscale size range is reached and do not come into 
play in larger materials.   
The dispersion of nano-sized particles in liquids is challenging due to 
the presence of very strong attractive inter-particle forces. The high 
percentage of the atoms interacting with each other and with other materials 
leads to agglomeration (formation of clusters) of particles. This essentially 
reduces the surface area and surface activity of the particles, which is a key 
 88 
aspect of nanomaterials. In other words, inefficient dispersion of 
nanomaterials in liquids may lead to polydisperse aggregates with various 
sizes and morphologies on the micron scale, resulting in different electrical 
properties and interactions that hinders potential utilization of nanoscale 
phenomenon [172]. Therefore, significant care was taken to ensure that the 
nanoparticles used in this study were well dispersed. 
2.4.7.1 Methods for dispersing nanomaterials 
Chapters 7 and 8 describe the first instance of gold and bismuth-based 
nanoparticles being embedded into novel multi-compartment 3D 
radiochromic dosimeters. In general, polyurethane resin precursors have a 
dynamic viscosity of approximately 600 cps @ 23 °C, which is much higher 
than that of water (0.928 cps @ 23 °C). Therefore, ensuring complete 
dispersion of nanoparticles in the nanocomposite compartments of the 
SMART dosimeters was challenging and required the development of an 
efficient and reliable method. 
There are a number of commonly used methods for homogenously 
disperse nanoparticles in liquids [172].The most common involve the use of 
vortex mixer which use a rotary motor to create a vortex inside liquids [173] 
and ultrasonication which utilise sound waves to break up agglomerated 
nanoparticles. Unlike vortex mixing, ultrasonication is shown to be efficient 
 89 
nanoparticles dispersing system due to the power of ultrasounds and the 
ability to disperse nanoparticles in relatively large volumes compared to 
vortex mixing which is limited to standard test tube volume [172]. 
During the process of ultrasonic disruption, sound waves propagate 
through the liquid medium in an alternating high and low pressure cycles at 
frequencies typically in 20-40 kHz range [174].  As a result, microscopic 
vapour bubbles are formed; a process known to as ultrasonic cavitation. 
These microscopic vapour bubbles alter the high and low pressure cycles 
resulting in the generation of localized shocks wave that releases tremendous 
mechanical and thermal energy stress on the attracting forces between the 
individual particles [174]. In addition, ultrasonic cavitation produces high 
speed liquid jets (up to 1000km/hr). The passage of these high speed jets 
between individual particles separate them from each other[174]. This makes 
ultrasonication an effective and efficient mean for the deagglomerating and 
dispersing nanomaterials in general. 
2.4.7.2 Procedure for dispersing nanoparticles by ultrasonication 
Sonication of nanoparticles was carried out using a Branson 2510 
ultrasonicator (Branson Ultrasonics Corporation, Danbury, CT, USA), 
operating at a frequency of 40 kHz and power of 100 W. The process involves 
adding the desired amount of nanoparticles to a predetermined amount of 
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part B (polyurethane resin precursor) in a beaker (made from borosilicate 
glass or polypropylene). Part B was chosen over Part A for nanoparticle 
dispersion since Part B does not react with moisture from the atmosphere and 
has a lower dynamic viscosity than Part A (2.5 and 8 cps at 23 °C, 
respectively). For the nanoparticles concentrations used in this thesis (< 0.5 
mM) it was found that sonication for 1 h at room temperature was sufficient 
to homogenously disperse the nanoparticles in the polyurethane precursor 
(Figure 2-5). This was verified by assessing the interbatch and intrabatch 
variability and linearity of response of the dosimeter cuvettes with 
nanocomposites to radiation (Chapter 7 and 8). 
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Figure 2-6: Photograph of gold and bismuth-based nanoparticles (a) before and (b) 
after dispersion in part B polyurethane precursor via ultrasonication for 1 h. 
 
2.4.8 Intrabatch and interbatch variability 
It has been reported that the PRESAGE® dosimeter has an interbatch 
variability of ~4% [90]. Since the SMART dosimeter contains a polymer 
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nanocomposite that is different from the PRESAGE dosimeter it was 
necessary to investigate the potential influence of the nanocomposite on both 
the intrabatch and interbatch variability of the dosimeter. To investigate the 
potential influence of metal nanoparticles on the consistency of response of 
the dosimeters to radiation dose, and to evaluate the homogeneity of the 
metal nanoparticle dispersion in the polyurethane matrix, intrabatch 
consistency was evaluated. Similarly, variation between different batches 
(interbatch consistency) was also determined so that dosimeters from 
different batches could be used in the same dosimetric application. For 
intrabatch consistency, eight dosimeter cuvettes from the same TE+0.5 mM 
Bi2O3 or AuNPs formulation batch were irradiated with the same dose and 
using the same radiation set-up. The mean and the standard deviation (SD) of 
ΔOD readings of the eight cuvettes were then calculated. For interbatch 
consistency, four dosimeter cuvettes from the TE+0.5 mM Bi2O3 or AuNPs 
formulation were taken from each of four different batches and irradiated 
alongside. The mean and the SD of each of the four dosimeters were then 
compared (Chapter 7 and 8). 
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2.5 Dosimeters irradiation 
Irradiation of the PRESAGE® and SMART dosimeters was carried out 
using both megavoltage and kilovoltage X-rays. The kilovoltage range of 
energies was derived from a clinical superficial X-ray therapy machine while 
the megavoltage X-ray beam was obtained from a medical-type linear 
accelerator (LINAC).  
2.5.1 Megavoltage beam irradiation 
Megavoltage irradiation was carried out at the Australian Radiation 
Protection and Nuclear Safety Agency (ARPANSA) using a 6 MV linear 
accelerator (Elekta Synergy, Crawley, UK). Various radiation doses ranging 
from 0-50 Gy at a dose rate of 5 Gy/ min (80 MU Gy-1) were used. The field 
size was set to 10 × 10 cm.  A 1.5 cm solid water block was placed on top of 
the dosimeter cuvettes, and the focus to surface distance (FSD) was set to 100 
cm from the solid water surface so that the maximum dose occurred at the 
surface of the dosimeter cuvettes. The cuvettes were surrounded by a bolus of 
solid water to provide a uniform scattered dose (Figure 2-6). Delivered 
radiation dose values at the dosimeter positions were verified using a 30012 
Farmer type ionisation chamber based on the IAEA TRS 398 protocol [175]. 
The collimator and gantry angles were set to 0 degrees. Room temperature 
was maintained at 22 °C during radiation exposure. To measure percentage 
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depth dose curve (PDD), large dosimeter blocks were submerged in water at 
room temperature with an FSD of 100 cm to the surface if the dosimeters 
(Figure 2-7). 
 
 
 
Figure 2-7: Irradiation geometry for the dosimeter cuvettes using megavoltage 
irradiation beams. 
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Figure 2-8: Photograph of megavoltage beam irradiation set-up of a PRESAGE® 
dosimeter 
 
2.5.2 Kilovoltage superficial X-ray beam irradiation 
In Chapter 5 were the influence of different metal compounds on the 
overall characteristics of the PRESAGE® dosimeter has been investigated, 
kilovoltage irradiation was performed. It was carried out at the William 
Buckland Radiotherapy Centre (The Alfred Hospital, Prahran, Australia). 
Only dosimeters containing the 3 and 10 mM of metal compounds were 
irradiated using a kilovoltage beam. The dosimeter cuvettes were irradiated 
with 100 kV X-ray energy from a superficial X-ray therapy machine 
(Therapax 3 Series; Pantak Inc., Branford, Connecticut) at various radiation 
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doses (0, 0.5, 1, 5, 10 and 30 Gy). A single-fraction irradiation with dose rate 
1.13 Gy/min, 15 cm diameter collimator, and 1.8 mm Al filter (4.9 mm Al 
HVL) were used. The distance between the radiation source and the surfaces 
of the PRESAGE® cuvettes was 25 cm.  
In Chapter 7 and Chapter 8 (section 8.4.1), the same kilovoltage 
irradiation procedure described in the previous section (3.2.) was followed 
except that, the radiation dose range was 0, 0.5, 1, 5, 10 and 20 Gy. 
In Chapter 8 (section 8.4.2) were a SMART dosimeter with 0.25 mM of 
AuNPs and Bi2S3-NPs was fabricated and irradiated using kilovoltage X-ray 
beam, the same irradiation procedure described in the previous section (3.2.) 
was followed except that, the energy used was 150 kV, dose rate of 1.19 
Gy/min, 0.2mm Al + 1.0 mm Cu filter (1.0 mm Cu HVL) and radiation dose 
range of 0, 0.5, 1, 5, 10 and 20 Gy were used (Figure 2-8). As in megavoltage 
irradiation, the cuvettes were surrounded by a bolus of solid water to provide 
a uniform scattered dose. For both kilovoltage and megavoltage irradiations 
the room temperature was maintained at ca. 22 °C during radiation exposure 
because of the reported dose response stability at that temperature [72].  
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Figure 2-9: Photograph of kilovoltage irradiation set-up of the SMART dosimeter 
with Bi2S3 and AuNPs (refer to chapter 8, section 8.4.2) 
 
2.5.2.1 Verification of dose uniformity using film dosimetry  
The uniformity of X-ray doses was verified using radiochromic film 
(GafChromicTM film EBT; International Specialty Products, Wayne, New 
Jersey) and 2570/1 Farmer dosimeter (NE Technology, Reading, United 
Kingdom). The dosimeter cuvettes and dosimeter blocks were placed at the 
centre of the beam to ensure the radiation dose delivered is uniformly 
distributed. To measure PDD, the dosimeter blocks were submerged in water 
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maintained at 22 °C and placed at the centre of the beam to ensure that the 
exposed area received uniform radiation dose. The relative dose profiles for 
the kilovoltage beams used in this thesis from film measurements are shown 
in Figure 2-10 and Figure 2-11.  
 
Figure 2-10: Dose profiles from radiochromic film irradiated using 100 kV X-rays; 
1.8 mm Al filter (4.9 mm Al HVL). 
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Figure 2-11: Dose profiles from radiochromic film irradiated using 150 kV X-rays; 
0.2 mm Al + 1.0 mm Cu filter (1.0 mm Cu HVL). 
 
2.6 Basic principles of spectrophotometry 
Chemical compounds, depending on their chemical structure, absorb 
or transmit light over different wavelength ranges of the electromagnetic 
spectrum. Spectrophotometry is a quantitative measurement of how much a 
chemical substance absorbs or transmits at a particular wavelength. This is 
achieved by using a spectrophotometer, which is an instrument that 
measures the amount of photons (intensity of light) absorbed after passing 
through a sample. The range of wavelengths of a UV-VIS spectrophotometer 
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can be classified into two different types; Ultraviolet (UV) light, which uses 
light over the range of 185 - 400 nm, and visible light, which uses light over 
the range of 400 -700 nm of electromagnetic radiation spectrum. 
2.6.1 Basic components 
Figure 2-12 illustrates the basic structure and components of a UV-VIS 
spectrophotometer, including a light source, a monochromator, a prism, a 
cuvette for the desired dosimeter, and a photoelectric detector.  
 
 
Figure 2-12: Basic components of a spectrophotometer 
 
The function of a monochromator is to produce a beam of radiation at 
a single wavelength (monochromatic), which can be selected from a range of 
wavelengths depending on the light source. The monochromator has several 
essential components: (1) an entrance slit that controls the width of the light 
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beam (ideally the slit width should be very small (~1 nm) to limit any 
diffraction of light), (2) a collimator that produces parallel light, (3) a 
wavelength selector that isolates a desired wavelength from the source 
(monochromators), and (4) an exit slit that has the same function of the 
entrance slit. The function of the prism is to provide a continuous spectrum in 
which the component wavelengths are separated in space (Figure 2-12). The 
photodetector (phototube) is used to convert the radiant energy received to a 
measurable signal.  
2.6.2 Absorbance data calculation 
The PRESAGE® and SMART dosimeters [19, 72] are radiochromic 
dosimeters that change colour upon exposure to ionising radiation. 
Therefore, the change in optical density (ΔOD) (also known as absorbance 
change) at a particular wavelength is measured when dealing with such 
dosimeters. In order to ensure that, the ΔOD of the PRESAGE® and SMART 
dosimeter cuvettes is only due to the absorbed radiation dose, ΔOD  values 
were obtained by subtracting the OD value of the irradiated cuvettes from 
that of the reference/blank cuvette (with zero radiation dose) [74, 162]. The 
reference cuvette has the exact same composition as the sample, except it is 
not exposed to any ionising radiation. Both absorbance and OD terms were 
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used interchangeably in the literature, however, the term OD is most 
commonly used in 3D dosimetric investigations. Therefore, in this thesis the 
latter term was used instead of the former. 
2.6.3 Optical absorption measurements 
In Chapters 3-8, the absorption spectra were acquired using a 
Shimadzu UV-1800 UV-VIS spectrophotometer (Perkin Elmer, Waltham, MA, 
USA). Initially, the absorption spectrum over the visible wavelength region 
(470–750 nm) with 1 nm intervals was recorded and used to determine the 
radiochromic response maxima (λmax) of the PRESAGE® and SMART 
dosimeters [74, 162]. An absorbance spectrum relates to the change in OD as a 
function of wavelength and is used to select the optimal wavelength for OD 
acquisitions in any given sample (Figure 2-13a). The spectrum is a plot of 
absorbance versus wavelength and is characterized by λmax at which the OD is 
the greatest. The value of λmax is essential for many reasons. For example, the 
wavelength is characteristic of each compound and in more advanced 
analysis, may provide information about structure of the sample being 
analysed. Furthermore, to obtain the highest sensitivity, analytical 
measurements must be acquired using light with a wavelength of λmax. In this 
work, all absorption acquisitions were recorded 1 hour post-irradiation. 
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Throughout this work the absorption spectrum of the PRESAGE® and 
SMART dosimeters were found to peak at the red region of the spectrum 
with a λmax at ca. 633 nm. Therefore, the spectrophotometer absorption 
wavelength was assigned to λ = 633 nm for all measurements. The OD values 
of each PRESAGE® and SMART dosimeter cuvettes were measured pre- and 
post-irradiation. In addition, the absorption spectrum of the ΔOD was 
acquired by subtracting the OD spectrum of the un-irradiated cuvette from 
the irradiated one (Figure 2-13b) [19, 74]. 
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Figure 2-13: (a) Absorbance vs. wavelength spectra for pre- and post-irradiated 
PRESAGE® dosimeter cuvettes irradiated with different doses. (b) The absorption 
spectrum of absorbance change acquired by subtracting the un-irradiated cuvette 
from the irradiated ones.  
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2.6.4. Post-response photostability 
In order to investigate the potential influence of different compositions 
of the PRESAGE® dosimeter, or the presence of nanoparticles in its advanced 
version (the SMART dosimeter), on bleaching (fading) of the ΔOD recorded, 
absorption acquisitions of the cuvettes were conducted at different time 
intervals ranging from 1-336 hours post-irradiation (refer to each chapter for 
specific time intervals). In between measurements the dosimeter cuvettes 
were stored in a cold (-18 °C) and dark environment to avoid any accidental 
absorbance change due to exposure to ultraviolet or visible light.   
2.7 Optical CT scanning  
The quest for high resolution 3D data sets for polymer dosimetry has 
stimulated since the introduction of the first gel dosimetry optical CT 
scanning system [52]. Generally, two categories of scanners based on the 
optical configuration have been adopted [176]. The first employs a rastering 
single laser beam and photodiode detector, which scans the dosimeter point-
by-point to create 2D maps of the optical density (maps of laser attenuation) 
through the dosimeter [177-180]. The 2D maps are then combined in the third 
spatial dimension to create 3D representations of the radiation-induced 
change in optical density distribution [180]. Because this system acquires 
point-by-point data, it is more accurate and less susceptible to imaging 
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artefacts. However, it is very slow requiring approximately 8 min of data 
acquisition per slice and a total scan times on the order of hours [176, 181]. 
The speed of data acquisition of such system configurations was recently 
improved [167]. The second optical design configuration is based on a 
combination of a wide field LED light illumination (cone beam) source and a 
CCD camera [167]. In this configuration 2D angular image projections are 
acquired thereby generating multiple slices of the dosimeter simultaneously 
[176] as illustrated in Figure 2-14. There have been a number of different 
configurations that share the same essential components (CCD-based 
detection schemes) over recent years [166, 167, 182-184]. The latter design 
allows for very fast volumetric data acquisition with a total scan time of less 
than 10 min, which is particularly advantageous from a clinical perspective 
[181, 185]. However, the data measurements provided by these scanners may 
suffer from light scatter artefacts resulting from the wide area of detection 
[176]. Nevertheless, recent methods have been suggested to minimise such 
imaging artefacts [185, 186]. 
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Figure 2-14: Schematic of a typical cone beam optical CT scanner. A 633 nm 
diffuse light beam filtered by an optical band pass filter placed in front of the 
camera scans the dosimeter. A two-dimensional (2D) projection of ΔOD in the 
horizontal direction is acquired at each step while the dosimeter is rotating. The 
data from multiple 2D projections over a 360° scan are used to reconstruct ΔOD of 
the dosimeter for one slice. Data for multiple slices are then combined to obtain 
3D readout. 
 
2.7.1 Procedure for optical CT scanning  
3D imaging was performed using a VistaTM cone beam optical CT 
scanner (Modus Medical Devices Inc., London, ON, Canada) with a 633 nm 
LED diffuse light panel (Figure 2-14a). The standard operating procedure of 
leaving the scanner to warm up for at least 1 h prior to performing a scan was 
followed to ensure light source stability. For each scan, a set of 512 light 
intensity transmission projections (1024 × 768 pixels each) were acquired over 
360º. This resulted in the production of 256 × 256 × 256 elements with a 
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reconstructed voxel resolution of 0.86 × 0.86 × 0.86 mm. A shutter speed of 
133.2 ms, and a frame rate of 7.5 fps were used. The scanner reconstructs a 3D 
map of the optical densities within an object suspended in the scanner’s field 
of view. This is done by capturing a series of 2D optical projections through 
the region of interest while the object is being rotated and then using 
Feldkamp-filtered back projection to construct the 3D map [181]. The SMART 
dosimeter was submerged in a matching refractive index solution of ethyl 
benzoate (n20/D 1.503) (Sigma-Aldrich). In addition, a couple of drops of a 
transparent oil-based green dye (Polytek; PA, USA) were added to the 
matching liquid until the colour of the matching fluid matched that of the un-
irradiated dosimeter as shown in Figure 2-15b. This makes better use of the 
dynamic range of the camera, and would allow images of a blank dosimeter 
to show zero contrast and any changes in image intensity are as a 
consequence of irradiation [95]. Optical CT data were processed and 3D 
distribution of linear attenuation coefficients reconstruction were carried out 
using an inhouse MATLAB code (Mathworks, Natic, MA), which uses 
filtered back-projection using the inbuilt Radon transform function. 
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Figure 2-15: (a) Image of the VistaTM commercial optical CT scanner used in this 
thesis. (b) Tuning the colour of the refractive index matching fluid. 
 
2.8 Radiological properties calculation 
In all Chapters, calculation of the Zeff of each novel PRESAGE® and 
SMART dosimeter and other materials of interest was carried out using the  
commonly employed Mayneord equation [102]: 
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                       Zeff    2.94√∑       Z 
2.94  
 
 =1
                                      (2-1) 
Where ai is the relative electron fraction of the ith element.   
However, in Chapter 6 the Zeff was also calculated using  photon 
attenuation data as well as the Mayneord equation [102]. For the former, the 
Zeff was calculated from the energy-dependent effective atomic number (auto-
zeff) software [187] using the elemental compositions tabulated in Chapter 6.  
For all Chapters, the mass density (ρ) of each novel PRESAGE® 
formulation and the TE compartment of the SMART dosimeter was 
determined by measuring the sample volume and weight after they had 
completely cured and were de-moulded at room temperature (22 °C). The 
electron to mass density (Ne) is expressed in number of electrons per unit 
mass. For a chemical element, the electron density is given by Ne = NAZ/A. 
This expression can be generalised to a compound, and one has: 
 
                          e =   
 Zeff
    
 =  
Zeff
   
                                          (2-2) 
 
Where NA is the Avogadro constant, Ai is the atomic mass of the ith 
element present in a molecule, and  A  is the average atomic mass of the 
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compound [188]. The value of Ne was then multiplied by the measured ρ to 
give the value of electron density (ρe) [101]. 
2.8.1 Radiation transport parameters 
The radiation transport parameters for the novel PRESAGE® 
formulations were analysed to determine their water equivalency. 
Photoelectric absorption, Compton scatter, pair production interaction cross 
sections (Chapter 3 and 6), photon attenuation, energy absorption and total 
stopping power for novel PRESAGE® dosimeter formulations (Chapter 6) and 
other materials of interest were obtained over the energy range 0.01 - 20 MeV 
using the compound rule and were calculated using the molecular formula of 
the novel PRESAGE® dosimeters and other materials of interests provided in 
Chapter 3 and 6.  
Photon cross section data were obtained using NIST XCOM X-ray 
attenuation database [189]. The total stopping power was calculated from 
NIST ESTAR database [190]. The NIST X-ray attenuation database was also 
used to obtain elemental data for the mass energy absorption coefficients over 
the energy range 10 keV–20 MeV. Subsequently, the energy absorption 
coefficients were calculated using the mixture rule [191]: 
 
 112 
                             (
µ
ρ
)
e 
=∑     =1  (
µ
ρ
)
e  
                        (2-3) 
Where (
µ
ρ
)
e 
 is the mass energy absorption coefficient of the compound 
and (
µ
ρ
)
e  
is the mass energy absorption coefficient of each constituent element 
in the compound [192]. 
2.9 Experimental uncertainties 
The accuracy of dosimetry measurements specifies the reproducibility 
of the measurements under similar conditions and can be estimated from the 
data obtained in repeated measurements. In principle, high precision is 
associated with a small standard deviation of the distribution of 
measurement results, which can be reduced by increasing the number of 
measurements [193]. 
There are two types of errors that are part of this and any other 
experimental work; experimental error and statistical error. Experimental 
errors arise from each step of the experiment, starting from the dosimeter 
preparation, irradiation and dosimeter scanning. In the PRESAGE® and 
SMART dosimeter preparation, error becomes a factor when different batches 
of the dosimeters are used for different experiments. Although the same 
methods and chemicals are used, there was an expected variation in the 
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weight percentage (wt%) of each chemical of approximately  ± 0.5%. In 
addition, many LMG dye batches were used in this work (>25), and although 
they were all purchased from the same supplier, it was noted that some 
batches differ in appearance than others, suggesting a slight variation in 
purity of some batches which might be a source of uncertainty in 
measurements. During irradiation, the accuracy of the dose delivered varies 
for different modalities used. The accuracy for X-ray dose delivery by linear 
accelerators and superficial X-ray therapy was ± 5%, measured using 
ionisation chambers. The dose profiles from radiochromic film show less than 
2% variation in the position (middle of the field) were the dosimeters were 
placed. In this work, EBT type gafchromic films were used to validate the 
uniformity of dose delivered to dosimeter cuvettes and dosimeter blocks 
which are shown in (section 2.5.2.1.). The typical uncertainty associated with 
film measurement can be attributed to possible errors in calibration, 
nonuniform thickness of the film and reading uncertainties of the 
densitometer.  The spectrophotometers were operated based on the standard 
operating procedure (SOP) supplied by the manufactures and due to their 
very high resolution (1 nm), they are considered to be accurate.  The cone 
beam optical CT scanner was also operated based on the SOP supplied by the 
manufactures. Commercial optical CT scanners such as that used in this work 
 114 
have an estimated accuracy of ± 5% of the optical elements in the scanner. In 
addition to that, data presented in all chapters (mean values ± standard 
deviation) was the result of three independent measurements. One way 
analysis of variance (ANOVA) was used to determine the significance of the 
difference between the control and experimental group. A difference was 
considered to be statistically significant when p<0.05. Statistical analysis was 
performed with the OriginPro 8.5 SR0 v7.5714 (B714) software. 
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Part of this chapter with content formatted for publication has been published as: 
Alqathami M, Blencowe A, Qiao G, Butler D, Geso M. Optimization of the sensitivity 
and stability of the PRESAGE™ dosimeter using trihalomethane radical initiators. 
Radiat Phys Chem 2012; 81(7):867-73. (see Appendix i for copyright permission). 
Chapter 3 
Optimising the PRESAGE® 
Dosimeter using Trihalomethane 
Radical Initiators  
 
3.1 Summary 
The aim of this chapter was to investigate the effect of trihalomethane 
radical initiators on the radiological properties, radiation dose sensitivity and 
post response photostability of the PRESAGE® dosimeter. Different 
PRESAGE® dosimeters containing 50 and 100 mM of iodoform (CHI3), 
bromoform (CHBr3) or chloroform (CHCl3) radical initiators were fabricated 
and irradiated with 6 MV photons over a range of radiation doses from 0 to 
30 Gy. A comparison between sensitivity and radiological properties of the 
PRESAGE® dosimeters with the different radical initiators was carried out. 
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Optical density changes of the dosimeters before and after irradiation were 
measured using a spectrophotometer. The incorporation of different radical 
initiators in the composition of the PRESAGE® dosimeter resulted in variation 
of the radiation dose sensitivity and radiological properties of the dosimeters 
depending on the type and concentration of the radical initiator used, with 
iodoform showing the highest dose-response slope followed by bromoform 
and chloroform. However, at 100 mM iodoform, the effective atomic number 
was significantly higher than water (Zeff = 16). This enhancement in dose-
response was found to be directly related to the carbon-halogen bond 
dissociation energy and to the radiological properties of each individual 
radical initiator used in this study. Furthermore, the post-response 
photostability of the PRESAGE® dosimeters over two weeks remained stable 
regardless of the trihalomethane radical initiator employed, with negligible 
change in the post-response photostability and linearity of the PRESAGE® 
dosimeters. 
3.2 Introduction 
The PRESAGE®/optical-CT dosimetry system has recently been 
introduced as a novel 3D radiochromic dosimetric system and proven to be 
capable of 3D dosimetry of several common clinical applications [90-93, 186, 
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194]. The PRESAGE® dosimeter differs significantly from gel dosimeters, 
consisting of a clear polyurethane resin containing radiation-sensitive 
reporter components (leuco dye) and halogenated carbon radical initiators. 
Halogenated carbons (or halocarbons) are a class of organic compounds 
containing covalently bonded halogens, such as chlorine (Cl), bromine (Br) or 
iodine (I) (Chapter 1 section 1.3.3.1.1). Upon irradiation of the dosimeter free 
radicals are generated from the homolysis of the bond between carbon and 
the halogen. These radicals oxidise the leuco dye, leading to a change in 
colour (optical density) caused by the radiolytic oxidation of the leuco dye 
[20, 195]. The change in optical density is linear with respect to the absorbed 
radiation dose [72]. Some of the attractive features and potential advantages 
of the PRESAGE® dosimeter over gel dosimeters include its lack of sensitivity 
to oxygen and diffusion [196]. Furthermore, in contrast to polymer gel 
dosimeters that use precursors dissolved in a fluidic matrix, the PRESAGE® 
dosimeter is solid, easily manipulated, can be fashioned into any shape and 
requires no supporting container. The latter is particularly important from an 
optical imaging prospective as it means that light has to pass through fewer 
interfaces on its transit through the dosimeter, therefore minimizing optical 
artefacts and simplifying any optical modelling required [15]. 
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Previous studies have reported that the sensitivity of the PRESAGE® 
dosimeters can be optimised by varying the weight percent (wt%) of the 
radical initiator in the composition [72, 81, 196]. However, the effect of the 
type and concentration of the halogen in the radical initiator on the sensitivity 
of the dosimeter to radiation dose and stability has thus far not been 
investigated. Such investigation is valuable when formulating PRESAGE® 
dosimeters for different dosimetric applications. For example, to detect low 
radiation doses (< 100 mGy), such as those delivered by diagnostic imaging 
scanners, the dosimeter should be very sensitive to radiation dose. In 
contrast, in special cases where very high radiation doses (> 150 Gy) are 
delivered to targets, such as in microbeam radiotherapy (MRT) [197-199] or 
high linear energy transfer (LET) particle proton therapy [200, 201], the 
PRESAGE® dosimeter should ideally be less sensitive to radiation dose so it 
can still give a linear response at very high doses and not become saturated 
(complete saturation of the dye) at the estimated saturation absorbance of 2.6 
at ca. 150 Gy [202].  
The aim of this chapter was to investigate the influence of I, Br, and Cl 
based trihalomethane radical initiators on the radiation dose sensitivity, post-
response photostability and radiological properties of the PRESAGE® 
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dosimeter, and also indentify specific dosimetric cases where a PRESAGE® 
dosimeter with a particular radical initiator might be desirable. 
3.3 Results and discussion  
The physical properties of PRESAGE® dosimeters with different 
radical initiators are provided in Table 3-1. It should be noted that as the 
concentration of the radical initiator in the PRESAGE® formulation increases, 
the Zeff   number and physical density also increases. This increase in Zeff and 
physical density is due to the high density and atomic numbers of the type of 
halogens in the radical initiator, with iodoform showing the highest influence 
on the radiological properties of the PRESAGE® dosimeter due to the high Z 
of iodine compared to bromine and chlorine (53, 35 and 17, respectively). The 
percentage increase in the overall radiological properties of the dosimeter is 
also proportional to the concentration of the radical initiator used. It is also 
noteworthy that all the PRESAGE® compositions introduced in this study 
have Zeff values slightly lower or higher than that of water (7.42), especially 
when using 100 mM of iodoform (Zeff = 16). In addition, the significant 
increase in Zeff when using iodoform as a radical initiator can be minimised 
by lowering the concentration of iodoform in the composition to 10-20 mM. 
 120 
 
Table 3-1: Relevant effective atomic number (Zeff), mean physical density (ρ), mass 
electron density (Ne) and electron density (ρe) of different PRESAGE® dosimeters 
fabricated in this study compared to water 
Material ρ  
(Kg m-3) 
ρe  
(×10 29 em -3) 
Ne  
(×1026 e kg -1) 
Zeff 
Water 1000 3.3428  3.3428  7.42 
PRESAGE® (Chloroform)        
50 mM 1045 3.4348 3.2868 6.41 
100 mM 1047 3.4392 3.2849 6.62 
PRESAGE® (Bromoform)       
50 mM 1072 3.5178 3.2815 8.50 
100 mM 1076 3.5231 3.2743 9.96 
PRESAGE® (Iodoform)       
50 mM 1094 3.5825 3.2747 13.02 
100 mM 1102 3.5938 3.2611 16.03 
 
The photoelectric absorption, Compton scattering and pair production 
cross sections for the PRESAGE® (iodoform 100 mM) formulation relative to 
water over the energy range from 0.01 to 100 MeV are shown in Figure 3-1, 3-
2 and 3-3. As described in chapter 1 (section 1.5), the occurrence of 
photoelectric absorption depends strongly on the atomic number of the 
absorbing material and is proportional to the Z number of the material by Z3 
and is dominant in the low energy X-ray range 10–100 keV [102]. A 
comparison between the photoelectric absorption cross section of both of the 
PRESAGE® (iodoform 100 mM) formulation and water shows significant 
variations (96%) with a peak around the K-absorption edge of iodine due to 
the photoelectric effect (Figure 3-1). Therefore, it can be concluded that with 
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low-energy X-rays, where photoelectric effects become predominant, the 
PRESAGE® dosimeter with 100 mM iodoform will not be water equivalent 
and hence, a dosimetric correction factor needs to be applied to correct for the 
variations. In comparison, it is expected that PRESAGE® formulations 
containing bromine- or chlorine-based initiators should be better in terms of 
water equivalency for low energy X-rays. Within the energy range from 1 to 
20 MeV, where Compton scattering is predominant [101], the difference 
between the PRESAGE® (iodoform 100 mM) formulation and water is small 
(< 2.5%), and is not noticeable (Figure 3-2). This is due to the fact that the 
probability of Compton scattering is almost independent of the Z number 
and heavily reliant on mass density [102]. In addition, if the energy of the 
photon is greater than 1.02 MeV, the photon may interact with the material 
through pair production [102]. Since pair production results from the 
interaction of incoming photon with the nucleus, the probability of this 
process increases significantly with atomic number [102]. Nevertheless, a 
comparison between the pair production cross section of the PRESAGE® 
(iodoform 100 mM) formulation compared to water revealed only a small 
variation (< 4%) over the energy range used (Figure 3-3). This suggests that 
the PRESAGE (iodoform 100 mM) formulation has better water equivalency 
when used in the dosimetry of megavoltage energies. The response of the 
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dosimeter to 6 MV energy was investigated as the response is more similar to 
water in this range and this energy is clinically relevant. 
 
 
Figure 3-1: Photon cross sections for photoelectric absorption of the PRESAGE® 
(iodoform 100 mM) formulation and water. 
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Figure 3-2: Photon cross sections for Compton scattering of the PRESAGE® 
(iodoform 100 mM) formulation and water. 
 
 
Figure 3-3: Photon cross sections for pair production of the PRESAGE® (iodoform 
100 mM) formulation and water. 
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The absorption spectra of PRESAGE® dosimeters with different radical 
initiators after exposure to 6 MV energy are shown in Figure 3-4. The 
absorption maximum (λmax) is found to peak at the red region (ca. 633 nm), 
which is a typical visible absorption λmax of the oxidised form of LMG 
(malachite green) and is in good agreement with previously published results 
[72]. Moreover, the absorption maxima corresponds to the helium-neon laser 
output or LED source (633 nm) of commercially available optical scanning 
systems, such as OCTOPUSTM (MGS Research) and VistaTM (Modus Medical 
Devices Inc.) [72]. Therefore, PRESAGE® dosimeters with different 
halocarbon radical initiators could be used in 3D dosimetry using these 
systems with optimum sensitivity.  
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Figure 3-4: Absorption spectra of PRESAGE® dosimeters containing 100 mM of 
different trihalomethane radical initiators after exposure to 30 Gy radiation dose, 
showing absorption maxima at 633 nm. The reference cuvette (control) is used as a 
baseline to establish the zero value. Each PRESAGE® composition is referred to by 
the type of radical initiator used. 
 
The measured absorbance changes at λ = 633 nm versus the radiation 
absorbed doses for all of the dosimeters are displayed in Figure 3-5, 3-6, 3-7 
and 3-8. In order to ensure that the changes in absorbance versus absorbed 
radiation dose are in fact due to the radiation dose absorbed by the 
dosimeter, the absorption values were obtained by subtracting the relevant 
value of a reference cuvette for the same batch with zero radiation dose 
(control) from that of the irradiated cuvettes [196]. Therefore, the dose-
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response changes post-irradiation are solely due to the absorbed radiation 
dose. Consequently, the intercepts of the dose–response plots are nearly zero. 
In all cases very good correlation coefficient linearity (R2 > 0.99) for the dose 
response was observed for PRESAGE® compositions with different 
halocarbon radical initiators over the applied radiation dose range.  
 
 
Figure 3-5:  Recorded optical density changes as a function of absorbed radiation 
dose for PRESAGE® dosimeters with different concentrations of iodoform radical 
initiator. Correlation coefficient parameters of each fitted line are tabulated in the 
inset. Error bars: ± standard deviation (n=3) in the measurement.  
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Figure 3-6:  Recorded optical density changes as a function of absorbed radiation 
dose for PRESAGE® dosimeters with different concentrations of bromoform 
radical initiator. Correlation coefficient parameters of each fitted line are 
tabulated in the inset. Error bars: ± standard deviation (n=3) in the measurement.  
 
Figure 3-7:  Recorded optical density changes as a function of absorbed radiation 
dose for PRESAGE® dosimeters with different concentrations of chloroform 
radical initiator. Correlation coefficient parameters of each fitted line are 
tabulated in the inset. Error bars: ± standard deviation (n=3) in the measurement. 
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Figure 3-8:  Dose-response comparison between the different halocarbon radical 
initiators investigated. Error bars: ± standard deviation (n=3) in the measurement.  
Each PRESAGE® composition is referred to by the name of the trihalomethane 
used. The data means are significantly different (p<0.05). 
 
The change in optical density varied significantly between the different 
halocarbons used, and was clearly visible to the naked eye (Figure 3-9). In all 
cases, the slope of the dose–response curves for PRESAGE® with iodoform 
showed higher sensitivity than with bromoform and chloroform at the same 
molar concentrations and applied radiation doses (Figure 3-8). The dose 
sensitivity is expressed as the change in optical linear attenuation coefficient 
(optical density) per Gray (units .Gy-1.cm-1). The sensitivity enhancement factor 
(SEF) was defined as the ratio between the slope of the PRESAGE® dosimeter 
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formulation with iodoform and the slop of the PRESAGE® dosimeter with either 
bromoform or chloroform [203]:  
SEF = 
Slope– PRESAGE®  dosimeter with iodoform  
 Slope– PRESAGE®  dosimeter with bromoform/chloroform  
 
 At a 100 mM concentration, the slope of the PRESAGE® dosimeters 
containing iodoform radical initiator was significantly higher than those 
containing chloroform and bromoform (SEF: 4.1; 1.4, respectively). 
Furthermore, the lowest dose detected by chloroform containing dosimeters 
was 0.5 Gy (0.003 ∆OD.Gy-1.cm-1), whereas with iodoform and bromoform 
there was a ∆OD at a much lower dose of 5 cGy, which is the lower limit used 
in this study. At 25 cGy, the PRESAGE® dosimeter containing 100 mM of 
iodoform gave 0.023 ∆OD.Gy-1.cm-1,  which is higher than the ∆OD observed 
for a commercially available formulation of the PRESAGE® dosimeter after 
delivering 10 Gy [194].  However, the downside for this increase in dose 
sensitivity when using iodoform is the significant increase in Zeff, which 
means that such dosimeters are not appropriate for low-energy X-rays. 
However, one suggested strategy to overcome that is to significantly lower 
the concentration of iodoform in the formulation. For example, the 
percentage increase in sensitivity when increasing the concentration of 
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iodoform from 50 to 100 mM is small (15%) (Figure 3-5). This suggests that a 
PRESAGE® formulation containing lower concentrations of iodoform (10-20 
mM) would not significantly differ in response than when using 100 mM of 
iodoform, and will still show a higher slope than chloroform and bromoform. 
 
 
Figure 3-9: Photographs of the PRESAGE® dosimeter cuvettes with different 
concentrations of chloroform, bromoform and iodoform radical initiators (a) 
before (0 Gy) and (b) after exposure to 30 Gy. Each PRESAGE® dosimeter is 
referred to by the type of halocarbon used in the composition (CHCl3 = 
chloroform, CHBr3 = bromoform, and CHI3 = iodoform). 
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This significant increase in sensitivity to radiation dose when using 
iodoform is due to the lower C–I bond dissociation energy (57.6 kcal.mol-1) 
compared to C–Br and C–Cl (72.1 and 83.7 kcal.mol-1, respectively) [204, 205]. 
Thus, less energy is required to cause homolysis of iodoform to afford free 
radicals than bromoform or chloroform. As indicated in chapter 1 (section 
1.5), the action of ionising radiation – which includes both photons and 
particles – is initiated by the transmission of its energy to a material as it 
traverses along its path. Therefore, gamma and X-rays deposit most of their 
energy through secondary electrons that are generated by photoelectric, 
Compton and pair production effects [206]. The probability of these 
interactions is heavily reliant on atomic number (Z), mass density (ρ), and 
electron density (ρe). Thus, it is expected that organoiodine compounds such 
as iodoform would increase the probability of interactions between photons 
and the dosimeter in the megavoltage energy range where Compton 
interaction is predominant [102, 207]. This is due to the high density of iodine 
(4.9 g.cm–3) compared to bromine and chlorine (3.1 and 1.6 g.cm-3, 
respectively). Therefore, the PRESAGE® dosimeters containing iodoform as a 
radical initiator can be used to detect very low radiation doses (in the mGy 
range), such as those used in diagnostic radiology, although the dosimeter 
would be saturated at radiation doses < 100 Gy, which is lower than the ca. 
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150 Gy previously reported [202]. In comparison, chloroform and 
organochlorine compounds in general are not as sensitive to radiation as 
organoiodine or organobromine compounds. As a result, dosimeters 
containing chloroform are expected to have much higher saturation points 
and might be ideal in dosimetric cases where the purpose is to measure 
extremely high radiation doses such as those used in MRT or high LET 
particle proton therapy [200]. It has been reported that, due to the high LET of 
the protons near the end of their range, recombination of free radicals results 
in a complete saturation of the 3D dosimeters leading to an underestimation 
of ca. 20% [200, 201, 208]. This suppression in response could be minimised by 
lowering the sensitivity of the dosimeter to radiation dose. PRESAGE® 
dosimeter formulations containing a radical initiator with lower sensitivity to 
radiation dose and hence, higher saturation point such as chloroform-based 
PRESAGE® formulations have the potential to minimise the reported dose 
underestimation caused by saturation of the dosimeter. PRESAGE® 
dosimeters with bromoform or iodoform radical initiators would not be ideal 
for such measurements as they would show similar dose underestimation 
near the end of the protons range [208]. Organoiodine compounds are also 
expected to increase the probability of radiation interaction with matter in 
kilovoltage X-ray energies via photo-absorption, which have been 
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demonstrated in several studies [203, 209-211]. In respect to the PRESAGE® 
dosimeter, the probability of photoelectron emissions from the halogen is 
dependent on the halogen atom’s K-edge electron binding energy [206]. Since 
iodine has a higher K-edge electron binding energy value (33.17 keV) than 
bromine and chlorine (13.47 and 2.88 keV, respectively), it is expected that 
organoiodine compounds such as iodoform would enhance the sensitivity of 
the PRESAGE® dosimeter to kilovoltage X-rays more than bromoform and 
chloroform via the photoelectric absorption. 
In terms of the concentration effect of the different radical initiators on 
the sensitivity of the PRESAGE® dosimeter, the increase in the sensitivity to 
radiation dose is found to be proportional to the concentration of the radical 
initiator in the composition. However, this relationship is only true until a 
certain limit. For example, in a recent study it was found that an increase in 
carbon tetrachloride radical initiator beyond 20 wt% retarded the sensitivity 
and photostability of the PRESAGE® dosimeter [196].  
The post-response photostability of the PRESAGE® dosimeters with 50 
and 100 mM of the different trihalomethane radical initiators are shown in 
Figure 3-10. The results demonstrate that the type and concentration of the 
trihalomethane radical initiator has no influence on the post-response 
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photostability of the PRESAGE® dosimeters over a period of one week from 
exposure. In general, all PRESAGE® compositions introduced in this 
investigation were stable over the period studied. This post-response 
photostability could be attributed to the relatively small concentration of 
radical initiators employed (< 4 wt%). A recent study has demonstrated that 
increasing the concentration of the radical initiator in the composition of the 
PRESAGE® dosimeter beyond ca. 10 wt% causes the radical initiator to 
continue oxidising the LMG dye after exposure to radiation, especially after 
the first couple of days from radiation exposure, leading to fluctuation in the 
post-response optical density change of the dosimeter [196].In addition, the 
delivered dose was found to have no influence on the post-response 
photostability of all formulation investigated. 
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Figure 3-10: Variation in optical density over time for PRESAGE® dosimeters 
containing 50 and 100 mM of different halocarbon radical initiators after exposure 
to 0.5 Gy. Each PRESAGE® composition is referred to by the type of radical 
initiator used used. Error bars: ± standard deviation. The solid line is a second 
order (k=2) polynomial fit. 
 
3.4 Conclusion 
In this chapter the influence of I, Br and Cl based trihalomethane 
radical initiators on radiation dose sensitivity, post-response photostability 
and radiological properties of the PRESAGE® dosimeter were investigated. 
The dosimeters were exposed to varying radiation doses using 6 MV energy. 
It was noted that, in general, incorporating iodoform in the composition of 
the PRESAGE® dosimeters enhances the sensitivity of the dosimeter to 
radiation dose more than bromoform or chloroform. At a 100 mM 
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concentration, the slope of the PRESAGE® dosimeter containing iodoform as 
a radical initiator was significantly higher than chloroform and bromoform 
(SEF: 4.1; 1.4, respectively), with a limitation of a large increase in Zeff. In 
addition, the sensitivity to radiation dose increases as the concentration of the 
radical initiator in the PRESAGE® dosimeter composition increases until a 
plateau is reached. The overall effect of the trihalomethanes on the sensitivity 
enhancement of the PRESAGE® dosimeter to radiation dose is directly related 
to the bond dissociation energies of the C─X (X = I, Br or Cl) bonds and the 
radiological properties of each individual radical initiator, which is in good 
agreement with previous studies.  
Overall, varying the concentration and type of trihalomethane radical 
initiator is found to be an efficient way to tune the sensitivity of the 
PRESAGE® dosimeter to radiation dose. For example, whether the 
PRESAGE® dosimeter needs to be sensitive/insensitive to radiation dose relies 
heavily on the dosimetric case. In general, PRESAGE® dosimeters containing 
organoiodine or organobromine compounds, or a combination, are ideal 
when measuring low radiation doses. Meanwhile, PRESAGE® dosimeters 
containing organochlorine compounds are ideal when measuring extremely 
high radiation doses. Since the concentration of the radical initiator has little 
 137 
effect on the sensitivity of the dosimeter to radiation dose, the concentration 
can be increased/decreased significantly to achieve water-equivalent 
radiological properties with minimal reduction in sensitivity to radiation 
dose. Finally, none of the three investigated trihalomethane radical initiators 
had a noticeable effect on the post-response photostability or linearity of the 
PRESAGE® dosimeter over the period of two weeks.  
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 Chapter 4  
Evaluation of Ultra-sensitive 
Leucomalachite Dye Derivatives for 
use in the PRESAGE® Dosimeter 
 
4.1 Summary 
In the previous chapter it was shown that the sensitivity of the 
PRESAGE® dosimeter could be tailored by using different trihalomethane 
radical initiators, although a trade of exists between sensitivity and 
radiological equivalency to water. Therefore, this chapter further investigates 
the possibility of tuning the properties of the PRESAGE® dosimeter through 
modification of another critical component, the photochromic leuco dye.  
Thus, a comparison between the commercially available leucomalachite green 
(LMG) dye and three newly synthesised derivatives (with either methoxy, 
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chloro or bromo substituents) incorporated into the PRESAGE® dosimeter 
was conducted to determine their effect on the sensitivity and post-response 
photostability of the dosimeter. In addition, the influence of the new LMG 
derivatives on the basic radiological properties of the PRESAGE® dosimeter 
was also investigated. The dosimeters were prepared in spectrophotometric 
cuvettes, irradiated with a 6 MV X-ray beam, and the change in optical 
density of each dosimeter was measured using a spectrophotometer. For all 
of the new LMG derivatives investigated, the sensitivity of the resulting 
dosimeters to radiation dose increased significantly relative to the 
unmodified LMG dosimeter, and was dependent on the type of LMG 
derivative used, with the bromo substituted derivative showing the highest 
increase in sensitivity (450%), followed by chloro and methoxy substituted 
derivatives (340 and 200%, respectively). Overall, the new LMG derivatives 
had only a minimal influence on the radiological properties of the PRESAGE® 
dosimeter, with the exception of the bromo substituted LMG, which 
increased the effective atomic number (Zeff) of the dosimeter by 9%. All of the 
LMG dyes investigated showed similar post-response photostability 
characteristics, with the methoxy substituted LMG showing a slight 
improvement in post-response photoretention. 
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4.2 Introduction 
Conceivably, one of the most significant developments in 3D 
dosimetry over the past decade was the introduction of the PRESAGE® 
dosimeter [73]. The PRESAGE® dosimeter is a unique 3D radiochromic 
dosimeter with great potential for clinical applications [90-95]. Unlike 
polymer gel dosimeters [15, 17], the PRESAGE® dosimeter is a transparent, 
solid polyurethane matrix containing leucomalachite green (LMG) dye as a 
reporter component and halocarbons (e.g., chloroform) as a radical source 
[72, 74]. Upon irradiation, free radicals are generated from the radiolysis of 
the halocarbon bonds and the number of free radicals produced is directly 
proportional to the C–X bond dissociation energy (X = Cl, Br, I) [74]. These 
free radicals oxidise the LMG dye leading to a change in colour (optical 
density), which is linear with respect to the absorbed radiation dose [72]. 
Contrary to polymer gel dosimeters, there have been no reports about the 
potential oxidation mechanism of the LMG dye by the radical initiator in 
PRESAGE® dosimeters. The oxidation of LMG ultimately results in the 
formation of malachite green (MG) (coloured form), although this may occur 
through several different pathways, which will be discussed in more detail 
later (vide infra). Some of the attractive features and advantages of the 
PRESAGE® dosimeter over gel dosimeters include its lack of sensitivity to 
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oxygen and diffusion [20, 72, 73]. Furthermore, the PRESAGE® dosimeter is 
solid, easily handleable, can be fashioned into any shape and requires no 
supporting container. Although the majority of studies have focused on 
clinical application of the PRESAGE® dosimeter, there have also been a 
number of studies concerned with the optimisation of the main components 
of the PRESAGE® dosimeter, with the ultimate aim of developing a suite of 
formulations for different applications [74]. For example, a detailed 
investigation into the potential influence of different halocarbon radical 
initiators on the overall characteristics of the PRESAGE® dosimeter has 
shown that there is a correlation between C-X bond strength and the 
sensitivity of the dosimeter to ionising radiation (10). In general, 
organoiodine initiators were found to possess the highest sensitivity, 
followed by organobromine and organochlorine initiators, respectively [74]. 
In addition, it has been reported that earlier PRESAGE® dosimeter 
formulations, due to their high effective atomic number (Zeff) of 8.65 [101], 
were not water-equivalent in the kilovoltage energy range (0.01 to 0.1 MeV) 
where photoelectric absorption is predominant [102]. This was attributed to 
the increase in the concentration of the high atomic number (Z) halocarbon 
radical initiator [101]. However, recently introduced formulations with 
significantly reduced halocarbon concentrations have shown great promise 
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for dosimetry of kilovoltage X-ray beams [207]. Indeed, the best strategy to 
improve the radiological properties of the PRESAGE® dosimeter is to reduce 
the concentration of high atomic number components (e.g., halocarbon 
initiators). The downside however, is a reduction in the sensitivity of the 
dosimeter to radiation dose. Although this has not been investigated by the 
authors [207], the sensitivity of a dosimeter to radiation dose is a key 
parameter to consider, since most dosimetric applications are performed with 
relatively low radiation doses (< 5 Gy), and therefore, the dosimeter needs to 
have a strong and linear response at low radiation doses, whilst maintaining 
tissue-like radiological properties.  Therefore, with the aim of developing a 
high sensitivity dosimeter with linear response at low radiation doses we 
investigated other potential approaches of improving the sensitivity of the 
dosimeter without significantly affecting the radiological properties. As part 
of a series of PRESAGE® dosimeter component-specific optimisation studies 
[74, 162], the aim of this study was to investigate several new LMG 
derivatives as a potential novel approach to enhance the sensitivity of the 
dosimeter to radiation dose. 
 143 
4.3 Results and discussion 
The molecular structure of the commercial LMG dye (systematic name 
4,4'-(phenylmethylene)bis(N,N-dimethylaniline)) and its derivatives 
employed in this study are shown in Figure 4-1. In the three new derivatives, 
one of the ortho aryl protons of LMG is substituted with either methoxy 
(MeO-LMG), chloro (Cl-LMG) or bromo (Br-LMG) groups  
(systematic names 4,4'-((2-methoxyphenyl)methylene)bis(N,N-
dimethylaniline), 4,4'-((2-chlorophenyl)methylene)bis(N,N-dimethylaniline) 
and 4,4'-((2-bromophenyl)methylene)bis(N,N-dimethylaniline), respectively). 
 
 
Figure 4-1: Molecular structure of the LMG derivatives investigated in this 
chapter. R = the substituted part of the parent LMG. 
 
Table 4-1 lists the radiological properties of the PRESAGE® dosimeters 
with commercial LMG and its substituted derivatives. The densities of the 
PRESAGE® dosimeters with commercial LMG, MeO-LMG, Cl-LMG and Br-
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LMG were found to be respectively 4.8, 5.2, 5.4 and 5.7% greater than that of 
water. This increasing trend in density can be attributed to the increasing 
molecular mass of the substituent upon going from H (LMG) to Br (Br-LMG). 
The calculated electron densities of LMG, MeO-LMG, Cl-LMG and Br-LMG 
were respectively determined to be 3.0, 3.4, 3.5 and 3.9% greater than that of 
water. The number of electrons per gram for all the PRESAGE® dosimeter 
formulations with the different LMG derivatives was lower than that of water 
by ca. 2%. In terms of Zeff,  the values for the PRESAGE® formulations with 
LMG, MeO-LMG and Cl-LMG were almost identical to water, whereas the Zeff 
for Br-LMG was 9% higher than that of water, which is attributed to the high 
atomic number (Z) of bromine (Z = 35). Therefore, since the probability of 
photoelectric interactions is proportional to the atomic number (Z) by Z3 
[102], it can be concluded that with low-energy X-rays were photoelectric 
effects are predominant the PRESAGE® dosimeter formulations introduced 
here could be considered water equivalent, with the exception of the 
formulation containing Br-LMG, whereby a dosimetric correction factor 
needs to be applied to correct for the variation. Alternatively, lowering the 
concentration of Br-LMG in the formulation would also lower the Zeff value of 
the dosimeter, although this would also be expected to affect the sensitivity to 
radiation dose [162]. In the megavoltage energy range (1–20 MeV) were 
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Compton effects resulting from an interaction between a photon and a free 
electron are predominant [102] and heavily reliant on ρ and ρe, the water 
equivalency of all the PRESAGE® formulations with different LMG 
derivatives is much closer to water and thus, a correction factor may not be 
needed.  
 
Table 4-1: Effective atomic number (Zeff), mean physical density (ρ), mass electron 
density (Ne) and electron density (ρe) of different PRESAGE® dosimeters 
fabricated in this study compared to water. 
Material ρ  
(kg m-3) 
ρe  
(×1029 e m -3) 
Ne 
(×1026 e kg -1) 
Zeff 
Water 1000 3.3428  3.3428  7.42 
PRESAGE® (LMG) 1048 3.4430 3.2853 7.45 
PRESAGE® (MeO-LMG) 1052 3.4566 3.2858 7.46 
PRESAGE® (Cl-LMG) 1054 3.4622 3.2848 7.50 
PRESAGE® (Br-LMG) 1057 3.4736 3.2832 8.14 
 
The absorption spectra of the PRESAGE® formulations with different 
LMG derivatives after oxidisation are shown in Figure 4-2. For all of the 
dosimeters, the λmax was found to peak at ca. 633 nm (red region of the 
spectrum), which is a typical visible absorption λmax of the oxidised form of 
LMG (malachite green). This suggests that the new LMG derivatives could be 
used with current optical tomography imaging systems such as VistaTM 
(Modus Medical Devices Inc.) with optimum sensitivity. 
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Figure 4-2: Normalised absorption spectra of the PRESAGE® dosimeters with the 
four dyes used in this study showing absorption maxima at ca. 633 nm. Reference 
cuvettes (same composition but with zero radiation dose) for each formulation 
were used as a baseline. 
 
The measured absorbance changes at a wavelength of 633 nm versus 
the absorbed radiation doses for all of the dosimeters are displayed in Figure 
4-3. In all cases a very good correlation coefficient linearity (R2 > 0.99) for the 
dose response was observed over the applied radiation dose range. This 
suggests that the new MeO-, Cl- and Br-LMG derivatives had no influence on 
the typical dose-response linearity of the standard PRESAGE® dosimeter 
formulation.  
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The percentage of enhancement in sensitivity was defined as the ratio 
between the slope of the PRESAGE® dosimeter with the substituted LMG 
derivative and the slope of the PRESAGE® dosimeter with the commercial 
unsubstituted LMG: 
% SEF = 
Slope– PRESAGE®  with LMG derivative  
×100 
   Slope– PRESAGE®  with commercial LMG  
 
It was found that the ∆OD varied significantly between LMG and its 
derivatives, with the dose–response curve for the dosimeter with Br-LMG 
showing the highest sensitivity, followed by those with Cl-LMG and MeO-
LMG (450 , 340  and 200% increase, respectively), relative to the commercial 
LMG (Figure 4-3). This difference was also clearly visible with the naked eye 
(Figure 4-4).  
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Figure 4-3: Recorded absorbance changes as a function of absorbed radiation dose 
for the PRESAGE® dosimeters with LMG dye and its derivatives. Correlation 
coefficient parameters of each fitted line are shown in the top left inset. Error bars: 
± standard deviation (n = 3). The data means are significantly different (p<0.05). 
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Figure 4-4: Photographs of the PRESAGE® dosimeter cuvettes with LMG and its 
derivatives (MeO-LMG, Cl-LMG and Br-LMG) (a) before irradiation and (b) after 
exposure to 30 Gy.  
 
The significant increase observed for the halogen substituted LMG 
derivatives could result from radiation induced homolysis of the arylhalide 
bond to generate radicals in addition to the generation of radicals from the 
radical initiator (tetrabromoethane) that was used in this study, leading to an 
overall increase in the radical concentration. This might explain the larger 
∆OD for the Br-LMG dosimeter over the Cl-LMG dosimeter, since the aryl-
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bromide bond dissociation energy (82 kcal.mol-1) is lower than that of the 
aryl-chloride (97 kcal.mol-1) [212]. Although the bond dissociation energies of 
arylhalides are greater than their alkyl analogues (alkyl-bromide and alkyl-
chloride bond dissociation energies = 72 and 84 kcal.mol-1, respectively) it is 
conceivable that homolysis of the arylhalide bond occurs upon irradiation. To 
test this hypothesis, dosimeters were prepared using LMG and Br-LMG 
without the addition of the tetrabromoethane radical initiator, and irradiated 
with 6 MV energy X-rays for a dose of 50 Gy. Interestingly, no ΔOD was 
noted, eliminating both radiolysis of the arylhalide bond as a possible source 
of radicals and radiation induced excitation of the dye as a mechanism of 
oxidation under these conditions. This also supports the hypothesis that the 
mechanism of LMG oxidation in the PRESAGE® dosimeter involves the initial 
formation of carbon centred radicals via the radiation induced homolysis of 
alkyl halocarbons (Figure 4-5). It is believed that these carbon centred radicals 
abstract the methine proton from LMG leading to a resonance stabilised 
radical cation form of the dye (Figure 4-5). This cationic radical is then 
converted to the cationic malachite green (MG), possibly through radical 
dimerisation with halide radicals followed by displacement of the halide 
anion or some other electron transfer process. However, this proposed 
mechanism does not provide any obvious justification for the trend in Δ OD 
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of the dosimeters with different substituted LMG derivatives. It seems 
unlikely that electronic effects resulting from the substituents are solely 
responsible for defining the activity of the LMG derivatives, since the 
methoxy substituent would impart an electron donating resonance effect on 
the adjacent aromatic group, and the bromo and chloro substituents would be 
expected to impart an electron withdrawing inductive effect (although it is 
also possible for halide substituents to impart a very weak resonance effect 
through donation from non-bonded lone pairs). Regards of this, all of the 
dosimeters containing substituted LMG derivatives are more sensitive to 
radiation than the parent LMG dye. In addition, it has been shown that 
electron withdrawing and donating substituents have little effect on the bond 
dissociation energies of the methine bond of triphenylmethane derivatives, 
such as LMG [213, 214]. Therefore, other factors need to be considered, 
including the possible coordination of the ortho substituents to the radical 
initiator to stabilise the radical centre, which in theory would bring the 
radical initiator into close proximity with the central methine of the dye and 
facilitate proton abstraction. Although it is evident that the ortho substituent 
of the LMG derivatives play an important role in the observed sensitivity of 
the dosimeters and it is clear that the sensitivity of the dosimeter can be 
tailored through the use of differently substituted LMG derivatives, no 
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obvious trends in dye sensitivity can be concluded from this preliminary 
study. Therefore, a wider selection of LMG derivatives with electron 
withdrawing and donating substituents at different positions (ortho versus 
para) will need to be investigated. 
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Figure 4-5: Proposed chemical scheme of radical induced oxidation of 
leucomalachite green (LMG) to malachite green (MG).  
 
The post-response photostability of the PRESAGE® dosimeters with 
different LMG derivatives are shown in Figure 4-6. The results demonstrate 
that all of the PRESAGE® compositions employed in this study had 
reasonable post-response photostability over a period of one week, with 
MeO-LMG showing a slight improvement in the retention of the post-
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response optical density value over the period studied. This reasonable post-
response photostability could be attributed to the small concentration of 
radical initiator employed (< 1 wt%). In addition, the absorbed radiation dose 
had no influence on the post-response photostability of all investigated leuco 
dyes. 
 
 
Figure 4-6: Variation in absorbance over time for the PRESAGE® dosimeters with 
the four dyes used in this study after exposure to 1 Gy. Error bars: ± standard 
deviation. The solid line is a second order (k=2) polynomial fit. 
 
Although increasing the concentration of the radical initiator in the 
composition of the PRESAGE® dosimeter would increase its sensitivity to 
radiation dose up to a certain limit (ca. 10 wt%) [74, 196], further increases 
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lead to continued oxidation of the LMG dye after exposure to radiation and 
fluctuation in the post-response optical density of the dosimeter, especially 
during the first couple of days post-irradiation [162]. Therefore, although the 
new LMG derivatives provide greatly increased sensitivity, whilst 
maintaining the dosimeters radiological similarity to water, the post-response 
stability could still be improved.  This could possibly be the achieved by 
including additives in the formulation that are known to improve the stability 
of LMG dyes [215].  
4.4 Conclusion 
In this chapter, the influence of newly developed LMG derivatives on 
the overall characteristics of the PRESAGE® dosimeter were investigated for 
potential use in the composition of the commercial PRESAGE® dosimeter. The 
dosimeter cuvettes were exposed to varying radiation doses using 6 MV X-
ray energy. Overall, all new LMG derivatives showed significant 
improvement over the commercial LMG, with Br-LMG showing the highest 
sensitivity enhancement. All three new LMG dye derivatives show no 
significant effects on the radiological properties when compared with the 
parent LMG except for Br-LMG, which increased the Zeff of the dosimeter by 
9%, which was attributed to the high Z number of bromine. This could be 
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rectified by lowering the concentration of the Br-LMG in the composition of 
the PRESAGE® dosimeter. In addition, the substituted LMG derivatives had 
no influence on the typical characteristics of the PRESAGE® dosimeter such as 
linearity and post-response photostability. Therefore, where higher 
sensitivity is required, particularly for low radiation doses, it is 
recommended that the commercial LMG used in the composition of the 
PRESAGE® dosimeter be replace by any of the newly synthesised derivatives, 
especially Br-LMG. 
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Chapter 5  
Optimising the PRESAGE® 
Dosimeter using Metal Compounds 
 
5.1 Summary 
In the previous chapter, it was shown that the sensitivity of the 
PRESAGE® dosimeter could be optimised using novel photochromic leuco 
dyes. However, they had little influence on the post-response photostability 
of the dosimeter. Therefore, in this chapter a further investigation into the 
possibility of tuning the characteristics of the PRESAGE® dosimeter through 
the introduction of novel components in the formulation has been carried out. 
In this chapter, the radiation-modifying effects of incorporating commercially 
available bismuth, tin and zinc-based compounds in the composition of the 
PRESAGE® dosimeter, and the feasibility of employing such compounds for 
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radiation dose enhancement were conducted. Furthermore, results in this 
chapter demonstrate that metal compounds can be included in the 
formulation to yield water-equivalent PRESAGE® dosimeters with enhanced 
dose response. Various concentrations of the metal compounds were added 
to a newly developed PRESAGE® formulation and the resulting dosimeters 
were irradiated with 100 kV and 6 MV photon beams. A comparison between 
sensitivity and radiological properties of the PRESAGE® dosimeters with and 
without the addition of metal compounds was carried out. Optical density 
changes of the dosimeters before and after irradiation were measured using a 
spectrophotometer. In general, when metal compounds were incorporated in 
the composition of the PRESAGE® dosimeter, the sensitivity of the dosimeters 
to radiation dose increased depending on the type and concentration of the 
metal compound, with the bismuth compound showing the highest dose 
enhancement factor. In addition, these metal compounds were also shown to 
improve the retention of the post-response absorption value of the 
PRESAGE® dosimeter over a period of 2 weeks. Thus, incorporating 1-3 mM 
(ca. 0.2 wt%) of any of the three investigated metal compounds in the 
composition of the PRESAGE®  dosimeter was found to be an efficient way to 
enhance the sensitivity of the dosimeter to radiation dose and stabilise its 
post-response for longer times. Furthermore, the addition of small amounts 
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of the metal compounds also accelerates the polymerisation of the PRESAGE® 
dosimeter precursors, significantly reducing the fabrication time. Finally, a 
novel water-equivalent PRESAGE® dosimeter formula optimised with metal 
compounds was proposed for clinical use in both kilovoltage and 
megavoltage radiotherapy dosimetry. 
5.2 Introduction 
As described in Chapter 1 (section 1.3.3.1), the 3D matrix of the 
PRESAGE®  dosimeter is composed of a polyurethane resin that is prepared 
through the step-growth polymerisation of isocyanate and alcohol (also 
known as polyols) functionalised precursors [82]. When the precursors are 
thoroughly blended in a specific ratio, a polymerization reaction is initiated 
and the mixture cures to afford a solid resin. However, this polymerisation 
reaction may occur slowly in the absence of a suitable catalyst [76, 84]. Metal 
compounds and amines have been extensively investigated as catalysts and 
in general, the former behave as Lewis acids, activating the isocyanate 
through complexation, whereas the latter behave as Lewis bases, activating 
the alcohol; both of which promote the isocyanate-alcohol reaction to proceed 
faster resulting in a complete cure response in a shorter period of time [76, 85, 
86]. The most commercially utilised metal compounds for manufacturing 
 160 
polyurethanes are tin-based compounds such as dibutiltin dilaurate 
(DBTDL), which is considered the standard catalyst for the promotion of the 
reaction of an isocyanate with active hydroxyl group of a polyol [76, 82-84]. 
However, a wide range of metal compounds, including metal carboxylates, 
are also capable of efficiently catalysing the reaction [85, 86].  
In addition, the action of ionising radiation – which includes both 
photons and particles – is initiated by the transmission of its energy to a 
material as it traverses along its path. Furthermore, gamma- and X-rays 
deposit most of their energy through secondary electrons that get generated 
by photoelectric, Compton and pair production effects [102]. The probability 
of these interactions is heavily reliant on atomic number (Z), mass density (ρ), 
and electron density (Ne) [101, 207]. Therefore, it was expected that 
incorporating metal compounds in the formulation of the PRESAGE® 
dosimeter would increase the probability of interactions between photons 
and the dosimeter. 
It has been reported that the sensitivity of PRESAGE® dosimeters can 
be optimised by varying the weight percent (wt%) of the two main radiation-
sensitive components in the formula; namely, the radical initiator and leuco 
dye [72, 74, 81]. However, the potential radiation-modifying effects of metal 
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compounds on the radiochromic response of the PRESAGE® dosimeter have 
thus far not been investigated. Such investigation might be valuable when 
formulating PRESAGE®  dosimeters to detect low radiation doses (< 0.5 Gy), 
which is the lower limit dose measurement recorded thus far [72]. Also, from 
a clinical prospective, the ability to fabricate case-specific PRESAGE® 
dosimeters in a significantly shorter time would enable rapid dosimetric 
measurements and optimisation of radiotherapy treatment plans.  
The aim of this chapter is to investigate the potential radiation dose 
enhancement effects of different commercially available heavy metal 
compounds on the PRESAGE® dosimeter. Their potential effects on the 
radiological properties and post-response stability were also investigated. In 
order to assess the effect of the metal compounds the concentrations of the 
radical initiator and reporter compounds were kept constant throughout and 
only the type and concentration of the metal compounds in the composition 
were varied. Optical density dose response was the base for comparison 
between each formulation. The metal compounds selected in this chapter 
were three compatible metal carboxylates, namely, dibutyltin dilaurate 
(DBTDL) (Merck), bismuth neodecanoate (Bi Neo) (Aldrich) and zinc octoate 
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(Zn Oct) (Alfa Aesar). The selection of these metal compounds was based 
upon the criteria indicated in Chapter 2 (section 2.3.1.3) of this thesis. 
5.3 Results and discussion  
The radiological properties of PRESAGE® dosimeters with metal 
compounds are provided in Table 5-1. It can be noted that as the 
concentration of metal compound in the PRESAGE® formulation increases, 
the Zeff number also increases. This increase in Zeff is due to the high atomic 
numbers of the metal atoms of the metal compounds (Bi: 83; Sn: 50; Zn: 30). 
The percentage increase in Zeff is also proportional to the type and 
concentration of the metal compound used. For example, 3 mM of Bi Neo will 
increase the Zeff more than 3 mM of Zn Oct. It is also noteworthy that of all 
PRESAGE® compositions introduced in this work have Zeff higher than that of 
water (7.42). Therefore, since the probability of photoelectric interactions is 
proportional to the atomic number (Z) by Z3 [102], it can be concluded that 
with low-energy X-rays were photoelectric effects become predominant the 
PRESAGE®  dosimeter will not be water equivalent and hence, a dosimetric 
correction factors needs to be applied to correct for the variations. However, a 
novel metal compound-optimised PRESAGE® dosimeter with an identical Zeff 
to that of water is also introduced later in this chapter; the newly formulated 
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novel PRESAGE® dosimeter and its radiological properties compared to 
water are presented in Table 5-2. The percentage increase in density (ρ) and 
electron density (ρe) of PRESAGE® dosimeters with and without metal 
compounds were not significant (Table 5-1). For example, upon addition of 3 
mM of metal compounds to the PRESAGE® formulation there is an increase 
in both ρ and ρe of 4.0% for Bi Neo, 3.8% for DBTDL and 3.7% for Zn Oct. 
Therefore, in the megavoltage energy range (1–20 MeV) were Compton 
effects resulting from an interaction between a photon and a free electron are 
predominant [102], the water equivalency of all PRESAGE®  compositions 
with metal compounds maybe better than low-energy X-rays, especially 
when using small concentrations (1-3 mM).  
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Table 5-1: Relevant Effective atomic number (Zeff), mean physical density (ρ), mass 
electron density (Ne) and electron density (ρe) of different PRESAGE® dosimeters 
fabricated in this study compared to water. 
Material ρ  
(Kg m-3) 
ρe  
(×10 29 em -3) 
Ne  
(×1026 e kg -1) 
Zeff 
Water 1000 3.3428  3.3428  7.42 
PRESAGE® 1044 3.4161 3.2721 7.47 
PRESAGE®+ Bi Neo         
1 mM 1085 3.5499 3.2718 7.90 
3 mM 1087 3.5561 3.2715 8.66 
6 mM 1089 3.5621 3.2710 9.60 
10 mM 1096 3.5843 3.2703 10.63 
PRESAGE®+ DBTDL         
1 mM 1082 3.5402 3.2719 7.53 
3 mM 1084 3.5467 3.2718 7.65 
6 mM 1086 3.5530 3.2717 7.83 
10 mM 1093 3.5758 3.2715 8.05 
PRESAGE®+ Zn Oct         
1 mM 1081 3.5370 3.2719 7.48 
3 mM 1083 3.5435 3.2719 7.49 
6 mM 1087 3.5564 3.2718 7.52 
10 mM 1092 3.5727 3.2717 7.55 
 
The absorption spectra of selected PRESAGE® dosimeters with and 
without metal compounds after exposure to 100 kV energy are shown in 
Figure 5-1. The absorption maximum (λmax) is found to peak at the red region 
of the spectrum (ca. 633 nm), which is a typical visible absorption λmax of the 
oxidised form of LMG (malachite green) and is in good agreement with 
previously published results [72]. Moreover, the absorption maxima 
corresponds to the helium-neon laser output or LED source (633 nm) of the 
commercially available optical scanning systems such as OCTOPUSTM (MGS 
Research) and VistaTM (Modus Medical Devices Inc.) [72]. Therefore, 
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PRESAGE® dosimeters with metal compounds could be used in 3D dosimetry 
using these systems with optimum sensitivity.  
 
 
Figure 5-1: Absorption spectra of for PRESAGE® dosimeters without and with 3 
mM of metal compounds. The radiation dose delivered is 30 Gy and the energy 
used is 100 kV. The reference cuvette (control) is used as a baseline to establish 
the zero value. 
 
The measured absorbance changes at λ = 633 nm versus the 
radiation absorbed doses for all of the dosimeters are displayed in Figure 5-2 
and 5-3. In order to ensure that the changes in absorbance versus absorbed 
radiation dose are in fact due to the radiation dose absorbed by the 
dosimeter, the absorption values were obtained by subtracting the relevant 
value of a reference cuvette for the same batch with zero radiation dose 
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(control) from that of the irradiated cuvettes [196]. Therefore, the dose-
response changes post-irradiation are solely due to the absorbed radiation 
dose. Consequently, the intercepts of the dose–response plots are nearly zero. 
In all cases a very good correlation coefficient linearity (R2 > 0.99) for the dose 
response was observed for PRESAGE® compositions with metal compounds 
over the applied radiation dose range.  
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Figure 5-2: Recorded optical density changes as a function of absorbed radiation 
dose for the PRESAGE® formulation without and with different concentrations of 
(a) Bi Neo (b) DBTDL and (c) Zn Oct metal compounds showing the response to 6 
MV photons energy. Correlation coefficient parameters of each fitted line are 
shown in the inset of each graph. Error bars: ± standard deviation (n = 3).  
 168 
 
Figure 5-3: Recorded optical density changes as a function of absorbed radiation 
dose for the PRESAGE® formulation without and with different concentrations of 
(a) Bi Neo (b) DBTDL and (c) Zn Oct metal compounds showing the response to 
100 kV energy. Correlation coefficient parameters of each fitted line are shown in 
the inset of each graph. Error bars: ± standard deviation (n = 3).  
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The dose enhancement was defined as the slope of the dose–
response curve [196]. The dose enhancement factor is defined as the ratio 
between the slope of the PRESAGE® dosimeter with metal compound and the 
slope of the PRESAGE®  dosimeter without any metal compound [203]:  
DEF = 
Slope– PRESAGE®  dosimeter with metal compound  
 Slope– PRESAGE®  dosimeter without metal compound  
 
There was a noticeable increase in the sensitivity of the PRESAGE® 
formulations containing metal compounds irradiated with both 6 MV and 100 
kV energies (Figure 5-2 and 5-3). This increase in optical density was also 
visible to the naked eye (Figure 5-4). For 6 MV photon energy, the slope of 
the dose–response curves for PRESAGE® with Bi Neo showed higher 
sensitivity than with DBTDL and Zn Oct at the same molar concentrations 
and applied therapeutic beam energy (Figure 5-5). DBTDL and Zn Oct 
showed a maximum DEF at a concentration of 3 mM (1.48 and 1.43, 
respectively) for 6 MV energy (Figure 5-5a). In contrast, Bi Neo showed a 
maximum DEF at a concentration of 1 mM (1.71) for the same energy (Figure 
5-5a). The overall enhancement with 6 MV energy could be attributed to the 
slight changes in the physical and electron densities of the PRESAGE® 
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compositions containing metal compounds, which could increase the 
probability of Compton interactions. 
 For 100 kV energy (Figure 5-3), the slopes of all the PRESAGE® 
compositions containing metal compounds increased more than for 6 MV 
energy. For example, at a concentration of 3 mM, the increase in DEF was 
50%, 33%, and 25% for Bi Neo, DBTDL, and Zn Oct, respectively (Figure 5-5). 
This increase could be attributed to the emission of photoelectrons from the 
metal atoms, which have short range and therefore, occur very densely 
around the metal atoms with a probability of emission dependent on the 
metal atom’s K-edge electron binding energy [206]. Since bismuth has a 
higher K-edge electron binding energy (90.05 keV) than tin and zinc (29.20, 
9.66 keV, respectively), it is expected than Bi Neo would enhance the 
sensitivity more than DBTDL and Zn Oct via the photoelectric absorption. 
 
Figure 5-4: Photographs of the reference PRESAGE® dosimeter cuvettes without 
metal compounds (control) and the same formulation with 3 mM Bi Neo, DBTDL 
and Zn Oct (a) before and (b) after exposure to 30 Gy using 100 kV energy. 
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It is noteworthy, that as mentioned earlier, the metal compounds 
used contain metal atoms bonded to organic molecules. Therefore, chemical 
factors may also contribute to the increase in absorbance upon irradiation 
when incorporating metal compounds in the composition of the PRESAGE® 
dosimeters. It is well known that irradiation of organic compounds can lead 
to the formation of very reactive ions, radicals, radical ions and intermediates. 
These reactive species could follow several complex chemical reaction 
pathways which are beyond the scope of this study. Nevertheless, these 
complex chemical pathways could result in rearrangements and/or formation 
of new bonds between the reactants, which could lead eventually to the 
formation of radical species or oxidised products [216]. For example, energy 
deposited by radiation could interact with the metal atom resulting in the 
production of secondary electrons (ions), and simultaneously, the energy 
deposited could lead to homolysis of the metal compound resulting in the 
production of organic radicals or ions. These organic radicals and ions or 
secondary electrons could interact directly with the LMG dye converting it to 
its oxidised form (MG) or indirectly by interacting with the halogenated 
carbon (radical initiator) resulting in the production of secondary radicals. 
Hence, increasing the extent of LMG dye oxidation. However, if these 
processes were to occur to any significant extent one would expect the 
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response of the dosimeter to increase as the concentration of the metal 
compound in the formulation is increased, which was not observed (Figure 5-
5).  
Interestingly, an overall reduction in the sensitivity of the 
PRESAGE® dosimeter is observed as the concentration of the metal 
compounds is increased (Figure 5-5). One explanation is that the increase in 
metal content in the PRESAGE® dosimeter formulation shields the 
radiosensitive components of the dosimeter form interacting with gamma- or 
X-rays. Moreover, this trend in reduction in sensitivity as a function of metal 
compound content could be an experimental proof for the known fact that 
metal compounds can inhibit or enhance the effects of radiations. For 
example, the fundamental principle of fabricating transparent (optically-
clear) radiation shielding involves mixing high concentrations (> 30 wt%) of 
heavy-metal compounds – like the ones used in this study – with polymeric 
materials such as epoxy or polyurethane resins [217, 218]. Therefore, one may 
assume that further increases in the concentration of the metal compounds in 
the PRESAGE® formulation (> 30 wt%) could yield a transparent radiation 
shield instead of a radiation dosimeter. 
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Figure 5-5: Comparison of DEF for various molar concentrations of metal 
compounds and irradiation energies. Error bars: ± mean standard deviation in the 
measurement. 
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Another attractive feature of metal compounds, especially those with 
carboxylate groups (RCO2-) like the ones used in this study, is their ability to 
act as highly efficient photostabilising agents for varies leuco dyes [215, 219]. 
In other words, they can act as singlet oxygen quenchers, reducing 
photofading (bleaching). A combination of singlet oxygen and light is 
thought to be the cause of bleaching of organic leuco dyes such as LMG [219]. 
In respect to the PRESAGE® dosimeter, incorporating metal carboxylate 
compounds in the formulation was found to minimise post-response 
photostability. The post-response stability curves of the PRESAGE® dosimeter 
without and with 3 mM metal compounds are shown in Figure 5-6. 
PRESAGE® formulations with metal carboxylate compounds showed a 
noticeable improvement in post-response photostabilisation compared to 
PRESAGE® only (control). For example, the response consumption after two 
weeks from exposure when incorporating 3 mM of Bi, Sn, and Zn compounds 
is small (ca. 8%). However, the response of the PRESAGE® dosimeter without 
these compounds is almost completely consumed within the same time frame 
(ca. 80%). A more comprehensive study of using metal carboxylates to 
minimise photofading of the PRESAGE® dosimeter is currently being 
undertaken. 
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Figure 5-6: Variation in optical density for PRESAGE® cuvette after exposure to 1 
Gy using 100 kV energy with and without 3mM metal compounds over a period 
of 312 hours. Error bars: ± standard deviation. The solid line is a second order 
(k=2) polynomial fit 
 
Although the metal compounds in this study have been shown to 
enhance the sensitivity and post-response photostability of the PRESAGE® 
dosimeter to radiation dose with a possible limitation of increasing the 
radiological properties of the dosimeter, in particular Zeff, we believe the type 
and concentration of such compounds should be considered a third factor for 
optimizing the sensitivity and structural integrity of the PRESAGE® 
dosimeter along with the already known factors that include the type and 
concentration of the radical initiator and leuco dye used in the formulation. 
For example, as mentioned earlier, we have formulated a water equivalent 
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metal compound-optimised novel PRESAGE® dosimeter for potential clinical 
use in both megavoltage and kilovoltage dosimetry without the need for any 
dosimetric correction factors. The radiological properties of the novel 
PRESAGE® composition are presented in Table 5-2. The tin compound, 
DBTDL, was added to the formulation to significantly reduce the fabrication 
time, minimise post-response photofading, and to enhance the sensitivity of 
the dosimeter to radiation dose. The radiological properties of the PRESAGE® 
dosimeter were matched to those of water by carefully adjusting the amount 
of the constituents (including the metal compound) in the formulation.  
Table 5-2: Effective atomic number (Zeff), mean physical density (ρ), mass electron 
density (Ne) and electron density (ρe) of the novel PRESAGE® dosimeter 
compared to water. 
Material Formula ρ  
(Kgm-3) 
ρe  
(×10 29 em -3) 
Ne  
(×1026 e kg -1) 
Zeff 
Novel  
PRESAGE® 
C18746N1239H32825O4455Cl360
Sn1 
1038 3.4106 3.2858 7.42 
Water H2O 1000 3.3428 3.3428 7.42 
 
The measured absorbance changes at λ = 633 nm versus the 
radiation absorbed doses for the PRESAGE® dosimeter compared to 
PRESAGE® (control) are displayed in Figure 5-7. It is noteworthy that the 
slope of the metal compound-optimised PRESAGE® dosimeter is higher (ca. 
40%) than the PRESAGE® dosimeter (control) with a lower Zeff (7.42 
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compared to 7.47) and overall radiological properties almost identical to 
water. Furthermore, to the best of our knowledge, this is the first PRESAGE® 
formulation with an identical Zeff number to that of water, which means no 
dosimetric correction factor is needed for kilovoltage radiation dosimetry in 
contrary to previously published formulations [101, 196, 207]. This is good 
evidence that even when adding high Z elements to the PRESAGE® 
formulation it is still possible to achieve water-equivalent radiological 
properties by tuning the type and amount of the chemical constituents. A 
more detailed investigation into the metal-optimised PRESAGE® dosimeters 
is provided in Chapter 6. 
 
Figure 5-7: Recorded optical density changes as a function of absorbed radiation 
dose for the PRESAGE® (control) formulation without metal compounds 
compared to the novel PRESAGE® formulation showing the response to 6 MV 
energy. Correlation coefficient parameters of each fitted line are shown in the 
inset. Error bars: ± standard deviation (n = 3). 
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5.4 Conclusion 
In this chapter, the radiation-modifying properties of three 
commercially available metal compounds on radiation dose enhancement, 
post-response stability and radiological properties of the PRESAGE® 
dosimeter have been investigated using a newly developed formulation. The 
characteristics and sensitivity to radiation dose of a new PRESAGE® 
dosimeter formula with and without various concentrations of metal 
compounds was studied. It was noted that, in general, incorporating metal 
compounds in the composition of the PRESAGE® dosimeters enhances the 
sensitivity of the dosimeter to radiation dose and improves post-response 
stability. An overall reduction in the DEF was observed as the concentration 
of the metal compounds in the PRESAGE® composition was increased. One 
explanation is that, the increase in the metal content in the PRESAGE® 
formulation could shield the radiosensitive components of the dosimeter 
from interacting with radiation. Furthermore, incorporating 3 mM (ca. 0.2 
wt%) of any of the three investigated metal compounds in the composition of 
the PRESAGE® dosimeter is found to be an efficient way to enhance the 
sensitivity of the dosimeter to radiation dose and catalyse the dosimeter 
formation, significantly reducing the fabrication time, and minimising its 
post-response photofading. In addition, varying the composition and 
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concentration of metal compounds along with other PRESAGE® constitutes 
can be utilised to optimise the PRESAGE® sensitivity, stability, and 
radiological properties to match those of water; as demonstrated by the 
introduction of a novel water-equivalent metal compound-optimised 
PRESAGE® dosimeter with nearly identical radiological properties. Thus, the 
PRESAGE® dosimeter has the potential to be used for both kilovoltage and 
megavoltage radiotherapy dosimetry without the need for dosimetric 
correction factors. A detailed characterization of novel metal-optimised 
PRESAGE® dosimeters is the basis of Chapter 6 of this thesis. Finally, 
incorporating metal compounds in the composition of the PRESAGE® 
dosimeter had no noticeable effect on the stability, linearity, and dose-rate 
dependency of the dosimeter.  
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Chapter 6  
Characterisation of Novel Water-
equivalent PRESAGE® for 
Megavoltage and Kilovoltage X-ray 
Beams Dosimetry  
 
6.1 Summary 
In the previous chapter, specific metal compounds were identified as 
novel agents for optimising the sensitivity, post-response stability, structural 
integrity and radiological properties of the PRESAGE® dosimeter. In this 
chapter three novel PRESAGE® dosimeters referred to as MO-PRESAGE® 
dosimeters 1, 2 and 3 (MO stands for metal-optimised) were introduced, and 
their sensitivity, as well as their water equivalency, were investigated. All 
three formulations contain very small concentrations (0.01 wt%) of metal 
compounds. The radiological properties were key factors that were 
considered when formulating the new dosimeters. The dosimeters were 
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prepared in spectrophotometric cuvettes, irradiated with a 6 MV X-ray beam, 
and the change in optical density of each dosimeter was measured using a 
spectrophotometer. In addition, the most promising formulation was 
fabricated into large dosimeter blocks to experimentally measure percentage 
depth dose curves for 6 MV and 100 kV beam energies.  The results show that 
all three formulations exhibit radiological properties closer to water than any 
of the commercially available PRESAGE® dosimeter formulations. For 
example, the novel MO-PRESAGE® 1, 2 and 3 have mass densities ranging 
from 3.9-4.4% higher than that of water, whereas the mass density for the 
commercial formulation is 5.3% higher. Also, the novel formulations have 
almost identical Zeff (> 0.999%) values to that of water, while the Zeff for the 
commercial formulation was 3.7% higher than that of water. In addition, the 
MO-PRESAGE® 3 dosimeter formulation showed > 50% reduction in 
deviation from water relative to the commercial formulation in term of both 
mass and energy attenuation coefficients. Furthermore, the probability of 
photoelectric absorption in the three different MO-PRESAGE® formulations 
varied from 1.3 times greater than that of water, compared to 1.8 times 
greater than that of water for the commercial formulation. The maximum 
variation in measured depth dose curves for the MO-PRESAGE® 3 dosimeter 
formulation for 6 MV and 100 kV beam energies were 2% and 4%, 
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respectively, compared to water. This formulation was also more sensitive to 
radiation than the other two new formulations introduced in this work as a 
result of the presence of alkylbromide radical initiators in the MO-PRESAGE® 
3 dosimeter formulation.  The authors concluded that all three novel MO-
PRESAGE® dosimeter formulations display excellent radiological properties, 
superior to any of the commercially available PRESAGE® dosimeter 
formulations and thus, can be used for the dosimetry of clinical megavoltage 
and kilovoltage X-ray beams.   
6.2 Introduction 
As indicated in previous chapters, the PRESAGE® dosimeter with its 
unique characteristics, has great potential for clinical applications [91, 95].  In 
order to maximise the usefulness of the PRESAGE® dosimeter as a 3D 
dosimetry tool, the dosimeter must be adaptable to meet application-specific 
dosimetry requirements. One imperative requirement is the water 
equivalency of the dosimeter. In order to use 3D dosimeters in radiotherapy 
dosimetry, they should be water-equivalent in term of their mass density (ρ), 
effective atomic number (Zeff), electrons to mass density (Ne), electron density 
(ρe), mass attenuation coefficient (µ/ρ), mass energy absorption coefficient 
(µen/ρ) and total electron mass stopping power (S/ρ)tot [220]. The radiological 
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water-equivalency of the PRESAGE® dosimeter has been previously 
investigated [101] and reported to differ significantly from water over an 
energy range from up to 0.1 MeV, in which photoelectric absorption is 
predominant as a result of the high Zeff (8.65) of the formulation studied. 
However, the radiological water-equivalency of new PRESAGE® dosimeter 
formulations have been investigated again recently [207]. The result of this 
theoretical study identified a PRESAGE® formulation (referred to as 
Formulation A) with a Zeff of 7.688 as being the closest PRESAGE® 
formulation to water yet. However, they did not provide a comparison 
between the sensitivity of the formulation to radiation dose, nor its post-
response photostability.  Such investigations are crucial, as it is well-known 
that the Zeff of the PRESAGE® dosimeter could be reduced by lowering the 
concentration of the high density components, in particular the radical 
initiator. Reducing the concentration of such critical components will 
ultimately lower the sensitivity of the dosimeter to radiation dose. As have 
been shown the previous chapter, reductions  in sensitivity could be rectified 
by incorporating very low concentrations of metal compounds in the 
formulation, whilst maintaining densities close to that of water [162].  
As a part of a series of PRESAGE® dosimeter component-specific 
optimisation studies [74, 162], the aim of this chapter was to investigate the 
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water-equivalent properties of three novel MO PRESAGE® dosimeter 
formulations. Comparison between the sensitivity and post-response 
photostability of the novel formulations were also investigated. For 
comparative purposes, Formulation A [207] reported in the literature, which 
is by far the closest to water in terms of radiological properties, was used as a 
benchmark in this investigation.  The three novel formulations are denoted as 
MO-PRESAGE® 1, MO-PRESAGE® 2 and MO-PRESAGE® 3. 
6.3 Results and discussion  
6.3.1 Radiological properties 
The radiological properties of three novel MO-PRESAGE® dosimeters 
and Formulation A [207] compared to water are tabulated (Table 6-1). In 
addition, the molecular formula and fractional elemental compositions of all 
investigated formulations are displayed in Table 6-2.  It was noted that the 
mass density of the MO-PRESAGE® 1, 2 and 3 formulations were closer to 
water (3.9, 4.3 and 4.4%, respectively) than Formulation A (5.3%). 
Furthermore, the reduction in density of MO-PRESAGE® 1, 2 and 3 can be 
attributed to the overall reduction in the concentration of the radical 
initiators. In addition, the polyurethane precursors used in this study had a 
closer density to water (1.036 g/cm3), which did not change significantly after 
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adding small concentrations of any of the additives (i.e., dye, radical initiator, 
metal compounds) used in this study. For example, the addition of 0.05 wt% 
of DBTDL (1.066 g.cm-3) to the composition of the PRESAGE® dosimeters only 
contributed to the final density by 0.0005 g.cm-3). In addition, all three novel 
MO-PRESAGE® dosimeter formulations have closer electron density to water 
than Formulation A, however, the difference is marginal. In general, the 
improvement in water equivalency of mass density results from reduction of 
the halogen content in the novel formulations.  Moreover, in order for the 
dosimeter to be used for high energy X-ray beams, it is imperative that the 
electron and mass densities are close to the values for water due to the 
dominance of Compton scattering over the therapeutic megavoltage energy 
range [102]. 
 
Table 6-1: Relevant Effective atomic number (Zeff), mean physical density (ρ), mass 
electron density (Ne) and electron density (ρe) of the novel PRESAGE® dosimeter 
formulations compared to water. 
 
       * Gorjiara et al., [207] 
ρ ρ e N e N e ρ e 
 (Kg m
-3
) (×10 
29
 em 
-3)
 (×10
26 
e kg 
-1
)  (relative 
to water)
(relative 
to water)
Water 1000 3.343 3.343 1.000 1.000 7.417
MO-PRESAGE 1 1039 3.410 3.282 0.982 1.020 7.410
MO-PRESAGE 2 1042 3.411 3.273 0.979 1.020 7.415
MO-PRESAGE 3 1044 3.421 3.277 0.980 1.023 7.416
Formulation A* 1053 3.440 3.267 0.977 1.029 7.688
Material Z eff
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Table 6-2: Relevant molecular formula and fractional elemental compositions of 
the three MO-PRESAGE® dosimeters formulations used in this study compared to 
water. (weight fractions denoted as Wx). 
Material Formula WC WN WH WO WCl WSn WBr WS WZn 
MO-PRESAGE 1 C64951N4391H113401O15791 Cl1414Sn1 0.6197 0.0488 0.0908 0.2006 0.0399 0.0001 0.0000 0.0000 0.0000 
MO-PRESAGE 2 C35904 N2426 H62685 O8728 Cl819 Zn1 0.6186 0.0487 0.0906 0.2003 0.0417 0.0000 0.0000 0.0000 0.0001 
MO-PRESAGE 3 C50455N3417H88064O12295Cl775Br17Sn1 0.6259 0.0494 0.0916 0.2032 0.0284 0.0001 0.0014 0.0000 0.0000 
Formulation A* C1758 N121H3000O442S4Cl30Br1 0.6178 0.0496 0.0885 0.2069 0.0311 0.0000 0.0023 0.0038 0.0000 
Water H2O 0.0000 0.0000 0.1119 0.8881 0.0000 0.0000 0.0000 0.0000 0.0000 
* Gorjiara et al., [207] 
 
A comparison between the Zeff of the MO-PRESAGE® 1, 2, 3 and 
Formulation A, and water, calculated using Mayneord’s equation [102],  are 
shown in Table 6-1.  It was noted that the Zeff for the MO-PRESAGE® 1, 2 and 
3 formulations are almost identical (> 0.999%), with MO-PRESAGE 3 showing 
the closest Zeff value to that of water. In comparison, the Zeff of Formulation A 
was 3.7% higher than water. The energy dependence of Zeff for MO-
PRESAGE® 1, 2, 3 and Formulation A are shown in Figure 6-1. It was 
observed that there is an almost constant region > 100 keV and a rapid Zeff 
variation region over the energy range < 100 keV for all formulations. The 
variation in Zeff values peak at approximately at 40 keV for all PRESAGE® 
formulations, with a maximum variation between Formulation A and MO-
PRESAGE® 1, 2, and 3 of 8.5, 4.1, 4.3 and 3.5%, respectively (Figure 6-2). The 
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discrepancy at approximately 40 keV would result from the difference of the 
mass energy absorption attenuation coefficient, which is at most.  1.23 times 
larger at 40 keV, and consistently larger between 20 and 60 keV than that of 
water. This energy range over which this peak occurs corresponds to the 
large difference in interaction probabilities (Figure 6-2) between all 
PRESAGE® dosimeter formulations and water. The decreasing trend in the 
Zeff plot at energies > 3 MeV results from the reduction of Compton scattering 
and increase of pair production occurring at higher energies. The MO-
PRESAGE® 3 formulation poses the closest Zeff to water throughout the 
energy range applied. The consistence region in the megavoltage energy 
range can be attributed to Compton scattering being the dominant photon 
interaction process in that region, which is independent of the Z number 
[102]. 
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Figure 6-1: Energy dependence of the effective atomic number of the PRESAGE® 
dosimeter formulations used in this investigation compared to water in terms of 
the total photon interactions.  
 
 
 
Figure 6-2: Effective atomic number (Zeff) ratio for the PRESAGE® dosimeter 
formulations relative to water.  
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6.3.2 Radiation transport parameters 
The photoelectric absorption, Compton scattering and pair production 
cross sections for the novel MO-PRESAGE® dosimeters and Formulation A 
relative to water over the energy range of 0.01 to 20 MeV are shown in Figure 
3. As indicated in previous chapters, the occurrence of photoelectric 
absorption depends strongly on the atomic number of the absorbing material 
and is proportional to the Z number of the material by Z3, and is dominant in 
the low energy X-ray range of 10–100 keV [102].  
A comparison between the photoelectric absorption cross section of all 
PRESAGE® dosimeters formulations and water revealed that Formulation A 
is approximately 30% higher than water, whereas MO-PRESAGE® 1, 2, and 3 
formulations  are ca. half of that (15%) variation at 50 keV energy (Figure 6-4). 
Although MO-PRESAGE® 1, 2, and 3 formulations contain tin and zinc, with 
K-absorption edges of  29.2 and 9.65 keV, respectively, they do not cause such 
large differences from water as their concentrations are very low in the novel 
formulations ca. 0.01 wt%).  Within the energy range up to 20 MeV, where 
Compton scattering is predominant [102], the difference is subtle. In addition, 
if the energy of the photon is greater than 1.02 MeV, the photon may interact 
with the material through pair production [102], as pair production results 
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from interactions with incoming photons and nuclei, the probability of this 
process increases rapidly with atomic number [102].  
 
 
Figure 6-3: Fractional interaction probabilities for the photoelectric absorption, 
Compton scattering, and pair production for the four PRESAGE® dosimeter 
formulations and water.  
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Figure 6-4: Fractional interaction properties ratio for the PRESAGE® dosimeter 
formulations relative to water.  
 
For the mass energy absorption coefficient ratio plot there was a 
prominent peak between 20 and 70 keV (Figure 6-5), which corresponds to 
the large difference in fractional interaction cross sections between all 
PRESAGE® dosimeter formulations and water. This peak indicates that the 
mass energy absorption coefficient of Formulation A is 1.23 times larger than 
that of water at ca. 40 keV, wheres MO-PRESAGE® 1, 2 and 3 formulations are 
only 1.1, 1.08 and 1.06 times higher, respectively. In other words, all the MO-
PRESAGE® formulations are > 50% closer to water than Formulation A. The 
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ratio plots were observed to decrease towards ca. 100 keV and remained 
within 2.5% up to 3 MeV. For higher energies (>3 MeV), the mass attenuation 
coefficient plots (Figure 6-6) for high Z materials (e.g. PRESAGE®) fall below 
the plot of low Z materials (e.g. water) as a result of the nuclear charge 
screening effect of the orbital electrons. 
 
 
Figure 6-5: The mass energy absorption coefficient ratios for the PRESAGE® 
dosimeter formulations investigated relative to water as function of photon 
energy. 
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Figure 6-6: The mass attenuation coefficients ratios for the PRESAGE® dosimeter 
formulations investigated relative to water as function of photon energy. 
 
The mass energy absorption coefficient (Figure 6-5) were similar to the 
mass energy attenuation coefficient (Figure 6-6)  since most electron 
interactions involving low Z materials locally deposit the vast majority of 
their energy by ionisation collisions, rather than being radiated away by 
Bremsstrahlung radiation. It was observed that the MO-PRESAGE® 
formulations were > 50% closer to water than Formulation A at 40 keV 
(Figure 6-5 and 6-6). The decreasing trend at energies greater than 1 MeV 
result from the reduction of photoelectric absorption and an increase in 
Compton scattering occurring at higher energies (Vide supra). Furthermore, 
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The mass stopping powers for the novel MO-PRESAGE® dosimeter 
formulations are closer to the values for water compared to the Formulation 
A with MO-PRESAGE® 3 dosimeter formulation showing the closest 
agreement (Figure 6-7).  The decreasing trend in this plot at energies greater 
than 3 MeV is due also to the reduction of reduction of photoelectric 
absorption and an increase in Compton scattering occurring at higher 
energies (Vide supra).  
 
 
Figure 6-7: The total stopping power ratios of the PRESAGE® dosimeter 
formulations investigated relative to water as function of photon energy.  
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6.3.3 Dose-response relationship  
The absorption spectra of the novel MO-PRESAGE® dosimeters are 
displayed in Figure 6-8 which shows the typical absorption maximum (λmax) 
of the chromatic form of LMG which occurs at ca. 633 nm. The measured 
absorbance changes at 633 nm versus the radiation absorbed doses for the 
novel MO-PRESAGE® dosimeters are displayed in Figure 6-9. As in previous 
chapters, for all dosimeters, absorption values were obtained by subtracting 
the relevant value of a reference cuvette for the same batch with zero 
radiation dose (control) from that of the irradiated cuvettes [74, 162]. 
Therefore, the dose-response changes post-irradiation are solely due to the 
absorbed radiation dose. Thus, the intercepts of the dose–response plots are 
nearly zero. In all dosimeter formulations, very good correlation coefficient 
linearity (R2 > 0.99) for the dose response was observed over the applied 
radiation dose range.  
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Figure 6-8: Normalised absorption spectra of the PRESAGE® dosimeters with the 
four dyes used in this study showing absorption maxima at ca. 633 nm. Reference 
cuvettes (same composition but with zero radiation dose) for each formulation 
were used as a baseline. 
 
Although the novel MO-PRESAGE® dosimeters share similar 
radiological properties, their sensitivity to radiation dose varied considerably 
(Figure 6-9) with MO-PRESAGE® 3 showing the highest sensitivity followed 
by MO-PRESAGE® 2 and 1. This apparent difference in sensitivity is 
attributed to the type and concentration of halogens used in the composition 
of each formulation. For example, free radicals are generated from the 
radiolysis of the halocarbon bonds and the number of free radicals produced 
is directly proportional to the C–X bond dissociation energy (X = Cl , Br, I) 
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[74].  Since the MO-PRESAGE® 3 formulation contains an alkylbromide 
(tetrabromoethane), which is more sensitive to radiation than alkylchlorides 
[162], free radicals are generated more readily upon exposure to ionising 
radiation, which in turn oxidises more LMG leading to a greater increase in 
optical density change. This is of a particular importance in dosimetry since 
the sensitivity of a dosimeter to radiation dose is a key parameter to consider, 
particularly since most dosimetric applications are performed with relatively 
low radiation doses (<5 Gy). Therefore, it is generally desirable that dosimeter 
have a strong and linear response at low radiation doses, whilst maintaining 
tissue-like radiological properties [39]. 
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Figure 6-9: Recorded absorbance changes as a function of absorbed radiation dose 
for the three MO-PRESAGE® dosimeter formulations showing the response to 6 
MV energy. Correlation coefficient parameters of each fitted line are shown in the 
bottom right inset. Error: ± standard deviation in the measurement (n=3). 
 
6.3.4 Post-response stability  
The post-response stability of the novel MO-PRESAGE® dosimeter 
formulations are shown in Figure 6-10. The results demonstrate that the 
inclusion of metal compounds in the novel formulation had no influence on 
the post-response photostability of the novel formulation which is in good 
agreement with our previous observations [162]. In general, all MO-
PRESAGE® dosimeter formulation were stable over the period studied which 
is attributed to the relatively small concentration of radical initiators 
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employed (< 5 wt%) [196] and inclusion of metal compounds, which have 
been shown previously to act as efficient photostabilising agents for leuco 
dyes, especially those with carboxylate groups (RCO2-), like the ones used in 
this study [162, 215, 219]. 
 
 
Figure 6-10: Variation in absorbance over time for the three MO-PRESAGE® 
dosimeters formulations after exposure to 1 Gy. Error bars represent the standard 
deviation in the measurement. The solid line is a second order (k=2) polynomial 
fit. 
 
6.3.5 Measured percentage depth dose curves 
The measured central axis percentage depth dose curves (PDD) for the 
MO-PRESAGE 3 formulation after exposure to 6 MV and 100 kV beam 
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energies compared with the ionisation chamber measurements are shown in 
Figure 6-11. Two dosimeter blocks (d × h = 4.5 × 8 cm) and (d × h = 4× 3.5 cm) 
were irradiated using 6 MV and 100 kV, respectively under full scatter 
condition as described in Chapter 2 (section 2.5.1). One can observe a subtle 
difference between the PDD of the MO-PRESAGE® 3 formulation and water 
for both energies with a maximum variation of 2 and 4% for 6 MV and 100 kV 
beams, respectively. This suggests that, MO-PRESAGE® 3 could be used in 
kilovoltage and megavoltage beams dosimetry without the need for a 
correction factor/s. 
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Figure 6-11: Measured relative percentage depth dose curves for the MO-
PRESAGE® 3 dosimeter formulation for (a) 6 MV and (b) 100 kV beam energies 
over the effective length of the dosimeter used in the measurement. IC=ionisation 
chamber. 
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6.4 Conclusion 
The aim of this chapter was to develop and characterise novel MO-
PRESAGE® dosimeter formulations and included metal compounds in their 
compositions to accelerate their polymerisation process, improve their post-
response stability and maintain good sensitivity to radiation dose. The 
dosimeters were carefully formulated to have water-equivalent 
characteristics so they can be used in both in both megavoltage and 
kilovoltage beams dosimetry. The results indicate all three novel PRESAGE® 
formulations have virtually identical radiological properties to water, being 
superior to the commercially available PRESAGE® dosimeter and those 
theoretically investigated in the literature (e.g., Formulation A [207]) and are 
therefore, better suited for clinical applications in both kilovoltage and 
megavoltage clinical x-ray beams. Finally, the novel MO-PRESAGE® 
dosimeter formulations with metal compounds had typical characteristics 
and can be measured using the same dose readout systems used for the 
commercial PRESAGE® dosimeters.  
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multi-compartment 3-dimensional radiochromic radiation dosimeters for 
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84(4): e549-e555 (see Appendix iv for copyright permission).  
Chapter 7  
Development of a Novel Multi-
compartment 3D Radiochromic 
Radiation Dosimeter for 
Nanoparticle-enhanced Radiotherapy 
Dosimetry 
 
7.1 Summary 
In previous chapters, a series of PRESAGE® dosimeter component-
specific investigations  revealed that altering the types and concentration of 
each constituent, or introducing new components in the chemical 
composition of the dosimeter results in novel dosimeters with optimised 
properties for clinical use. In this chapter, the first example of a novel multi-
compartment radiochromic radiation dosimeter will be introduced. In 
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addition, its applicability for 3D dosimetry of nanoparticle-enhanced 
radiotherapy is demonstrated. As an initial investigation, a novel multi-
compartment phantom radiochromic dosimeter was formulated and 
designed to mimic a tumour loaded with AuNPs (50 nm diameter) at a 
concentration of 0.5 mM surrounded by normal tissues. The novel dosimeter 
is referred to as the Sensitivity Modulated Advanced Radiation Therapy 
(SMART) dosimeter. The dosimeters were irradiated with 100 kV and 6 MV 
X-ray energies. Dose enhancement produced from the interaction of X-rays 
with  the AuNPs was quantitatively determined using spectrophotometric 
and cone-beam optical CT scanning by quantitatively comparing the change 
in optical density and 3D data sets of the dosimetric measurements between 
the tissue-equivalent (control) and control + AuNPs compartments. The 
interbatch and intrabatch variability, and post-response stability of the 
dosimeters with AuNPs were also assessed. The results provided radiation 
dose enhancement factors (DEFs) of 1.77 and 1.11 for 100 kV and 6 MV X-ray 
energies, respectively. The results of this study are in good agreement with 
previous observations; however, for the first time we provide direct 
experimental confirmation and 3D visualisation of the radiosensitisation 
effect of AuNps. The dosimeters with AuNPs exhibit small (< 3.5%) 
interbatch variability, and negligible (< 0.5%) intrabatch variability. The 
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SMART dosimeter yields the first experimental insights concerning the 
spatial distributions and elevated dose in nanoparticle-enhanced 
radiotherapy, which cannot be performed using any of the current methods. 
In addition, the results presented here are considered the first direct 
experimental confirmation of metal nanoparticle-enhanced radiotherapy. As 
a result, it can be concluded that the SMART dosimeter can be used as a novel 
independent method for nanoparticle-enhanced radiotherapy dosimetry. 
7.2 Introduction 
The utilisation of metal nanoparticles in the biomedical field is 
becoming increasingly common for applications such as imaging, drug 
delivery and cancer radiotherapy [142, 168]. From a therapeutic perspective, a 
combination of low energy ionising radiation and high atomic number (Z) 
heavy metals such as gold (Z  = 79) have been shown to enhance the effects of 
radiation [120-123, 142]. A preferential increase of photoelectric interactions 
and the short range of their interaction products (photoelectrons, 
characteristic X-rays, Auger electrons) produce a localised boost in radiation 
dose within tissue loaded with such metal nanoparticles compared to normal 
tissues as result of the large numbers of low energy free radicals produced 
that lead to an increase in cells killing. [120, 168, 206]  
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Is indicated in Chapter 1 (section 1.7.1), the metal nanoparticle-enhanced 
radiotherapy effect has been previously demonstrated using Monte Carlo 
simulations [125, 126, 148]. Furthermore, in vivo and in vitro studies have 
demonstrated that gold nanoparticles are good radiation enhancing agents 
for cancer radiotherapy [120, 122, 123]. However, the major limitation of these 
methods is the inability to perform in-depth investigations into the influence 
of these metal nanoparticles on the 3D spatial aspects of the radiation dose 
distribution, which includes doses to surrounding critical structures, and the 
effects of particle type, morphology and surface chemistry on radiotherapy 
dose enhancement. Therefore, there was an urgent need to develop an 
independent experimental approach to answer these questions. One potential 
method is to utilise 3D dosimeters to better understand the radiation-metal 
nanoparticle interaction outcomes. 3D polymer gel and radiochromic 
dosimeters are fabricated from radiation-sensitive materials that change their 
properties (e.g., optical absorption/scattering, X-ray absorption, NMR or 
acoustic) when absorbing a radiation dose, and have been developed to 
model experimentally and improve dose delivery  [16]. Each type of 
dosimeter has its unique way of interacting with radiation, and they have 
distinctive methods of recording the radiation dose distribution in 3D 
compared to conventional ion chambers and two-dimensional dosimeters 
 207 
(2D) such as films, which are limited to point or planar measurements [15, 
16]. However, attempts to exploit current 3D radiation dosimeters in metal 
nanoparticle dosimetry are yet to be documented.  
The novel 3D radiochromic dosimeter is referred to as the Sensitivity-
Modulated Advanced Radiation Therapy (SMART) dosimeter, and can be 
considered a more advanced version of the PRESAGE dosimeter [72], (see 
Chapter 2 section 2.4.1 for details about the fabrication process of different 
types of the SMART dosimeters). Like the PRESAGE dosimeter, the SMART 
dosimeter is insensitive to oxygen and can be readily fabricated in any size or 
shape. In this study we formulated, designed and fabricated dual-
compartment SMART dosimeters comprised of clear polyurethane matrix 
containing a halocarbon radical initiator and leucomalachite green (LMG) dye 
as a reporter compound. Radiolysis of the halocarbons leads to the generation 
of free radicals, which in turn react with the LMG dye converting it to its 
oxidised form, malachite green (coloured) [72].  
7.3 Results  
The SMART dosimeters fabricated in this study with double-stack and 
cylinder-in-cylinder designs are shown in Figure 7-1. Interestingly, the two 
polyurethane resins blend seamlessly together without any interfacial 
 208 
artifacts or diffusion between the two components (Figure 7-1a). The outer 
compartment of the SMART dosimeter (cylinder-in-cylinder design, Figure 7-
1b) has been specifically formulated to be water-equivalent (control) in terms 
of its radiological properties (Table 7-1). The inner compartment of the 
dosimeter (Figure 7-1b) has the same control composition of the outer 
compartment, however, it is doped with 0.5 mM of AuNPs. This 
concentration was chosen as it has been demonstrated to produce 
biologically-effective radiation dose enhancement [120]. 
 
Table 7-1: Radiological properties of the control formulation of the SMART 
dosimeter compared to water. 
Material Formula ρ  
(kg m-3) 
ρe 
(×10 29 em -3) 
Ne  
(×1026 e kg -1) 
Zeff 
Control  formulation C805N55H1404O197Br1 1044 3.4303 3.2858 7.42 
Water H2O 1000 3.3428 3.3428 7.42 
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Figure 7-1: Different SMART dosimeter designs. (a) A double-stack SMART 
dosimeter design with an AuNps doped compartment (clear) and undoped 
compartment (dyed yellow). (a’) The same double-stack SMART dosimeter after 
exposing half of it to radiation, showing the radiation induced change in optical 
density. A transparent yellow dye was added to the undoped compartment to 
allow the two compartments to be visually distinguished. (b) The actual cylinder-
in-cylinder SMART dosimeter analysed in this study after irradiation. The red 
arrows indicate the direction of irradiation. 
 
A comparison between the mass attenuation coefficients for the control 
formulation and water revealed only a very slight variation (< 1%) over the 
therapeutic energy range (Figure 7-2, highlighted region). Furthermore, an 
excellent agreement was also achieved when comparing the percentage depth 
dose (PDD) for the control formulation of the SMART dosimeter with a 
standard ionisation measurement performed in water (Figure 7-3). The 
maximum variation between the measured and standard PDD was < 1% 
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down to a depth of 3 cm, which is the working length of the SMART 
dosimeter employed here. 
 
 
Figure 7-2: Mass attenuation coefficient of the control formulation compared with 
water. The highlighted area represents the therapeutic energy range used in 
cancer radiotherapy.  
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Figure 7-3: Comparison between measured and standard PDD of the control 
formulation for a kVp energy radiation source.  
 
A comparison between the absorption spectra of the control dosimeter 
formulation with and without AuNPs (after irradiation with 10 Gy) over the 
visible wavelength region (470–750 nm) revealed similar absorption profiles 
with maxima located at λ = 633 nm (Figure 7-4). This is a typical visible 
absorption λmax of the oxidised form of LMG (malachite green) and is in 
excellent agreement with previously published results [20, 72, 73, 194]. In 
addition, this infers that the addition of AuNPs to the formulation does not 
affect the typical characteristics of the dosimeter. Therefore, all absorbance 
acquisitions were acquired at λ = 633 nm. 
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Figure 7-4: A comparison between the absorption spectra of the control dosimeter 
formulation with and without AuNPs (after irradiation with 10 Gy) using 100 Kv 
energy.   
 
The measured change in optical density (∆OD) versus the radiation 
absorbed dose at λ = 633 nm are depicted in Figure 7-5 and Figure 7-6. 
Excellent correlation coefficient linearity (R2 > 0.999) for the dose response 
was observed for both the control dosimeter compositions (with and without 
AuNPs) over the applied radiation dose range and energies (Figure 7-5 and 
Figure 7-6).  
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Figure 7-5: ∆OD as a function of absorbed radiation dose for the control 
dosimeters with and without AuNPs after exposure to 100 kV energy. Error bars: ± 
standard deviation (n = 3). The data means are significantly different (p<0.05). 
 
Furthermore, the linearity of the control dosimeter doped with AuNPs 
is a good indication that the nanoparticles are homogeneously dispersed 
throughout the polymeric matrix. The dose enhancement factor (DEF) was 
defined as the ratio between the slope of the control dosimeter doped with 
AuNPs and the slope of undoped control dosimeter. The DEF was calculated 
to be 1.77 and 1.11 for 100 kV and 6 MV, respectively. The small enhancement 
observed with 6 MV energy (11%) is in good agreement with previous studies 
[123, 126, 142], and results from the fact that with megavoltage energies, 
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photoelectric absorption is not the dominant interaction process [120, 122]. 
While Compton effect is dominant in such energy range and depends on a 
combination of physical and free electron densities, which in effect only 
varies slightly between the undoped and AuNPs-doped dosimeters. 
Therefore, no further investigations using 6 MV energies were carried out.  
 
 
Figure 7-6: ∆OD as a function of absorbed radiation dose for the control 
dosimeters with and without AuNPs irradiated with 6 MV energy. Error bars: ± 
standard deviation (n = 3). 
 
Although the control dosimeter cuvettes clearly demonstrate the dose 
enhancement obtained with AuNPs they do not provide any 3D visualization 
of the radiation-induced ∆OD distribution nor information about radiation 
 215 
beam profiles, which are of great importance in radiation dosimetry related to 
radiotherapy. However, the dual-compartment SMART dosimeter containing 
a control outer compartment and an AuNP-doped control inner compartment 
(Figure 7-1b) provides the perfect opportunity to conduct such studies. The 
SMART dosimeter was irradiated from the top using a single uniform 15 cm 
diameter circular beam of 10 Gy radiation dose. The rational for using 
relatively large field size is to ensure uniform dose distribution across the 
surface of the SMART dosimeter. A 3D rendering of optical density change 
within the dosimeter post-irradiation was performed using a cone-beam 
optical CT scanner (Figure 7-7a). In order to determine the radiation-induced 
ΔOD, pre- and post-irradiation scans of the SMART dosimeter were acquired 
using the same acquisition parameters. The post-irradiation scans were then 
subtracted from the pre-scans revealing a 3D OD change that is solely due to 
the absorbed radiation dose [177, 179, 186, 221]. The inner AuNPs-doped 
control compartment of the dosimeter shows a significantly higher increase in 
OD (> 70%) compared with the surrounding control compartment (Figure 7-
7b). The significant change in OD in the area doped with AuNPs is caused 
solely by the presence of high radiation absorbing elements (AuNPs) in the 
SMART dosimeter. This was supported by a refractometry comparison 
between the polyurethane composition with and without AuNPs, which 
 216 
revealed that they have an identical refractive index (RI) value of 1.496, as is 
indicated from the well-defined edges of both compartments (Figure 7-7a). 
This property is particularly advantageous from an optical imaging 
prospective as it means that imaging artefacts resulting from RI mismatch are 
eliminated, thus simplifying any optical modelling [15]. In addition, this 
allows the measurement of radiation dose at the boundaries, which cannot 
currently be measured using any of the available 3D dosimetric methods. 
 
 
 
Figure 7-7: (a) 3D rendering of the radiation induced ΔOD within the SMART 
dosimeter. (b) Reconstructed cross-sectional radiation induced ΔOD. The centre of 
the SMART dosimeter surrounded by a dashed line represents the area doped 
with AuNPs. 
 
When exposed to radiation, photoelectric absorption in the AuNPs-
doped inner compartment of the SMART dosimeter causes an instantaneous 
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emission of large numbers of low energy photoelectrons and Auger electrons, 
which are thought to be responsible for the radiation dose enhancement (3, 4) 
since they qualify to be considered equivalent to the high LET radiations in 
their effects on the DNA molecules. This can also be observed clearly in the 
central transverse plane (Figure 7-7b), where there is a local boost in 
radiation-induced OD in the compartment doped with AuNPs (central area 
with dashed borders). Therefore, the gain from adding metal nanoparticles in 
terms of a localised boost in radiation dose, dose to surrounding structures 
and dose distribution can be assessed for the first time by converting the 
ΔOD to absolute dose and then comparing the 3D dose distribution between 
the control and doped compartments given by the optical scanning.  
The boost in OD in the doped area can also be seen when plotting OD 
line profiles through different transverse planes of the SMART dosimeter 
(Figure 7-8). From the optical CT measurement, the DEF was determined to 
be 1.73 (SD: 0.12) by taking the ratio of the ΔOD at the centre of the AuNPs-
doped compartment relative to the undoped compartment, which is in good 
agreement with the spectrophotometry results (DEF = 1.77) obtained from the 
cuvette dosimeters. The slight discrepancy between both measurements 
could be attributed to the fact that the spectrophotometer and the optical CT 
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scanner use a slightly different illumination spectrum and how does that 
affect their measurements or accuracy [194].  
 
 
Figure 7-8: ΔOD line profiles through the transverse plane at different depths of 
the SMART dosimeter. The highlighted area on the profiles represents the 
compartment doped with AuNPs. The actual SMART dosimeter is shown in the 
top right inset. 
 
The influence of the metal nanoparticles in general on the consistency 
of response of the dosimeters to radiation dose (intrabatch variability) was 
also determined. Furthermore, it was also imperative to calculate the 
variation between differences batches (interbatch variability) in order to 
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determine if dosimeters from different batches could be used in the same 
dosimetric application. Thus, the interbatch variability of the dosimeters with 
AuNPs was determined to be only < 3.5% (Table 7-2), whereas the intrabatch 
variability was negligible (< 0.5%).  
 
Table 7-2: Intrabatch consistency for four different batches of the control +0.5 mM 
AuNPs formulation after exposure to 5 Gy using 100 kV energy. 
Batch ΔOD Mean SD  
1 0.0582 0.29 
2 0.0543 0.22 
3 0.0557 0.27 
4 0.0552 0.23 
 
In addition, the influence of the AuNPs on bleaching (photofading) of 
the recorded ΔOD, and potential impact on recorded doses after delayed 
read-out times (e.g., dosimeter post-response stability) was investigated 
(Figure 7-9). It was found that the control dosimeters without and with 
AuNPs displayed minimal (6.3 and 4.5% respectively) photofading after 168 
hours post-irradiation when stored in a cold (-18 °C) and dark environment 
to avoid any accidental exposure to ultraviolet or visible light.  
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Figure 7-9: Variation in ΔOD over time for the control and control+0.5mM AuNPs 
formulations after exposure to 10 Gy using 100 kV energy. Error bars: ± standard 
deviation (n = 3). 
 
7.4 Discussion 
In agreement with other published studies, this chapter represents the 
first experimental demonstration that AuNPs, as a result of their high Z 
number, can preferentially absorb more low-energy X-rays than tissue and 
may be utilised to achieve a localised radiation dose enhancement in areas 
doped with AuNPs using 3D dosimetry. This enhancement is profound when 
irradiating the target with kilovoltage X-rays where photoelectric effects are 
dominant and AuNPs provide high probability cross section for photon 
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interaction by photoelectric effects. The high LET and short range of 
photoelectric interaction products produce localised dose enhancement in the 
areas doped with AuNPs. In the SMART dosimeter system, the Auger 
electrons produced are hypothesised to promote radical formation from 
halocarbons and radiolytic oxidation of the LMG dye. Consequently, this 
leads to superior radiation-induced OD change effects in the compartment of 
the SMART dosimeter containing AuNPs. 
In addition, it has been demonstrated in this chapter that the control 
formulation of the SMART dosimeter has an identical Zeff to water and can 
therefore be used to mimic the interactions between radiations and tissue. 
Furthermore, the principle of a novel multi-compartment phantom 
radiochromic dosimeter introduced here allows the tailorable design and 
fabrication of dosimeters with multiple compartments seamlessly fused 
together in the same device, mimicking a tumour loaded with AuNPs 
surrounded by normal tissues, which in our opinion provides a useful 
analogy to  real patient dosimetric situation. Future studies are expected to 
elucidate the influence of AuNPs characteristics on 3D dose distribution and 
dose to surrounding critical structures; in particular the downstream effects 
for tissues beyond the dose enhancement region, which should experience a 
dose-sparing effect. Although a single radiation field was used in this 
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chapter, more complex beam arrangements and treatment delivery 
techniques could also be employed in order to quantify the net effect. The 
ultimate potential clinical application of the SMART dosimeter is as a relative 
3D dosimeter for nanoparticle-enhanced radiotherapy. An intermediate 
application would likely include the validation of planning calculations 
incorporating the dose enhancement effects of nanoparticle infusion of 
targets.  
The work reported in this chapter presents several important 
innovations and advancements including the development of a 3D 
radiochromic dosimeter that mimics the radiological properties of water, and 
a process for fabricating multi-compartment 3D radiation dosimeters with 
nanocomposites. Also, a direct experimental confirmation of the metal 
nanoparticle-enhanced radiotherapy has been demonstrated for the first time. 
Collectively, these unique characteristics highlight that the SMART dosimeter 
is an extremely versatile and efficient independent method of experimentally 
modelling the interactions between radiations and metal nanoparticles; in 
particular, in clinical or research centres where metal nanoparticle-enhanced 
radiotherapy is of interest. For example, bismuth nanoparticles (BiNPs) and 
bismuth sulfide nanoparticles (Bi2S3) have been shown to enhance in vivo 
imaging with no reported toxicity, and theoretical calculations have predicted 
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higher radiation dose enhancement with bismuth than gold [119, 155]. 
However, considering the extensive investigations involving 
radiosensitisation using AuNPs, no investigations have been carried out to 
investigate the potential superiority of BiNPs over AuNPs. Therefore, the 
SMART dosimeter system could be utilised to compare both types of 
nanoparticles in terms of dose enhancement prior to conducting potential in 
vitro or in vivo investigations. Such comparison between gold and bismuth 
nanoparticles using the SMART dosimeter system has been carried and is the 
subject of Chapter 8.  
Finally, the SMART dosimeter introduced here has the following 
potential limitations: Although the concentration of AuNPs used in this study 
(0.5 mM) is commonly used in previously mentioned studies, a significant 
increase in the concentration (> 1.5 mM) might affect the optical clarity of the 
dosimeter hence, affecting both spectrophotometric and optical CT 
measurements. In addition, some metallic nanoparticles might not suspend 
efficiently in the polymer or aggregate. However, this might be another 
advantage of this dosimeter since studies have shown that AuNPs form 
clusters of 300–500 nm in diameter inside cellular compartments [126]. 
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7.5 Conclusion 
In this chapter, we have developed the first multi-compartment 
polymer nanocomposite 3D radiation dosimeter and demonstrated how its 
unique properties can be exploited to experimentally study metal 
nanoparticle-radiation interactions in 3D. The overall results of this study 
are in good agreement with previous Monte Carlo simulations, and in vivo 
and in vitro studies. However, the significance of the SMART dosimeter 
resides in the ability to perform comprehensive experimental 3D 
visualisation of nanoparticle-enhanced radiotherapy, which cannot be 
performed using any of the previously mentioned methods; this includes 
the ability to acquire 3D visualization of radiation dose distributions and 
hence, the ability to compare between the 3D spatial aspects of the 
radiation dose distribution in areas loaded with nanoparticles and 
normal/control areas. In addition, the SMART dosimeter provides the 
unique opportunity to conduct more complex investigations to answer 
questions that are of tremendous importance, such as the influence of 
particle composition, size, concentration and morphology on radiation 
dose enhancement.  
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Chapter 8 
Initial Investigations of the Dose 
Enhancement by Bismuth 
Nanoparticles using a Novel Multi-
compartment 3D Radiochromic 
Dosimeter  
 
8.1 Summary 
In the previous chapter it was shown that the SMART dosimeter could 
be utilised as a dosimeter and a phantom simultaneously in the dosimetry of 
nanoparticle-enhanced radiotherapy. The previous chapter also documented 
the first phantom-based experimental confirmation of the nanoparticle-
enhanced radiotherapy using the well-investigated gold nanoparticles 
(AuNPs). Although previous studies have focused on AuNPs, no studies 
have been conducted to investigate the potential of other high atomic number 
(Z) nanomaterials, such as bismuth-based nanoparticles. Therefore, in this 
chapter, the first experimental validation and quantification of the dose 
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enhancement capability of commercially available forms of bismuth 
nanoparticles (bismuth oxide (Bi2O3-NPs) and bismuth sulfide (Bi2S3-NPs)) 
and their potential superiority over AuNPs in terms of radiation dose 
enhancement have been investigated. Dosimeter cuvettes doped with and 
without nanoparticles and different SMART dosimeter arrangements were 
employed for measuring radiation dose enhancement produced from the 
interaction of X-rays with metal nanoparticles, and to investigate the 3D 
spatial distribution of ionising radiation dose deposition. Dosimeters were 
irradiated with kilovoltage and megavoltage X-ray energies and doses were 
calculated using a spectrophotometer and optical CT scanner.  The radiation 
dose enhancement factors (DEFs) obtained for ca. 50 nm diameter Bi2O3-NPs 
and AuNPs were 1.90 and 1.77, respectively, for 100 kV energy and a 
nanoparticle concentration of 0.5 mM. In addition, the DEFs of ca. 5 nm 
diameter Bi2S3-NPs and AuNPs were determined to be 1.38 and 1.51, 
respectively, for 150 kV energy and a nanoparticle concentration of 0.25 mM. 
The results demonstrate that both bismuth-based nanoparticles can enhance 
the effects of radiation.  The DEF of Bi2O3-NPs was 12% more than AuNPs of 
the same size, whereas the DEF for Bi2S3-NPs was 13% lower than AuNPs of 
the same size for kV energies. For 6 MV energy the DEFs for all the 
investigated nanoparticles were lower (< 15%) than with kilovoltage energy.  
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8.2 Introduction 
As experimentally demonstrated in the previous chapter, a 
combination of low-energy ionising radiation and heavy metal nanoparticles 
(i.e., AuNPs) enhances the effects of radiation. A preferential increase of 
photoelectric interactions produce a localised boost in radiation dose within 
tissue loaded with such metal nanoparticles compared to normal tissue [120, 
168]. This was attributed mainly to the low energy free radicals (such as 
Auger electrons and photoelectrons). In addition, the radiation dose 
enhancement capabilities of high Z nanoparticles have been predicted using 
Monte Carlo simulations [126, 143, 222], and in vitro studies have 
demonstrated that AuNPs  are excellent radiation enhancing agents for 
cancer radiotherapy [120-125]. However, it was not until very recently that 
the radiation dose enhancement effect of AuNPs was quantified and 
validated experimentally [19]. 
Among the currently studied nanoparticles, gold (Au) and bismuth 
(Bi)-based nanomaterials are emerging as promising candidates for 
biomedical applications [119, 120]. AuNPs in particular have been shown to 
enhance in vivo imaging [138, 223, 224], as well as being efficient radiation 
dose enhancing agents in in vitro investigations [120, 123, 141, 142]. In 
comparison, relatively few studies have been conducted with bismuth-based 
 228 
nanoparticles, although their large X-ray mass attenuation coefficient (Bi: 
5.74, Au: 5.16 cm2 kg − 1 at 100 kV) makes them particularly attractive as 
contrast agents [119, 153, 154], which has been demonstrated in in vivo 
computed topography (CT) imaging studies [154].   
Considering the extensive investigations involving radiation dose 
enhancement using AuNPs [105], it is surprising that no studies have 
previously been conducted to investigate the potential efficiency of using 
bismuth-based nanoparticles as radiation dose enhancing agents. As a result 
of bismuth’s larger atomic number (Z = 83) compared to gold (Z = 79) and the 
~Z4 relationship to photoelectric cross section, bismuth-based nanoparticles 
would be expected to enhance the effects of low-energy X-rays (through 
photoelectric interactions) to a greater extent. Furthermore, there are a 
number of advantages of using bismuth-based nanomaterials as radiation 
dose enhancement agents. Firstly, despite its location amid toxic heavy metals 
in the periodic table, bismuth and most of its compounds are considered 
harmless [152]. For example, Pepto-Bismol® is a widely available over-the-
counter medicine in the USA for stomach disorders [152, 225]. In addition, 
bismuth nanoparticles have been shown to possess low toxicity and leave no 
residue in organisms [119, 153]. Secondly, bismuth nanoparticles can be 
readily prepared in various well-defined shapes and sizes [226, 227], and with 
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(bio)functional surface coatings [153]. Finally, bismuth is one of the least 
expensive of the high Z elements [154]. 
Therefore, the aim of this chapter was to demonstrate the applicability 
of using bismuth-based nanoparticles as dose enhancing agents and 
investigate their potential superiority over AuNPs in terms of improving the 
efficiency of radiotherapy treatment. As in the previous chapter, the radiation 
dose enhancement produced from the interaction of X-rays with both 
bismuth nanoparticles and AuNPs was investigated using a tissue equivalent 
SMART dosimeter. The nanoparticles were homogeneously dispersed within 
the dosimeters and following irradiation the dose enhancement was 
calculated by quantitatively comparing the radiation induced change in 
optical density of the dosimeter. The dosimeters were specifically formulated 
to be tissue equivalent in terms of their radiological properties, which is 
particularly important for clinical radiation dosimetry where exact tissues 
mimics are required to avoid any corrections and approximations. In 
addition, undoped and nanoparticle-doped dosimeters were fabricated in 
spectrophotometric cuvettes to evaluate the linearity of the dosimeters after 
irradiation, to compare the absorption spectrum and to calculate the dose 
enhancement factor (DEF) of the nanoparticles. 
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8.3 Bismuth nanoparticles 
Bismuth is readily oxidised by atmospheric oxygen, and is therefore 
mainly available in air-stable bismuth oxide (Bi2O3) or bismuth sulfide forms 
(Bi2S3) [152]. Bi2O3 contains more elemental bismuth than Bi2S3 (90 and 80 wt% 
bismuth, respectively), thus an equivalent mole quantity of Bi2O3 would be 
expected to enhance the radiation dose more than Bi2S3. Nevertheless, both 
Bi2O3-NPs and Bi2S3-NPs were selected for this investigation. Description of 
nanoparticles synthesis can be found in Chapter 2 (section 2.4.6.2). 
It is imperative to point out that the goal of this chapter was not to 
compare between the metal content of each type of nanoparticles in term of 
dose enhancement, but rather the different nanoparticles as a whole (e.g., 
size, type of metal). 
8.4 Results and discussion 
8.4.1 Dose enhancement using bismuth oxide nanoparticles  
As in Chapter 7, the SMART dosimeter employed for this study was a 
cylinder-in-cylinder configuration consisting of an inner compartment doped 
with 50 nm diameter Bi2O3-NPs (Figure 8-1a) and an undoped outer 
compartment. Description of the fabrication of the SMART dosimeters can be 
found in Chapter 2 (section 2.4.5). 
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The SMART dosimeter after exposure to 100 kV X-ray energy is shown in 
Figure 8-1.The inner Bi2O3-NPs doped compartment of the dosimeter 
displayed a significantly higher deposition of radiation dose (> 80%) 
compared with the surrounding control compartment (Figure 8-1b). The 
significant change in dose deposition in the area doped with Bi2O3-NPs is 
caused solely by the presence of radiation absorbing elements (bismuth) in 
the SMART dosimeter.  
 
 
Figure 8-1: (a) Photographs of the actual SMART dosimeter doped with 0.50 mM 
Bi2O3-NPs (50 nm diameter) after irradiation at 100 kV. (b) Reconstructed radiation 
dose distribution at a depth of 1 cm into the dosimeter from the irradiated surface. 
The centre of the SMART dosimeter surrounded by a dashed line represents the 
area doped with Bi2O3-NPs.  
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When exposed to kV X-ray energies, photo-absorption in the Bi2O3-
NPs doped inner compartment of the SMART dosimeter causes an 
instantaneous emission of low energy photoelectrons and Auger electrons, 
which are believed to be responsible for the radiation dose enhancement [120, 
228]. This can also be observed clearly in the transverse plane (Figure 8-1b, 
central area with dashed borders), where there is a local boost in radiation 
dose in the compartment doped with Bi2O3-NPs. Therefore, the gain from 
utilising Bi2O3-NPs in terms of a localised boost in radiation dose, relative to 
the dose to surrounding structures is clearly demonstrated for the first time 
here by comparing the 3D dose distribution between the control and doped 
compartments given by the optical CT.  
In addition, the boost in optical density in the Bi2O3-NPs doped area 
can also be seen when plotting optical density line profiles through different 
transverse planes of the SMART dosimeter (Figure 8-2) and depth dose 
curves (Figure 8-3). From the optical CT measurement, the DEF was 
determined to be 1.94 (SD = 0.13) by taking the ratio of the ΔOD at the centre 
of the Bi2O3-NPs doped compartment relative to the undoped compartment 
throughout the effective depth of the dosimeter and taking the average value. 
The significance of this result lies in the fact that all radiotherapy involves a 
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collateral dose to surrounding normal tissue. Thus, the aim in radiotherapy is 
always to maximise the therapeutic ratio, i.e., to deliver at least the required 
dose to the target, while keeping the dose to healthy tissue as low as possible. 
With a DEF of almost 2, the clinically effective prescribed dose can be 
delivered to the tumour while exposing the patient to approximately half as 
much radiation, thereby halving the risk of secondary cancer induction in 
healthy tissue (under the Linear-No-Threshold assumption). Complications 
in nearby organs at risk (OAR) receiving significant doses as a result of their 
proximity to the treatment field would also be reduced. Therefore, the unique 
multi-compartment arrangement of the SMART dosimeter allows 
quantification of the dose reduction achievable in regions surrounding the 
nanoparticle doped region. 
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Figure 8-2: ΔOD line profiles through the transverse plane at different depths of 
the SMART dosimeter. (Z) refers to the depth from the irradiated surface of the 
dosimeter. 
 
 
Figure 8-3: Variation in ΔOD with depth through the undoped and 0.5mM Bi2O3-
NPs doped compartments of the SMART dosimeter. The actual SMART dosimeter 
is shown in the insets. 
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In order to validate the DEF values obtained with Bi2O3-NPs and 
AuNPs, nanoparticle-doped spectrophotometric dosimeter cuvettes were 
employed to measure the radiation-induced ΔOD caused by the 
nanoparticles when irradiated using kV energy X-rays. As a control and 
reference, dosimeter cuvettes were also prepared without nanoparticles and 
irradiated using identical parameters. To eliminate nanoparticle size as a 
variable, 50 nm diameter Bi2O3-NPs and AuNPs (synthesised as previously 
described [19]) were used. In addition, different concentrations of 
nanoparticles (0.10, 0.25 and 0.50 mM) were used to investigate the 
relationship between dose enhancement and concentration of nanoparticles. 
The ∆OD versus the applied radiation dose was measured at λ 633 nm for all 
of the dosimeter cuvettes (Figure 8-4). Overall, excellent correlation 
coefficient linearity (R2 > 0.999) for the dose response was observed for both 
the control and nanoparticle doped dosimeters over the applied radiation 
dose range (Figure 8-4). The dose-response linearity of the dosimeters doped 
with Bi2O3-NPs and AuNPs is a good indication that the nanoparticles are 
homogeneously dispersed throughout the polymeric matrix [19]. However, it 
is generally agreed that nanoparticles do not distribute homogeneously in 
targets, but rather form small clusters/aggregates in different cellular 
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compartments [125, 147]. This distribution is also heavily influenced by the 
surface chemistry/functionality of the particles. It has been shown than 
AuNPs form clusters of 300-500 nm in diameter in cell vesicles, and these 
clusters function effectively as a single large nanoparticles [126]. This infers 
that a tumour (as a whole) would arguably have a fairly uniform distribution 
of these nano-clusters on a macroscopic scale. If desired, it would be possible 
to fabricate a SMART dosimeter with nanoparticles of diameters similar to 
those of the reported clusters (300-500 nm), although this is outside the scope 
of this study. 
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Figure 8-4: Recorded ∆OD as a function of applied radiation dose for the undoped 
control and nanoparticle doped dosimeter cuvettes with different concentrations 
(0.10, 0.25 and 0.50 mM) of (a) AuNPs and (b) Bi2O3-NPs irradiated with 100 kV 
energy X-rays. Correlation coefficient parameters of each fitted line are shown in 
the inset. Error bars: ± standard deviation (n = 3). The data means are significantly 
different (p<0.05). 
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For the dosimeter cuvettes the DEF was determined from the ratio 
between the slope of the dosimeter doped with metal nanoparticles and the 
slope of the undoped dosimeter (control). The calculated DEFs for 100 kV 
energy X-rays are summarized in Table 8-1. For 100 kV energy X-rays, both 
Bi2O3-NPs and AuNPs displayed a significant dose enhancement effect (DEF 
= 1.90, 1.77, respectively) at a nanoparticle concentration of 0.50 mM. 
Although the effective atomic number of Bi2O3 (Zeff = 80) is almost identical to 
Au (Zeff = 79), the Bi2O3-NPs were found to enhance the effect of kV X-rays 
12% more than the AuNPs. Also, it was noted that the DEF obtained from the 
3D dosimeter and optical CT results (DEF = 1.94) was slightly higher than that 
obtained from the spectrophotometric analysis (DEF = 1.90). The slight 
discrepancy between these measurements could be attributed to a small 
volume averaging contribution over the depth of the cuvettes and a depth-
averaged result from the optical CT scanner. In addition, the DEFs were 
found to increase with nanoparticle concentration, which is in good 
agreement with previous theoretical studies [120]. However, the increase in 
DEF with increasing nanoparticle concentration did not appear to follow a 
linear relationship, indicating that significant dose enhancement could still be 
achieved with much lower nanoparticle concentrations [123]. The apparent 
non-linear relationship between DEF and nanoparticle concentration is 
 239 
currently the subject of further investigations. For 6 MV energy X-rays, a 
small enhancement (< 15%)  was observed for both Bi2O3-NPs and AuNPs, 
which is in good agreement with previous studies [123, 126, 142], and results 
from the fact that, with megavoltage energies, photoelectric absorption is not 
the dominant interaction process [120, 122].  
 
Table 8-1: Calculated DEFs for the different concentrations of 50 nm diameter 
Bi2O3-NPs and AuNPs irradiated with 100 kV energy X-rays.  
Nanoparticle 
concentration 
(mM) 
DEF 
  AuNPs Mean SD Bi2O3-NPs Mean SD 
0.10 1.45 0.0012 1.52 0.0016 
0.25 1.60 0.0018 1.67 0.0015 
0.50 1.77 0.0032 1.90 0.0024 
 
The absorption spectra of selected nanoparticle-doped dosimeter 
cuvettes and the control dosimeter after irradiation using 100 kV energy X-
rays are shown in Figure 8-5.  
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Figure 8-5: A comparison between the absorption spectra of the control and 
sample dosimeter cuvettes with different concentrations of AuNPs and Bi2O3-NPs 
after irradiation with 10 Gy, using 100 kV energy X-rays.   
 
As in previous chapters, the absorption maximum (λmax) was found to 
peak at the red region of the spectrum (ca. 633 nm), which is a typical visible 
absorption λmax of the oxidised form of Leucomalachite green (LMG) and is in 
good agreement with previously published results [19, 72]. In addition, such 
absorption maxima corresponds to the helium-neon laser output or LED 
source (633 nm) of the commercially available optical scanning systems [72]. 
Therefore, 3D dosimetry using these systems could be utilised with optimum 
sensitivity 
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Figure 8-6: Variation in ΔOD over time for the control and control+0.5mM AuNPs 
and Bi2O3-NPs dosimeter formulations after exposure to 10 Gy using 100 kV 
energy. Error bars: ± standard deviation.  
 
The post-response stability of the dosimeter cuvettes with and without 
0.5 mM of Bi2O3-NPs and AuNPs are shown in Figure 8-6. The results 
demonstrate that both types of nanoparticles have no influence on the post-
response photo-stability of the dosimeters over the period studied. In terms 
of interbatch and intrabatch consistency, the dosimeters with Bi2O3-NPs 
exhibit small interbatch consistency (< 4%), and negligible intrabatch 
consistency (< 0.5%), which are similar to those obtained for the AuNPs 
doped dosimeters [19]. 
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8.4.2 Dose enhancement using bismuth Sulfide nanoparticles  
In this section, a comparison between 5 nm diameter Bi2S3-NPs and 
AuNPs was conducted to determine their dose enhancing capabilities. To 
allow simultaneous irradiation of both nanoparticles a new SMART 
dosimeter arrangement was employed, which consisted of an undoped outer 
compartment with two inner cylinder cavities doped with either Bi2O3-NPs or 
AuNPs (0.25 mM concentration) (Figure 8-7a). In addition, dosimeters 
cuvettes were also fabricated with and without the nanoparticles (Figure 8-
7b). Description of the fabrication of the SMART dosimeters can be found in 
Chapter 2 (section 2.4.4) 
 
Figure 8-7: (a) Photograph of the SMART dosimeter doped with 0.25 mM of Bi2S3-
NPs and AuNPs after irradiation with a dose of 10 Gy. (b) Dosimeter cuvettes with 
and without Bi2S3-NPs and AuNPs before and after irradiation with a dose of 20 
Gy. All dosimeters were irradiated using 150 kV energy.  
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The SMART dosimeter after 150 kV irradiation is shown in Figure 8-8. 
It can clearly be observed that the Bi2S3-NPs increase the radiation dose 
deposition in a similar fashion to AuNPs; two localised boosts in optical 
density are clearly visible on the reconstructed cross-sectional radiation 
induced ΔOD (Figure 8-8a) and the 3D rendering of the radiation induced 
ΔOD within the SMART dosimeter (Figure 8-8b). However, unlike Bi2O3-NPs, 
the dose enhancement achieved with Bi2S3-NPs was lower than that gained 
with AuNPs, with the optical CT measurements providing DEFs of 1.41 and 
1.54, respectively (SD = 0.11). These values were calculated by taking the ratio 
for ΔOD at the centre of the Bi2S3-NPs and AuNPs doped compartments 
relative to the undoped compartment throughout the effective depth of the 
dosimeter and taking the average DEF value. The lower enhancement with 
Bi2S3-NPs (DEF = 1.41) relative to Bi2O3-NPs (DEF = 1.67) at a concentration of 
0.25 mM could be attributed to several factors, including the lower elemental 
content of bismuth in the sulfide form relative to the oxide form (80 and 90 
wt% bismuth, respectively), or the difference in nanoparticle size. These 
differences are the subject of continuing investigations.  
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Figure 8-8: (a) Reconstructed radiation dose distribution at a depth of 1 cm into the 
dosimeter from the irradiated surface. (b) 3D rendering of the radiation induced 
ΔOD within the SMART dosimeter used.  
 
In addition, the increase in optical density in the compartments doped 
with Bi2S3-NPs and AuNPs were apparent when plotting optical density line 
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profiles through different sagittal planes of the SMART dosimeter (Figure 8-
9).  
 
 
Figure 8-9: Variation in ΔOD with depth through the undoped and 0.25mM Bi2S3-
NPs and AuNPs-doped compartments of the SMART dosimeter used.  
 
The measured ∆OD versus the radiation absorbed dose at λ = 633 nm 
for the dosimeter cuvettes are shown in Figure 8-10. As in the previous 
results, excellent correlation coefficient linearity (R2 > 0.999) for the dose 
response was observed for both dosimeter compositions (with and without 
nanoparticles) over the applied radiation dose range and energies (Figure 8-
10). The DEFs were calculated to be 1.51 and 1.38 for AuNPs and Bi2S3-NPs, 
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respectively, which were very similar to the values obtained using the 
SMART dosimeter  
 
 
Figure 8-10: Recorded ∆OD as a function of applied radiation dose for the 
undoped control and nanoparticle doped dosimeter cuvettes with 0.25 mM of 
AuNPs Bi2S3-NPs irradiated with 150 kV energy X-rays. Correlation coefficient 
parameters of each fitted line are shown in the inset. Error bars: ± standard 
deviation (n = 3). The data means are significantly different (p<0.05). 
 
In addition, it was noted that nanoparticles with larger diameter with 
greater sizes increased the generation of secondary electrons thus, increasing 
dose deposition. For example, at 0.25 mM concentration, 50 nm diameter 
AuNPs provided higher DEF compared with 5 nm diameter AuNPs (DEF= 
1.60 and 1.38, respectively).This could be because the portion of higher 
 247 
energy photons from a given poly-energetic beam spectrum which have less 
of a probability of interacting with a small particles than a larger one [147]. 
8.5 Conclusion 
This chapter provides the first experimental evidence of the efficacy of 
two different types of bismuth-based nanoparticles as radiation dose 
enhancement agents. In addition, the radiation dose enhancement achieved 
with Bi2O3-NPs and Bi2S3-NPs compared to the well-studied AuNPs were 
presented. Overall, Bi2O3-NPs showed a 12% additional dose enhancement 
benefit over that exhibited by AuNPs whereas Bi2S3-NPs showed a 13% lower 
dose enhancement than AuNPs when irradiated under identical conditions. 
However, further studies are required to fully understand the effect of other 
elements in the bismuth-based nanoparticles on their DEFs. The enhancement 
for all of the nanoparticles was greatest when irradiating the target with kV 
X-rays, where photoelectric effects are dominant. Meanwhile, low DEFs (< 
15%) were obtained for all nanoparticles with 6 MV energy X-rays since 
photoelectric absorption is not the dominant interaction process [120, 122].  
Considering the fact that bismuth is non-toxic, can be readily prepared 
in nanoparticle form, and is one of the least expensive heavy metals, further 
investigations to fully understand the processes of radiation dose 
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enhancement achieved by bismuth-based nanomaterials are clearly justifiable 
based upon this study. 
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Chapter 9 
Conclusions and Future Directions  
 
9.1 Conclusions  
The inspiration behind this work is the belief that a better 
understanding of current 3D dosimeters and development of novel ones will 
promote clinical applications of 3D dosimetry for delivery of more effective 
and efficient radiotherapy. In addition, exploiting 3D dosimetry in evaluating 
the efficiency of different nanoparticles in enhancing the effects of radiation, 
and to answer the lingering questions about the radiosensitisation capabilities 
of metal nanoparticles will bring their utilisation into clinical radiotherapy 
practice forward. Therefore, the two main objectives of this thesis were, 
firstly, to carry out a series of PRESAGE® dosimeter component-specific 
studies to optimise each of its main components and explore the possibilities 
of including novel components in the formulation, and secondly, to develop 
an independent dosimetric method that reveals the way in which metal 
nanoparticles interact with ionising radiation in a 3D environment. Results 
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obtained from this thesis have provided a comprehensive understanding of 
how the PRESAGE® dosimeter operates and how each of its typical and novel 
components could be used for optimisation to suit specific dosimetric 
situations, and developed a novel independent method for nanoparticle-
enhanced radiotherapy dosimetry. The major findings of this thesis include 
the following: 
 The thesis describes an investigation into the influence of iodoform, 
bromoform and chloroform radical initiators on the general characteristics of 
the PRESAGE® dosimeter. It has been observed that the incorporation of 
different radical initiators in the composition of the PRESAGE® dosimeter 
resulted in variation of the radiation dose sensitivity and radiological 
properties of the dosimeters depending on the type and the concentration of 
the radical initiator used, with iodoform showing the highest dose-response 
slope followed by bromoform and finally chloroform. In addition, this 
enhancement in dose-response was found to be directly related to the carbon-
halogen bond dissociation energy and to the radiological properties of each 
individual radical initiator used in this study.  
 In this thesis, newly synthesised LMG derivatives (with either 
methoxy, chlorine or bromine substituents) were investigated for potential 
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use in the composition of the commercial PRESAGE® dosimeter. In general, 
all new LMG derivatives showed significant improvement over the currently 
available commercial version. In addition, they also had negligible influence 
on the typical characteristics of the PRESAGE® dosimeter. In addition, all 
LMG dyes investigated in this work showed similar post-response 
photofading characteristics except the methoxy-LMG derivative, which 
showed a slight improvement in post-response photo-retention. It has been 
recommended that, where higher sensitivity is required, the commercial 
LMG used in the composition of the PRESAGE® dosimeter be replaced by any 
of the newly synthesised derivatives, especially the bromine-substituted 
LMG. 
 A chemical scheme of radical-induced oxidation of LMG has been 
proposed.  It takes place through the abstraction of the hydrogen atom from 
the tertiary carbon in LMG; the removal of this particular atom results in an 
organic free radical that is stabilised by conjugation of electrons from the lone 
pair of nitrogens via the aromatic groups. Subsequent electron transfer results 
in the formation of MG (green colour), the cationic oxidised form of LMG 
(colourless) 
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 The radiation-modifying effects of incorporating commercially 
available bismuth, tin and zinc-based compounds in the composition of the 
PRESAGE® dosimeter have been investigated. It was established that, when 
metal compounds were incorporated in the composition of the PRESAGE® 
dosimeter, the sensitivity of the dosimeters to radiation dose increased 
depending on the type and concentration of the metal compound, with the 
bismuth compound showing the highest dose enhancement factor. In 
addition, due to their chemical structure, these metal compounds were also 
shown to improve the retention of the post-response absorption value of the 
PRESAGE® dosimeter over a period of 2 weeks.  
 It was determined that incorporating 1-3 mM of any of the three 
investigated metal compounds in the composition of the PRESAGE® 
dosimeter results in an efficient way of enhancing the sensitivity of the 
dosimeter to radiation dose and to stabilise its post-response reading for 
longer times. Furthermore, the addition of small amounts of the metal 
compounds reduces the fabrication time significantly because of their 
catalysing properties, therefore, enabling rapid dosimetric measurements and 
optimisation of radiotherapy treatment plans. Further attempts to increase 
the concentration of metal compounds in the formulation of the PRESAGE® 
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dosimeter (>10 mM) has been found to lead to significant deviation in the 
dosimeter’s radiological properties from water. 
 Novel metal-optimised PRESAGE® dosimeters were formulated for 
use in both megavoltage and kilovoltage beams dosimetry. Their water-
equivalency was evaluated both theoretically and experimentally.  It was 
shown that, unlike the commercial formulation, all novel PRESAGE® 
dosimeter formulations with metal compounds were water-equivalent,  had 
the typical characteristics and can be measured using the same dose readout 
systems used for the commercial PRESAGE® dosimeters. They were 
recommended for kilovoltage and megavoltage beams dosimetry without the 
need to apply dosimetric correction factor/s. 
 A novel independent dosimetric method that reveals the way in which 
nanoparticles interact with ionising radiation and the 3D spatial dose 
distributions of the dose enhancement has been developed. It has been 
denoted the SMART dosimeter. The fabrication method of the SMART 
dosimeter has allowed the imitation of a target volume/s surrounded by 
healthy structures.  
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 A novel method for investigating the dependence of the DEFs and the 
3D spatial aspects of the radiation dose distribution on composition, aspect 
ratio, and polymer coating of the nanoparticles has been introduced. 
 The thesis has yielded the first experimental insights concerning the 
spatial distributions and elevated dose in target volumes bearing 
nanoparticles, which cannot be performed using methods such as Monte 
Carlo simulation and in vitro biological investigations, and provided the first 
phantom-based direct experimental confirmation of metal nanoparticle-
enhanced radiotherapy using AuNPs. 
 Research into exploiting bismuth-based nanoparticles as radiotherapy 
enhancing agents has been pioneered in this thesis. Utilising the SMART 
dosimeter, a 3D quantification of the DEF produced by bismuth oxide and 
bismuth sulfide nanoparticles has revealed that in general bismuth-based 
nanoparticles were efficient dose enhancing agents, and have great potential 
for applications in clinical radiotherapy.  
9.2 Future directions 
Indeed, this research has answered many questions and also 
provided the opportunity to investigate theories and ideas not previously 
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obtained; as such, there are ample experimental and theoretical investigations 
to be tackled in future. As a continuation to the initial work, the following 
investigations are currently being undertaken to complement the initial 
findings; 
 Megavoltage electron beam represent an important treatment modality 
in modern radiotherapy; because electrons have a short range in tissues (less 
than 5 cm deep), it is often used in the treatment of superficial tumours. As 
electrons travel through a medium, they interact in ways that differ from that 
of photons. Because the PRESAGE® dosimeter does not require a container 
and hence can measure surface doses, an investigation into the feasibility of 
using the PRESAGE® dosimeter as a relative dosimeter in electron 
radiotherapy is suggested.  
 PRESAGE® dosimeters containing organoiodine or organobromine 
compounds (high sensitivity to radiation), or a combination, that are very 
sensitive to radiation dose should be investigated for their feasibility in 
measuring low radiation doses (< 100 mGy), such as those delivered by 
diagnostic imaging scanners.  
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Meanwhile, the feasibility of using PRESAGE® dosimeters containing 
organochlorine (low sensitivity to radiation) compounds in special cases 
where very high radiation doses (> 150 Gy) are delivered to targets such as in 
microbeam radiotherapy should be carried out. 
 It would also be valuable to replace the polyurethane plastic that forms 
the 3D matrix for the PRESAGE® dosimeter by transparent polyurethane 
rubber which is deformable. This would allow the development of a 
deformable dosimeter for experimental validation of deformable dose 
calculation algorithms.  
Furthermore, in this thesis, the SMART dosimeter was developed and 
has been employed to measure the 3D spatial aspect of the dose enhancement 
produced in target volumes bearing nanoparticles. Also, to compare between 
gold and bismuth nanoparticles. However, the SMART dosimeter approach 
would allow various valuable investigations in addition to its initial usage, 
which is nanoparticle-enhanced radiotherapy dosimetry. A few of these 
investigations that are currently in progress are outlined below: 
 The SMART dosimeter can be used to simulate inhomogeneity in 
tissues, leading to many clinical applications such as the determination of the 
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dose distributions inside and around an inhomogeneity in 3D for advanced 
techniques such as IMRT and tomotherapy. The procedure would be to 
conduct a whole treatment chain test from imaging to treatment using the 
SMART dosimeter as a phantom in place of the patient. This would represent 
a unique way of determining dose distribution in 3D in and surrounding an 
inhomogeneity and could be used for treatment validation.  
 In a similar way, the SMART dosimeter can be used in some cases to 
validate the dose inside a tumour and surrounding it in the healthy structures 
and the best way of experimentally validating that would be to employ the 
SMART dosimeter in a similar way to that explained above. 
 In proton therapy, which is becoming an increasingly attractive 
treatment modality, the change of the range (and hence position of the Bragg 
peak) when the beam passes through an inhomogeneity, including tumours, 
has been a challenging issue. It is anticipated that it would be possible to 
validate the range change in such SMART dosimeter and include such 
changes in the treatment plan before delivery to patients.  
 The method of the SMART dosimeter fabrication also allows the 
fabrication of phantoms that can be located by optical or radiological image 
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guidance using intrinsic density variation. The registration of the image 
guidance with the treatment radiation is then obtained by irradiating the 
phantom and measuring the displacement from the planned position. 
 Considering that, bismuth is not toxic, can be made into nanomaterials 
and readily functionalised, and one of the least expensive heavy metals, the 
results obtained from this thesis recommend further Monte Carlo 
simulations, in vitro, and in vivo investigations involving bismuth-based 
nanoparticles to validate and fully understand dose enhancement achieved 
by bismuth-based nanoparticles.   
 Results obtained from this thesis have answered some of the lingering 
questions about the radiosensitisation capabilities of metal nanoparticles. 
Studies are currently being conducted by our group to answer other 
important questions such as:  (1) How does the photon energy, nanoparticles 
aspect ratio, and polymer coating influence the spatial distribution of the 
dose generated in the entire target and surrounding normal structures; (2) 
How would other high Z, less expensive, and non-toxic metal nanopartciles 
such as bismuth (Z = 83) and tantalum (Z = 73) compare to gold in terms of 
dose enhancement, photon energy dependency, etc. Instead of conducting 
multiple experiments to answer these questions, the SMART dosimeter is 
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currently being employed to allow a macroscopic comparison between the 
different metal nanoparticles exposed to different energies in terms of dose 
enhancement and 3D spatial dose distribution. Such findings are of 
tremendous importance in defining the optimal use of metal nanoparticles as 
radiosensitisers as part of a potential clinical strategy. 
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